Document:

EX-4.1

 Exhibit 4.1 

Execution Version 
  

 
 SENIOR NOTES INDENTURE 

Dated as of January 8, 2021 

Between 
 EQM MIDSTREAM PARTNERS,
LP 
 and 
 THE BANK OF NEW YORK
MELLON TRUST COMPANY, N.A., 
 as Trustee 

4.50% SENIOR NOTES DUE 2029 
 4.75%
SENIOR NOTES DUE 2031 
  
  

 TABLE OF CONTENTS 
  

							
	 	 	 	  	Page	 
	 ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 
	  	 	1	 
	 Section 1.01
	 	Definitions	  	 	1	 
	 Section 1.02
	 	Other Definitions	  	 	9	 
	 Section 1.03
	 	Rules of Construction	  	 	10	 
	 Section 1.04
	 	Acts of Holders	  	 	11	 
		
	 ARTICLE 2 THE NOTES 
	  	 	13	 
			
	 Section 2.01
	 	Form and Dating; Terms	  	 	13	 
	 Section 2.02
	 	Execution and Authentication	  	 	13	 
	 Section 2.03
	 	Registrar and Paying Agent	  	 	14	 
	 Section 2.04
	 	Paying Agent to Hold Money in Trust	  	 	14	 
	 Section 2.05
	 	Holder Lists	  	 	14	 
	 Section 2.06
	 	Transfer and Exchange	  	 	15	 
	 Section 2.07
	 	Replacement Notes	  	 	16	 
	 Section 2.08
	 	Outstanding Notes	  	 	16	 
	 Section 2.09
	 	Treasury Notes	  	 	16	 
	 Section 2.10
	 	Temporary Notes	  	 	17	 
	 Section 2.11
	 	Cancellation	  	 	17	 
	 Section 2.12
	 	Defaulted Interest	  	 	17	 
	 Section 2.13
	 	CUSIP and ISIN Numbers	  	 	17	 
		
	 ARTICLE 3 REDEMPTION 
	  	 	18	 
			
	 Section 3.01
	 	Notices to Trustee	  	 	18	 
	 Section 3.02
	 	Selection of Notes to Be Redeemed or Purchased	  	 	18	 
	 Section 3.03
	 	Notice of Redemption	  	 	18	 
	 Section 3.04
	 	Effect of Notice of Redemption	  	 	19	 
	 Section 3.05
	 	Deposit of Redemption or Purchase Price	  	 	20	 
	 Section 3.06
	 	Notes Redeemed or Purchased in Part	  	 	20	 
	 Section 3.07
	 	Optional Redemption	  	 	20	 
	 Section 3.08
	 	Mandatory Redemption	  	 	21	 
		
	 ARTICLE 4 COVENANTS 
	  	 	21	 
			
	 Section 4.01
	 	Payment of Notes	  	 	21	 
	 Section 4.02
	 	Maintenance of Office or Agency	  	 	21	 
	 Section 4.03
	 	Taxes	  	 	22	 
	 Section 4.04
	 	Stay, Extension and Usury Laws	  	 	22	 
	 Section 4.05
	 	Existence	  	 	22	 
	 Section 4.06
	 	Reports and Other Information	  	 	22	 
	 Section 4.07
	 	Compliance Certificate	  	 	23	 
	 Section 4.08
	 	Limitation on Liens	  	 	24	 
	 Section 4.09
	 	Limitation on Sale-Leaseback Transactions	  	 	26	 
	 Section 4.10
	 	Future Subsidiary Guarantors	  	 	26	 
	 Section 4.11
	 	Offer to Repurchase Upon Change of Control	  	 	26	 

  
 -i- 

							
	 	 	 	  	Page	 
	 ARTICLE 5 SUCCESSORS 
	  	 	29	 
			
	 Section 5.01
	 	Merger, Consolidation or Sale of All or Substantially All Assets	  	 	29	 
	 Section 5.02
	 	Successor Entity Substituted	  	 	30	 
		
	 ARTICLE 6 DEFAULTS AND REMEDIES 
	  	 	30	 
			
	 Section 6.01
	 	Events of Default	  	 	30	 
	 Section 6.02
	 	Acceleration	  	 	31	 
	 Section 6.03
	 	Other Remedies	  	 	32	 
	 Section 6.04
	 	Waiver of Past Defaults	  	 	32	 
	 Section 6.05
	 	Control by Majority	  	 	32	 
	 Section 6.06
	 	Limitation on Suits	  	 	33	 
	 Section 6.07
	 	Rights of Holders to Receive Payment	  	 	33	 
	 Section 6.08
	 	Collection Suit by Trustee	  	 	33	 
	 Section 6.09
	 	Restoration of Rights and Remedies	  	 	33	 
	 Section 6.10
	 	Rights and Remedies Cumulative	  	 	34	 
	 Section 6.11
	 	Delay or Omission Not Waiver	  	 	34	 
	 Section 6.12
	 	Trustee May File Proofs of Claim	  	 	34	 
	 Section 6.13
	 	Priorities	  	 	34	 
	 Section 6.14
	 	Undertaking for Costs	  	 	35	 
		
	 ARTICLE 7 TRUSTEE 
	  	 	35	 
			
	 Section 7.01
	 	Duties of Trustee	  	 	35	 
	 Section 7.02
	 	Rights of Trustee	  	 	36	 
	 Section 7.03
	 	May Hold Securities	  	 	37	 
	 Section 7.04
	 	Trustee’s Disclaimer	  	 	37	 
	 Section 7.05
	 	Notice of Defaults	  	 	37	 
	 Section 7.06
	 	Compensation and Indemnity	  	 	37	 
	 Section 7.07
	 	Replacement of Trustee	  	 	38	 
	 Section 7.08
	 	Successor Trustee by Merger, etc.	  	 	40	 
	 Section 7.09
	 	Eligibility; Disqualification	  	 	40	 
		
	 ARTICLE 8 LEGAL DEFEASANCE AND COVENANT DEFEASANCE 
	  	 	40	 
			
	 Section 8.01
	 	Option to Effect Legal Defeasance or Covenant Defeasance	  	 	40	 
	 Section 8.02
	 	Legal Defeasance and Discharge	  	 	40	 
	 Section 8.03
	 	Covenant Defeasance	  	 	41	 
	 Section 8.04
	 	Conditions to Legal or Covenant Defeasance	  	 	41	 
	 Section 8.05
	 	Deposited Money and Government Securities to Be Held in Trust; Other Miscellaneous Provisions	  	 	43	 
	 Section 8.06
	 	Repayment to the Partnership	  	 	43	 
	 Section 8.07
	 	Reinstatement	  	 	43	 
		
	 ARTICLE 9 AMENDMENT, SUPPLEMENT AND WAIVER 
	  	 	44	 
			
	 Section 9.01
	 	Without Consent of Holders	  	 	44	 
	 Section 9.02
	 	With Consent of Holders	  	 	44	 
	 Section 9.03
	 	Revocation and Effect of Consents	  	 	46	 
	 Section 9.04
	 	Notation on or Exchange of Notes	  	 	46	 

  
 -ii- 

							
	 	 	 	  	Page	 
	 Section 9.05
	 	Trustee to Sign Amendments, etc.	  	 	46	 
		
	 ARTICLE 10 GUARANTEES 
	  	 	46	 
			
	 Section 10.01
	 	Guarantee	  	 	46	 
	 Section 10.02
	 	Limitation on Subsidiary Guarantor Liability	  	 	48	 
	 Section 10.03
	 	Execution and Delivery	  	 	48	 
	 Section 10.04
	 	Subrogation	  	 	49	 
	 Section 10.05
	 	Benefits Acknowledged	  	 	49	 
	 Section 10.06
	 	Release of Note Guarantees	  	 	49	 
		
	 ARTICLE 11 SATISFACTION AND DISCHARGE 
	  	 	49	 
			
	 Section 11.01
	 	Satisfaction and Discharge	  	 	49	 
	 Section 11.02
	 	Application of Trust Money	  	 	50	 
		
	 ARTICLE 12 MISCELLANEOUS 
	  	 	51	 
			
	 Section 12.01
	 	Notices	  	 	51	 
	 Section 12.02
	 	Certificate and Opinion as to Conditions Precedent	  	 	52	 
	 Section 12.03
	 	Statements Required in Certificate or Opinion	  	 	53	 
	 Section 12.04
	 	Rules by Trustee and Agents	  	 	53	 
	 Section 12.05
	 	No Personal Liability of Directors, Officers, Employees, Members, Partners and Stockholders	  	 	53	 
	 Section 12.06
	 	Governing Law	  	 	53	 
	 Section 12.07
	 	Waiver of Jury Trial	  	 	53	 
	 Section 12.08
	 	Force Majeure	  	 	54	 
	 Section 12.09
	 	No Adverse Interpretation of Other Agreements	  	 	54	 
	 Section 12.10
	 	Successors	  	 	54	 
	 Section 12.11
	 	Severability	  	 	54	 
	 Section 12.12
	 	Counterpart Originals	  	 	54	 
	 Section 12.13
	 	Table of Contents, Headings, etc.	  	 	54	 
	 Section 12.14
	 	PDF Delivery of Signature Pages	  	 	55	 
	 Section 12.15
	 	U.S.A. PATRIOT Act	  	 	55	 
	 Section 12.16
	 	Payments Due on Non-Business Days	  	 	55	 

  
 -iii- 

			
	Appendix A	 	Provisions Relating to Initial Notes and Additional Notes
		
	Exhibit A-1	 	Form of 2029 Note
	Exhibit A-2	 	Form of 2031 Note
	Exhibit B	 	Form of Supplemental Indenture to Be Delivered by Subsequent Subsidiary Guarantors

  
 -iv- 

 INDENTURE, dated as of January 8, 2021, between EQM Midstream Partners, LP, a Delaware
limited partnership (the “Partnership”), and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”). 

W I T N E S S E T H 

WHEREAS, the Partnership has duly authorized the creation and issue of $800,000,000 aggregate principal amount of 4.50% Senior Notes due 2029
(the “2029 Notes”) and $1,100,000,000 aggregate principal amount of 4.75% Senior Notes due 2031 (the “2031 Notes” and, together with the 2029 Notes, the “Initial Notes”); and 

WHEREAS, all things necessary to make this Indenture a valid agreement of the Issuer, in accordance with its terms, have been done; and 

NOW, THEREFORE, the Partnership and the Trustee agree as follows for the benefit of each other and for the equal and ratable benefit of the
Holders of the Notes. 
 ARTICLE 1 

DEFINITIONS AND INCORPORATION BY REFERENCE 

Section 1.01 Definitions. 

“Additional Notes” means additional Notes (other than the Initial Notes) issued from time to time under this Indenture in
accordance with Section 2.01. 
 “Affiliate” of any specified Person means any other Person, directly or indirectly,
controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,”
“controlled by” and “under common control with”) when used with respect to any Person means possession, directly or indirectly, of the power to direct the management and policies of such Person, directly or
indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 

“Agent” means any Registrar or Paying Agent. 

“Bankruptcy Law” means Title 11, U.S. Code, as amended, or any similar federal, state or foreign law for the relief of
debtors. 
 “Beneficial Owner” has the meaning assigned to such term in Rule 13d-3
and Rule 13d-5 under the Exchange Act, except that in calculating the beneficial ownership of any particular “person” (as that term is used in Section 13(d)(3) of the Exchange Act), such
“person” will be deemed to have beneficial ownership of all securities that such “person” has the right to acquire by conversion or exercise of other securities, whether such right is currently exercisable or is exercisable only
after the passage of time. The terms “Beneficially Owns” and “Beneficially Owned” have a corresponding meaning. For purposes of this definition, a Person shall be deemed not to Beneficially Own securities that are
the subject of a stock, unit or asset purchase agreement, merger agreement or similar agreement (or voting or option or similar agreement related thereto) until consummation of the transactions or, as applicable, series of related transactions
contemplated by such agreement. 

  
 -1- 

 “Board of Directors” means: 

(1) with respect to a corporation, the Board of Directors of the corporation or (other than for purposes of determining Change
of Control) any duly authorized committee of the Board of Directors; 
 (2) with respect to a partnership, the Board of
Directors or Board of Managers of the general partner of the partnership (as applicable); and 
 (3) with respect to any
other Person, the board or committee of such Person serving a similar function. 
 “Business Day” means each day that is
not a Saturday, Sunday or other day on which banking institutions in New York, New York are authorized or required by law to close. 

“Capital Stock” means: 

(1) in the case of a corporation, corporate stock; 

(2) in the case of an association or business entity, any and all shares, interests, participations, rights or other
equivalents (however designated) of corporate stock; 
 (3) in the case of a partnership or limited liability company,
partnership interests (whether general or limited) or membership interests; and 
 (4) any other interest or participation
that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person, but excluding from all of the foregoing any debt securities convertible into Capital Stock, whether or not such
debt securities include any right of participation with Capital Stock. 
 “Change of Control” means the occurrence of any
of the following: 
 (1) the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or
consolidation), in one or a series of related transactions, of all or substantially all of the properties or assets of the Partnership and its Subsidiaries taken as a whole to any “person” (as that term is used in Section 13(d) of the
Exchange Act), other than a Qualified Owner; 
 (2) the adoption of a plan relating to the liquidation or dissolution of the Partnership or
the removal of the General Partner by the limited partners of the Partnership; or 
 (3) the consummation of any transaction (including any
merger or consolidation), the result of which is that any “person,” other than a Qualified Owner, becomes the Beneficial Owner, directly or indirectly, of more than 50% of the Voting Stock of the Partnership, the General Partner or
Equitrans Midstream Corporation, measured by voting power rather than number of shares or member interests. 
 Notwithstanding the
preceding, (a) a conversion of the Partnership from a limited partnership to a corporation, limited liability company or other form of entity or an exchange of all of the outstanding limited partner interests for capital stock in a corporation,
for member interests in a limited liability company or for Equity Interests in such other form of entity shall not constitute a Change of Control, so long as following such conversion or exchange the “persons” (as defined above) who
Beneficially Owned the Capital Stock of the Partnership immediately prior to such transactions continue to Beneficially Own in the aggregate more than 50% of the Voting Stock of such entity, or continue to

  
 -2- 

 
Beneficially Own sufficient Equity Interests in such entity to elect a majority of its directors, managers, trustees or other persons serving in a similar capacity for such entity and (b) a
“person” or “group” shall not be deemed to Beneficially Own securities subject to a stock, unit or asset purchase agreement, merger agreement or similar agreement (or voting or option or similar agreement related thereto) until
the consummation of the transactions contemplated by such agreement or, as applicable, series of related transactions contemplated by such agreement. No Change of Control will be deemed to have occurred unless and until such Change of Control has
actually been consummated. 
 “Change of Control Triggering Event” means the occurrence of a decrease in the rating of the
Notes by one or more gradations by any two Ratings Agencies (including gradations within the rating categories, as well as between categories), within 60 days after the earlier of (x) a Change of Control, (y) the date of public notice of
the occurrence of a Change of Control or (z) public notice of the intention of the Partnership to effect a Change of Control (which 60-day period shall be extended so long as the rating of the Notes is
under publicly announced consideration for possible downgrade by a Ratings Agency); provided, however, that a Change of Control Triggering Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in
respect of a particular Change of Control (and thus will not be deemed a Change of Control Triggering Event for purposes of the definition of Change of Control) unless the Ratings Agencies making the reduction in rating to which this definition
would otherwise apply announce or publicly confirm or inform the Trustee in writing at the request of the Partnership or the Trustee that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a
result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Change of Control Triggering Event). 

“Code” means the Internal Revenue Code of 1986, as amended. 

“Comparable Treasury Issue” means the U.S. Treasury security selected by the Quotation Agent as having a maturity comparable
to the remaining term of the Notes of the applicable series, determined as if such Notes matured on the applicable Par Call Date (the “Remaining Life”), that would be utilized, at the time of selection and in accordance with
customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the Remaining Life of such Notes. 

“Comparable Treasury Price” means, with respect to any redemption date: 

 

	 	•	 	 the average of the Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and
lowest Reference Treasury Dealer Quotations, or 

  

	 	•	 	 if the Quotation Agent is unable to obtain at least four such Reference Treasury Dealer Quotations, the average
of all Reference Treasury Dealer Quotations obtained by the Quotation Agent. 

 “Consolidated Net Tangible
Assets” means, at any date of determination, the total amount of consolidated assets of the Partnership and its Subsidiaries after deducting therefrom (1) all current liabilities (excluding (a) any current liabilities that by
their terms are extendable or renewable at the option of the obligor thereon to a time more than 12 months after the time as of which the amount thereof is being computed and (b) current maturities of long-term debt), and (2) the value
(net of any applicable reserves) of all goodwill, trade names, trademarks, patents and other like intangible assets, all as set forth, or on a pro forma basis would be set forth, on the consolidated balance sheet of the Partnership and its
Subsidiaries for the most recently completed fiscal quarter, prepared in accordance with GAAP. 

  
 -3- 

 “Corporate Trust Office of the Trustee” shall be at the address of the
Trustee specified in Section 12.01 or such other address as to which the Trustee may give notice to the Holders and the Partnership.  

“Credit Agreement” means that certain Third Amended and Restated Credit Agreement, dated as of October 31, 2018, by and
among the Partnership, Wells Fargo Bank, National Association, as Administrative Agent, Swing Line Lender and an L/C Issuer, and the other lenders party thereto, providing for revolving credit borrowings and letters of credit, including any related
notes, guarantees, collateral documents, instruments and agreements executed in connection therewith, and, in each case, as amended, restated, modified, renewed, extended, refunded, replaced or refinanced in whole or in part from time to time. 

“Custodian” means the Trustee, as custodian for the Depositary with respect to the Notes in global form, or any successor
entity thereto. 
 “Debt” of any Person at any date means any obligation created or assumed by such Person for the
repayment of borrowed money and, without duplication, any guarantee by such Person of any such obligation of others. 

“Default” means any event that is, or after notice or passage of time or both would be, an Event of Default.  
 “Definitive Note” means a certificated Initial Note or Additional Note
(bearing the Restricted Notes Legend if the transfer of such Note is restricted by applicable law) that does not include the Global Notes Legend.  

“Depositary” means, with respect to the Notes of any series issuable or issued in whole or in part in global form, the Person
specified in Section 2.03 as the Depositary with respect to the Notes, and any and all successors thereto appointed as Depositary hereunder and having become such pursuant to the applicable provision of this Indenture.  
 “DTC” means the Depository Trust Company. 

“Equity Interests” means Capital Stock and all warrants, options or other rights to acquire Capital Stock (but excluding any
debt security that is convertible into, or exchangeable for, Capital Stock). 
 “Exchange Act” means the Securities
Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder. 
 “Fitch” means Fitch
Ratings, Inc., or any successor to the rating agency business thereof. 
 “GAAP” means generally accepted accounting
principles in the United States set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board
or in such other statements by such other entity as may be approved by a significant segment of the accounting profession of the United States, as in effect from time to time. 

“General Partner” means EQGP Services, LLC, a Delaware limited liability company, and its successors and permitted assigns as
general partner of the Partnership or as the business entity with the ultimate authority to manage the business and operations of the Partnership. 

  
 -4- 

 “Government Securities” means securities that are (1) direct
obligations of the United States for the timely payment of which its full faith and credit of the United States is pledged or (2) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United
States the timely payment of which is unconditionally guaranteed as a full faith and credit obligation of the United States, which, in either case, are not callable or redeemable at the option of the issuer thereof, and shall also include a
depositary receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act), as custodian with respect to any such Government Securities or a specific payment of principal of or interest on any such Government Securities held by
such custodian for the account of the holder of such depositary receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from
any amount received by the custodian in respect of the Government Securities or the specific payment of principal of or interest on the Government Securities evidenced by such depositary receipt. 

“Guarantee” means (1) any obligation, contingent or otherwise, of any Person directly or indirectly guaranteeing any
Debt of any other Person and (2) any obligation, direct or indirect, contingent or otherwise, of such Person: 
 (a) to
purchase or pay (or advance or supply funds for the purchase or payment of) such Debt of such other Person (whether arising by virtue of partnership arrangements, or by agreement to keep-well, to purchase assets, goods, securities or services, to take-or-pay, or to maintain financial statement conditions or otherwise); or 

(b) entered into for purposes of assuring in any other manner the obligee of such Debt of the payment thereof or to protect
such obligee against loss in respect thereof (in whole or in part); provided, however, that the term “Guarantee” will not include endorsements for collection or deposit in the ordinary course of business. 

“Holder” means a Person in whose name a Note is registered on the Registrar’s books. 

“Indenture” means this Indenture, as amended or supplemented from time to time. 

“Independent Financial Advisor” means an accounting, appraisal, investment banking firm or consultant to Persons engaged in
similar businesses of nationally recognized standing that is, in the good faith judgment of the Partnership, qualified to perform the task for which it has been engaged. 

“Initial Notes” has the meaning set forth in the recitals hereto. 

“Interest Payment Date” means January 15 and July 15 of each year to the Stated Maturity of the 2029 Notes and
January 15 and July 15 of each year to the Stated Maturity of the 2031 Notes. 
 “Issue Date” means
January 8, 2021. 
 “Lien” means, with respect to any asset, any mortgage, lien, security interest, pledge, charge or
other encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law. 

“Moody’s” means Moody’s Investors Service, Inc., or any successor to the rating agency business thereof. 

  
 -5- 

 “Note Guarantee” means, individually, any Guarantee of payment of the Notes
and the Partnership’s other Obligations under this Indenture by a Subsidiary Guarantor pursuant to the terms of this Indenture and any supplemental indenture thereto, and, collectively, all such Guarantees. 

“Notes” means the Initial Notes and more particularly means any Note authenticated and delivered under this Indenture. For
all purposes of this Indenture, the term “Notes” shall also include any Additional Notes that may be issued under a supplemental indenture and Notes to be issued or authenticated upon transfer, replacement or exchange of Notes. 

“Obligations” means any principal, interest (including any interest accruing subsequent to the filing of a petition in
bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest is an allowed claim under applicable state, federal or foreign law), other monetary obligations,
penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and banker’s acceptances), damages and other liabilities, and Guarantees of payment of such principal, interest, penalties,
fees, indemnifications, reimbursements, damages and other liabilities, payable under the documentation governing any Debt. 

“Offering Memorandum” means the offering memorandum dated January 4, 2021 related to the offer and sale of the Notes.

 “Officer” means the Chief Executive Officer, the President, the Chief Financial Officer, any Executive Vice President,
any Senior Vice President, any Vice President, the Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Assistant Secretary of a Person, including, with respect to the Partnership, any such officer of the General Partner that the
Board of Directors or Board of Managers of the General Partner (as applicable) shall have duly authorized to act hereunder. 

“Officer’s Certificate” means a certificate signed on behalf of the Partnership by any Officer of the General Partner.

 “Opinion of Counsel” means a written opinion acceptable to the Trustee from legal counsel. Such counsel may be an
employee of or counsel to the Partnership, the General Partner or an Affiliate of any of the foregoing. 
 “Par Call Date”
means July 15, 2028 with respect to the 2029 Notes and July 15, 2030 with respect to the 2031 Notes. 

“Partnership” means the party named as such in the first paragraph of this Indenture or any successor obligor to its
obligations under this Indenture and the Notes pursuant to Article 5. 
 “Person” means any individual, corporation,
partnership, limited liability company, joint venture, incorporated or unincorporated association, joint stock company, trust, unincorporated organization or government or other agency, instrumentality or political subdivision thereof or other
entity of any kind. 
 “Principal Property” means, whether currently owned or leased or subsequently acquired, any
pipeline, gathering system, terminal, storage facility, processing plant or other plant or facility located in the United States of America or any territory or political subdivision thereof owned or leased by the Partnership or any of its
Subsidiaries and used in transporting, distributing, terminalling, gathering, treating, processing, marketing or storing natural gas, natural gas liquids or other hydrocarbons, except (1) any property or asset consisting of inventories,
furniture, office fixtures and equipment (including data processing equipment), vehicles and equipment used on, or useful with, vehicles (but 

  
 -6- 

 
excluding vehicles that generate transportation revenues) and (2) any such pipeline or other plant or facility that, in the good faith opinion of the Board of Directors or Board of Managers
of the General Partner (as applicable) as evidenced by resolutions of the Board of Directors or Board of Managers of the General Partner (as applicable), is not material in relation to the activities of the Partnership and its Subsidiaries, taken as
a whole. 
 “Principal Subsidiary” means any of the Partnership’s Subsidiaries that owns or leases, directly or
indirectly, a Principal Property. 
 “Qualified Owner” means each of (i) Equitrans Midstream Corporation;
(ii) any Person that is controlled by Equitrans Midstream Corporation; and (iii) any group (within the meaning of the Exchange Act) that includes one or more of the Persons described in the preceding clause (i) or (ii); provided
that such Persons described in the preceding clause (i) or (ii) control more than 50% of the total voting power of such group. Any “person” (as that term is used in Section 13(d)(3) of the Exchange Act) whose acquisition of
Beneficial Ownership of any Voting Stock of the Partnership, the General Partner or Equitrans Midstream Corporation constitutes a Change of Control in respect of which a Change of Control Offer or an Alternate Offer is made in accordance with the
requirements of this Indenture will thereafter, together with its affiliates, constitute an additional Qualified Owner. 

“Quotation Agent” means a Reference Treasury Dealer selected by the Partnership. 

“Rating Agencies” means Moody’s, S&P and Fitch or, if Moody’s, S&P or Fitch shall not make a rating of the
Notes publicly available, a nationally recognized statistical rating agency or agencies, as the case may be, selected by the Partnership, which shall be substituted for Moody’s, S&P or Fitch, as the case may be. 

“Record Date” for the interest payable on any applicable Interest Payment Date means the January 1 or July 1
(whether or not a Business Day) next preceding such Interest Payment Date of the 2029 Notes and the January 1 or July 1 (whether or not a Business Day) next preceding such Interest Payment Date of the 2031 Notes. 

“Reference Treasury Dealer” means each of Barclays Capital Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC, and
their respective successors, so long as it is a primary U.S. government securities dealer (a “Primary Treasury Dealer”); provided, however, that if any of the foregoing shall cease to be a Primary Treasury Dealer, the
Partnership will substitute therefor another Primary Treasury Dealer. 
 “Reference Treasury Dealer Quotations” means, with
respect to each Reference Treasury Dealer and any redemption date for the Notes of any series, an average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue for such Notes (expressed in each case as
a percentage of its principal amount) quoted in writing to the Quotation Agent by that Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

“Responsible Officer” means any officer within the corporate trust department of the Trustee having direct responsibility for
the administration of this Indenture or any other officer to whom any corporate trust matter is referred because of such Person’s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the
administration of this Indenture. 
 “S&P” means S&P Global Ratings, a division of S&P Global, Inc., or any
successor to the rating agency business thereof. 

  
 -7- 

 “Sale-Leaseback Transaction” means the sale or transfer by the Partnership
or any Principal Subsidiary of any Principal Property to a Person (other than the Partnership or a Principal Subsidiary) and the taking back by the Partnership or any Principal Subsidiary, as the case may be, of a lease of such Principal Property.

 “SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated
thereunder. 
 “Significant Subsidiary” means a Subsidiary of the Partnership that is a “significant subsidiary”
of the Partnership as such term is defined in Rule 1-02(w) of Regulation S-X as in effect on the date of this Indenture. 

“Stated Maturity” means, with respect to any security, the date specified in the agreement governing or certificate relating
to such security as the fixed date on which the final payment of principal of such security is due and payable, including pursuant to any mandatory redemption provision, but not including any contingent obligations to repay, redeem or repurchase any
such principal prior to the date originally scheduled for the payment thereof. 
 “Subsidiary” of any Person means
(1) any corporation, association or other business entity of which more than 50% of the total voting power of equity interests entitled, without regard to the occurrence of any contingency, to vote in the election of directors, managers,
trustees or equivalent Persons thereof is at the time of determination owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of such Person or any combination thereof; or (2) in the case of a
partnership, more than 50% of the partners’ equity interests, considering all partners’ equity interests as a single class, is at such time of determination owned or controlled, directly or indirectly, by such Person or one or more of the
other Subsidiaries of such Person or any combination thereof. 
 “Subsidiary Guarantor” means each Subsidiary that may
provide a Note Guarantee after the Issue Date; provided that upon release or discharge of such Subsidiary from its Note Guarantee in accordance with this Indenture, such Subsidiary shall cease to be a Subsidiary Guarantor. 

“Swap Contract” means (1) any and all rate swap transactions, basis swaps, credit derivative transactions, forward rate
transactions, commodity swaps, commodity options, forward commodity contracts, equity or equity index swaps or options, bond or bond price or bond index swaps or options or forward bond or forward bond price or forward bond index transactions,
interest rate options, forward foreign exchange transactions, cap transactions, floor transactions, collar transactions, currency swap transactions, cross-currency rate swap transactions, currency options, spot contracts, futures contracts traded on
or subject to the rules of a designated contract market, or any other similar transactions or any combination of any of the foregoing (including any options to enter into any of the foregoing), whether or not any such transaction is governed by or
subject to any master agreement, and (2) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps
and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, any North American Energy Standard Board Master Agreement, or any other master agreement, including any such obligations or liabilities under any master
agreement. 
 “Transfer Restricted Notes” means Definitive Notes and any other Notes that bear or are required to bear the
Restricted Notes Legend. 

  
 -8- 

 “Treasury Rate” means, with respect to any redemption date for any series
of Notes, the rate per year equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, calculated using a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the
Comparable Treasury Price for that redemption date; provided, however, that if no maturity is within three months before or after the applicable Par Call Date, yields for the two published maturities most closely corresponding to such
United States Treasury security will be determined and the Treasury Rate will be interpolated or extrapolated from those yields on a straight line basis rounding to the nearest month. The Treasury Rate will be calculated by the Quotation Agent on
the third business day preceding the redemption date. 
 “Trust Indenture Act” means the Trust Indenture Act of 1939, as
amended. 
 “Trustee” means The Bank of New York Mellon Trust Company, N.A., as Trustee, until a successor replaces it in
accordance with the applicable provisions of this Indenture and thereafter means the successor serving hereunder.  

“Voting Stock” of any specified Person as of any date means the Capital Stock of such Person that is at the time entitled
(without regard to the occurrence of any contingency) to vote in the election of such Persons’ directors, managers, trustees or other persons serving in a similar capacity for such entity. 

Section 1.02 Other Definitions. 
  

			
	 Term
	  	 Defined in Section

	 “Agent Members” 
	  	2.1(c) of Appendix A
	 “Applicable Procedures” 
	  	1.1(a) of Appendix A
	 “Alternate Offer” 
	  	4.11(f)
	 “Authentication Order” 
	  	2.02(c)
	 “Bankruptcy Custodian” 
	  	6.01(a)
	 “Change of Control Offer” 
	  	4.11(a)
	 “Change of Control Payment” 
	  	4.11(a)
	 “Change of Control Settlement Date” 
	  	4.11(a)
	 “Clearstream” 
	  	1.1(a) of Appendix A
	 “Covenant Defeasance” 
	  	8.03
	 “Definitive Notes Legend” 
	  	2.2(e) of Appendix A
	 “Distribution Compliance Period” 
	  	1.1(a) of Appendix A
	 “ERISA Legend” 
	  	2.2(e) of Appendix A
	 “Euroclear” 
	  	1.1(a) of Appendix A
	 “Event of Default” 
	  	6.01(a)
	 “Expiration Date” 
	  	1.04(j)
	 “Global Note” 
	  	2.1(b) of Appendix A
	 “Global Notes Legend” 
	  	2.2(e) of Appendix A
	 “Guaranteed Obligations” 
	  	10.01(a)
	 “Legal Defeasance” 
	  	8.02(a)
	 “Note Register” 
	  	2.03(a)
	 “Paying Agent” 
	  	2.03(a)
	 “QIB” 
	  	1.1(a) of Appendix A
	 “Registrar” 
	  	2.03(a)
	 “Regulation S” 
	  	1.1(a) of Appendix A
	 “Regulation S Global Note” 
	  	2.1(b) of Appendix A
	 “Regulation S Notes” 
	  	2.1(a) of Appendix A

  
 -9- 

			
	 Term
	  	 Defined in Section

	 “Restricted Notes Legend” 
	  	2.2(e) of Appendix A
	 “Rule 144” 
	  	1.1(a) of Appendix A
	 “Rule 144A” 
	  	1.1(a) of Appendix A
	 “Rule 144A Global Note” 
	  	2.1(b) of Appendix A
	 “Rule 144A Notes” 
	  	2.1(a) of Appendix A
	 “Successor” 
	  	5.01(1)
	 “Unrestricted Global Note” 
	  	1.1(a) of Appendix A

 Section 1.03 Rules of Construction. 

Unless the context otherwise requires: 

(1) a term defined in Section 1.01 or 1.02 has the meaning assigned to it therein; 

(2) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(3) “or” is not exclusive; 

(4) words in the singular include the plural, and words in the plural include the singular; 

(5) provisions apply to successive events and transactions; 

(6) unless the context otherwise requires, any reference to an “Appendix,” “Article,” “Section,”
“clause,” “Schedule” or “Exhibit” refers to an Appendix, Article, Section, clause, Schedule or Exhibit, as the case may be, of this Indenture; 

(7) the words “herein,” “hereof” and other words of similar import refer to this Indenture as a whole and
not any particular Article, Section, clause or other subdivision; 
 (8) “including” means including without
limitation; 
 (9) references to sections of, or rules under, the Securities Act or the Exchange Act shall be deemed to
include substitute, replacement or successor sections or rules adopted by the SEC from time to time unless otherwise provided in this Indenture; 

(10) unless otherwise provided, references to agreements and other instruments shall be deemed to include all amendments and
other modifications to such agreements or instruments, but only to the extent such amendments and other modifications are not prohibited by the terms of this Indenture; and 

(11) in the event that a transaction meets the criteria of more than one category of permitted transactions or listed
exceptions, the Partnership may classify such transaction as it, in its sole discretion, determines. 

  
 -10- 

 Section 1.04 Acts of Holders. 

(a) Any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be given or taken by
Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by an agent duly appointed in writing. Except as herein otherwise expressly provided, such action shall become
effective when such instrument or instruments or record or both are delivered to the Trustee and, where it is hereby expressly required, to the Partnership and to the extent applicable, the Subsidiary Guarantors. Proof of execution of any such
instrument or of a writing appointing any such agent, or the holding by any Person of a Note, shall be sufficient for any purpose of this Indenture and (subject to Section 7.01) conclusive in favor of the Trustee, the Partnership and the
Subsidiary Guarantors, if made in the manner provided in this Section 1.04. 
 (b) The fact and date of the execution by any Person of
any such instrument or writing may be proved (1) by the affidavit of a witness of such execution or by the certificate of any notary public or other officer authorized by law to take acknowledgments of deeds, certifying that the individual
signing such instrument or writing acknowledged to him the execution thereof or (2) in any other manner deemed reasonably sufficient by the Trustee. Where such execution is by or on behalf of any legal entity other than an individual, such
certificate or affidavit shall also constitute proof of the authority of the Person executing the same. The fact and date of the execution of any such instrument or writing, or the authority of the Person executing the same, may also be proved in
any other manner that the Trustee deems sufficient. 
 (c) The ownership of Notes shall be proved by the Note Register. 

(d) Any request, demand, authorization, direction, notice, consent, waiver or other action by the Holder of any Note shall bind every future
Holder of the same Note and the Holder of every Note issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof, in respect of any action taken, suffered or omitted by the Trustee, the Partnership or the Subsidiary
Guarantors in reliance thereon, whether or not notation of such action is made upon such Note. 
 (e) The Partnership may set a record date
for purposes of determining the identity of Holders entitled to make, give or take any request, demand, authorization, direction, notice, consent, waiver or other action provided in this Indenture to be made, or to vote on or consent to any action
authorized or permitted to be taken by Holders; provided that the Partnership may not set a record date for, and the provisions of this paragraph shall not apply with respect to, the giving or making of any notice, declaration, request or
direction referred to in clause (f) below. Unless otherwise specified, if not set by the Partnership prior to the first solicitation of a Holder made by any Person in respect of any such action, or in the case of any such vote, prior to such
vote, any such record date shall be the later of 30 days prior to the first solicitation of such consent or vote or the date of the most recent list of Holders furnished to the Trustee prior to such solicitation or vote. If any record date is set
pursuant to this clause (e), the Holders on such record date, and only such Holders, shall be entitled to make, give or take such request, demand, authorization, direction, notice, consent, waiver or other action (including revocation of any
action), whether or not such Holders remain Holders after such record date; provided that no such action shall be effective hereunder unless made, given or taken on or prior to the applicable Expiration Date by Holders of the requisite
principal amount of Notes, or each affected Holder, as applicable, on such record date. Promptly after any record date is set pursuant to this paragraph, the Partnership, at its own expense, shall cause notice of such record date, the proposed
action by Holders and the applicable Expiration Date to be given to the Trustee in writing and to each Holder in the manner set forth in Section 12.01. 

(f) The Trustee may set any day as a record date for the purpose of determining the Holders entitled to join in the giving or making of
(1) any notice of default under Section 6.01(a), (2) any declaration of acceleration referred to in Section 6.02, (3) any direction referred to in Section 6.05 or (4) any request to pursue a remedy as permitted in
Section 6.06. If any record date is set pursuant to this paragraph, the Holders on such record date, and no other Holders, shall be entitled to join in such notice, declaration, request or direction, whether or not such Holders remain Holders
after such record date; 

  
 -11- 

 
provided that no such action shall be effective hereunder unless made, given or taken on or prior to the applicable Expiration Date by Holders of the requisite principal amount of Notes or
each affected Holder, as applicable, on such record date. Promptly after any record date is set pursuant to this paragraph, the Trustee, at the Partnership’s expense, shall cause notice of such record date, the proposed action by Holders and
the applicable Expiration Date to be given to the Partnership and to each Holder in the manner set forth in Section 12.01. 
 (g)
Without limiting the foregoing, a Holder entitled to take any action hereunder with regard to any particular Note may do so with regard to all or any part of the principal amount of such Note or by one or more duly appointed agents, each of which
may do so pursuant to such appointment with regard to all or any part of such principal amount. Any notice given or action taken by a Holder or its agents with regard to different parts of such principal amount pursuant to this paragraph shall have
the same effect as if given or taken by separate Holders of each such different part. 
 (h) Without limiting the generality of the
foregoing, a Holder, including a Depositary that is the Holder of a Global Note, may make, give or take, by a proxy or proxies duly appointed in writing, any request, demand, authorization, direction, notice, consent, waiver or other action provided
in this Indenture to be made, given or taken by Holders, and a Depositary that is the Holder of a Global Note may provide its proxy or proxies to the Beneficial Owners of interests in any such Global Note through such Depositary’s standing
instructions and customary practices. 
 (i) The Partnership may fix a record date for the purpose of determining the Persons who are
Beneficial Owners of interests in any Global Note held by a Depositary entitled under the procedures of such Depositary, if any, to make, give or take, by a proxy or proxies duly appointed in writing, any request, demand, authorization, direction,
notice, consent, waiver or other action provided in this Indenture to be made, given or taken by Holders; provided that if such a record date is fixed, only the Beneficial Owners of interests in such Global Note on such record date or their
duly appointed proxy or proxies shall be entitled to make, give or take such request, demand, authorization, direction, notice, consent, waiver or other action, whether or not such Beneficial Owners remain Beneficial Owners of interests in such
Global Note after such record date. No such request, demand, authorization, direction, notice, consent, waiver or other action shall be effective hereunder unless made, given or taken on or prior to the applicable Expiration Date. 

(j) With respect to any record date set pursuant to this Section 1.04, the party hereto that sets such record date may designate any day
as the “Expiration Date” and from time to time may change the Expiration Date to any earlier or later day; provided that no such change shall be effective unless notice of the proposed new Expiration Date is given to the
other party hereto in writing, and to each Holder of Notes in the manner set forth in Section 12.01, on or prior to both the existing and the new Expiration Date. If an Expiration Date is not designated with respect to any record date set
pursuant to this Section 1.04, the party hereto which set such record date shall be deemed to have initially designated the 90th day after such record date as the Expiration Date with respect thereto, subject to its right to change the
Expiration Date as provided in this Section 1.04(j). 

  
 -12- 

 ARTICLE 2 

THE NOTES 
 Section 2.01 Form and Dating;
Terms. 
 (a) Provisions relating to the Initial Notes, the Additional Notes and any other Notes issued under this Indenture are set
forth in Appendix A, which is hereby incorporated in and expressly made a part of this Indenture. The Notes and the Trustee’s certificate of authentication shall each be substantially in the forms of
Exhibit A-1 and Exhibit A-2 hereto, which are hereby incorporated in and expressly made a part of this Indenture. The Notes may have notations, legends or
endorsements required by law, rules or agreements with national securities exchanges to which the Partnership is subject, if any, or usage (provided that any such notation, legend or endorsement is in a form acceptable to the Partnership).
Each Note shall be dated the date of its authentication. The Notes shall be in denominations of $2,000 and integral multiples of $1,000 in excess thereof. 

(b) The aggregate principal amount of Notes of each series that may be authenticated and delivered under this Indenture is unlimited. 

The terms and provisions contained in the Notes shall constitute, and are hereby expressly made, a part of this Indenture, and the Partnership
and the Trustee, by their execution and delivery of this Indenture, expressly agree to such terms and provisions and to be bound thereby. However, to the extent any provision of any Note conflicts with the express provisions of this Indenture, the
provisions of this Indenture shall govern and be controlling. 
 The Notes shall be subject to repurchase by the Partnership pursuant to a
Change of Control Offer as provided in Section 4.11, and otherwise as not prohibited by this Indenture. The Notes shall not be redeemable, other than as provided in Article 3. 

Additional Notes of any series ranking pari passu with the Initial Notes of such series may be created and issued from time to time by
the Partnership without notice to or consent of the Holders and shall be consolidated with and form a single class with the Initial Notes of such series and shall have the same terms as to status, redemption or otherwise (other than issue date,
issue price and, if applicable, the first Interest Payment Date and the first date from which interest will accrue) as the Initial Notes of such series. Any Additional Notes of any series shall be issued with the benefit of a supplemental indenture
to this Indenture. 
 Section 2.02 Execution and Authentication. 

(a) At least one Officer shall execute the Notes on behalf of the Partnership by manual, facsimile or electronic signature. If an Officer whose
signature is on a Note no longer holds that office at the time a Note is authenticated, the Note shall nevertheless be valid. 
 (b) A Note
shall not be entitled to any benefit under this Indenture or be valid or obligatory for any purpose until authenticated substantially in the forms of Exhibit A-1 and Exhibit
A-2 attached hereto by the manual, facsimile or electronic signature of an authorized signatory of the Trustee. The signature shall be conclusive evidence that the Note has been duly authenticated and
delivered under this Indenture. 
 (c) On the Issue Date, the Trustee shall, upon receipt of a written order of the Partnership signed by an
Officer (an “Authentication Order”), authenticate and deliver the Initial Notes. In addition, at any time and from time to time, the Trustee shall, upon receipt of an Authentication Order, authenticate and deliver any Additional
Notes in an aggregate principal amount specified in such Authentication Order for such Additional Notes issued hereunder. 
 (d) The Trustee
may appoint an authenticating agent acceptable to the Partnership to authenticate Notes. An authenticating agent may authenticate Notes whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes
authentication by such agent. An authenticating agent has the same rights as an Agent to deal with Holders, the Partnership or an Affiliate of the Partnership. 

  
 -13- 

 (e) The Trustee shall authenticate and make available for delivery upon a written order of
the Partnership signed by one Officer (a) Initial Notes for original issue on the Issue Date in an aggregate principal amount of $800,000,000 of 2029 Notes and in an aggregate principal amount of $1,100,000,000 of 2031 Notes, (b) subject
to the terms of this Indenture, Additional Notes and (c) any Unrestricted Global Notes issued in exchange for any of the foregoing in accordance with this Indenture. Such order shall specify the amount of the Notes to be authenticated, the date
on which the original issue of Notes is to be authenticated and whether the Notes are to be Initial Notes, Additional Notes or Unrestricted Global Notes. 

Section 2.03 Registrar and Paying Agent. 

(a) The Partnership shall maintain an office or agency where Notes may be presented for registration of transfer or for exchange
(“Registrar”) and at least one office or agency where Notes may be presented for payment (“Paying Agent”). The Registrar shall keep a register of the Notes (“Note Register”) and of their transfer
and exchange. The Partnership may appoint one or more co-registrars and one or more additional paying agents. The term “Registrar” includes any
co-registrar, and the term “Paying Agent” includes any additional paying agent. The Partnership may change any Paying Agent or Registrar without prior notice to any Holder. The Partnership
shall notify the Trustee in writing of the name and address of any Agent not a party to this Indenture. If the Partnership fails to appoint or maintain another entity as Registrar or Paying Agent, the Trustee shall act as such. The Partnership or
any of its Subsidiaries may act as Paying Agent or Registrar. 
 (b) The Partnership initially appoints DTC to act as Depositary with respect
to the Global Notes. The Partnership initially appoints the Trustee to act as Paying Agent and Registrar for the Notes and to act as Custodian with respect to the Global Notes. 

Section 2.04 Paying Agent to Hold Money in Trust. 

The Partnership shall, no later than 11:00 a.m. (New York City time) on each due date for the payment of principal, premium, if any, and
interest on any of the Notes, deposit with a Paying Agent a sum sufficient to pay such amount, such sum to be held in trust for the Holders entitled to the same, and (unless such Paying Agent is the Trustee) the Partnership shall promptly notify the
Trustee of its action or failure so to act. The Partnership shall require each Paying Agent other than the Trustee to agree in writing that such Paying Agent shall hold in trust for the benefit of Holders or the Trustee all money held by such Paying
Agent for the payment of principal, premium, if any, and interest on the Notes, and shall notify the Trustee of any default by the Partnership in making any such payment. While any such default continues, the Trustee may require a Paying Agent to
pay all money held by it to the Trustee. The Partnership at any time may require a Paying Agent to pay all money held by it to the Trustee. Upon payment over to the Trustee, a Paying Agent shall have no further liability for the money. If the
Partnership or a Subsidiary acts as Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of the Holders all money held by it as Paying Agent. Upon any bankruptcy or reorganization proceedings relating to the
Partnership, the Trustee shall serve as Paying Agent for the Notes. 
 Section 2.05 Holder Lists. 

The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of
all Holders. If the Trustee is not the Registrar, the Partnership shall furnish to the Trustee at least two Business Days before each Interest Payment Date and at such other times as the Trustee may request in writing, a list in such form and as of
such date as the Trustee may reasonably require of the names and addresses of the Holders. 

  
 -14- 

 Section 2.06 Transfer and Exchange. 

(a) The Notes shall be issued in registered form and shall be transferable only upon the surrender of a Note for registration of transfer and
in compliance with Appendix A. 
 (b) To permit registrations of transfers and exchanges, the Partnership shall execute and the Trustee shall
authenticate Global Notes and Definitive Notes upon receipt of an Authentication Order in accordance with Section 2.02 or at the Registrar’s request. 

(c) No service charge shall be imposed in connection with any registration of transfer or exchange (other than pursuant to Section 2.07),
but the Holders shall be required to pay any transfer tax or similar governmental charge payable in connection therewith (other than any such transfer taxes or similar governmental charge payable upon exchange or transfer pursuant to Sections 2.10,
3.06 and 9.04). 
 (d) All Global Notes and Definitive Notes issued upon any registration of transfer or exchange of Global Notes or
Definitive Notes shall be the valid obligations of the Partnership, evidencing the same Debt, and entitled to the same benefits under this Indenture, as the Global Notes or Definitive Notes surrendered upon such registration of transfer or exchange.

 (e) Neither the Partnership nor the Registrar shall be required (1) to issue, to register the transfer of or to exchange any Note
during a period beginning at the opening of business 15 days before the day of any selection of Notes for redemption under Section 3.02 and ending at the close of business on the day of selection, (2) to register the transfer of or to
exchange any Note so selected for redemption, or tendered for repurchase (and not withdrawn) in connection with a Change of Control Offer, in whole or in part, except the unredeemed or unpurchased portion of any Note being redeemed or repurchased in
part or (3) to register the transfer of or to exchange any Note between a Record Date and the next succeeding Interest Payment Date. 

(f) Prior to due presentment for the registration of a transfer of any Note, the Trustee, any Agent and the Partnership may deem and treat the
Person in whose name any Note is registered as the absolute owner of such Note for the purpose of receiving payment of principal, premium, if any, and (subject to the Record Date provisions of the Notes) interest on such Notes and for all other
purposes, and none of the Trustee, any Agent or the Partnership shall be affected by notice to the contrary. 
 (g) Upon surrender for
registration of transfer of any Note at the office or agency of the Partnership designated pursuant to Section 4.02, the Partnership shall execute, and the Trustee shall authenticate and mail, in the name of the designated transferee or
transferees, one or more replacement Notes of any authorized denomination or denominations of a like aggregate principal amount. 
 (h) At
the option of the Holder, Notes may be exchanged for other Notes of any authorized denomination or denominations of a like aggregate principal amount upon surrender of the Notes to be exchanged at such office or agency. Whenever any Global Notes or
Definitive Notes are so surrendered for exchange, the Partnership shall execute, and the Trustee shall authenticate and mail, the replacement Global Notes and Definitive Notes which the Holder making the exchange is entitled to in accordance with
the provisions of Appendix A. 
 (i) All certifications, certificates and Opinions of Counsel required to be submitted to the Registrar
pursuant to this Section 2.06 to effect a registration of transfer or exchange may be submitted by mail or by facsimile or electronic transmission. 

  
 -15- 

 Section 2.07 Replacement Notes. 

If a mutilated Note is surrendered to the Trustee or if a Holder claims that its Note has been lost, destroyed or wrongfully taken and the
Trustee receives evidence to its satisfaction of the ownership and loss, destruction or theft of such Note, the Partnership shall issue and the Trustee, upon receipt of an Authentication Order, shall authenticate a replacement Note if the
Trustee’s requirements are otherwise met. If required by the Trustee or the Partnership, an indemnity bond must be provided by the Holder that is sufficient in the judgment of the Trustee and the Partnership to protect the Partnership, the
Trustee, any Agent and any authenticating agent from any loss that any of them may suffer if a Note is replaced. The Partnership may charge the Holder for the expenses of the Partnership and the Trustee in replacing a Note. Every replacement Note is
a contractual obligation of the Partnership and shall be entitled to all of the benefits of this Indenture equally and proportionately with all other Notes duly issued hereunder. Notwithstanding the foregoing provisions of this Section 2.07, in
case any mutilated, lost, destroyed or wrongfully taken Note has become or is about to become due and payable, the Partnership in its discretion may, instead of issuing a new Note, pay such Note. 

Section 2.08 Outstanding Notes. 
 (a)
The Notes outstanding at any time are all the Notes authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation, those reductions in the interest in a Global Note effected by the Trustee in accordance with
the provisions hereof, and those described in this Section 2.08 as not outstanding. Except as set forth in Section 2.09, a Note does not cease to be outstanding because the Partnership or an Affiliate of the Partnership holds the Note.

 (b) If a Note is replaced pursuant to Section 2.07, it ceases to be outstanding unless the Trustee receives proof satisfactory to it
that the replaced Note is held by a protected purchaser, as such term is defined in Section 8-303 of the Uniform Commercial Code in effect in the State of New York. 

(c) If the principal amount of any Note is considered paid under Section 4.01, it ceases to be outstanding and interest on it ceases to
accrue from and after the date of such payment. 
 (d) If a Paying Agent (other than the Partnership, a Subsidiary or an Affiliate of any
thereof) holds, on the maturity date, any redemption date or any date of purchase pursuant to an offer to purchase, money sufficient to pay Notes payable or to be redeemed or purchased on that date, then on and after that date such Notes shall be
deemed to be no longer outstanding and shall cease to accrue interest. 
 Section 2.09 Treasury Notes. 

In determining whether the Holders of the requisite principal amount of Notes have concurred in any direction, waiver or consent, Notes
Beneficially Owned by the Partnership, or by any Affiliate of the Partnership, shall be considered as though not outstanding, except that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver
or consent, only Notes that a Responsible Officer of the Trustee actually knows are so owned shall be so disregarded. Notes so owned which have been pledged in good faith shall not be disregarded if the pledgee establishes to the satisfaction of the
Trustee the pledgee’s right to deliver any such direction, waiver or consent with respect to the Notes and that the pledgee is not the Partnership or any obligor upon the Notes or any Affiliate of the Partnership or of such other obligor. 

  
 -16- 

 Section 2.10 Temporary Notes. 

Until definitive Notes are ready for delivery, the Partnership may prepare and the Trustee, upon receipt of an Authentication Order, shall
authenticate temporary Notes. Temporary Notes shall be substantially in the form of definitive Notes but may have variations that the Partnership considers appropriate for temporary Notes and as shall be reasonably acceptable to the Trustee. Without
unreasonable delay, the Partnership shall prepare and the Trustee shall authenticate definitive Notes in exchange for temporary Notes. Holders and beneficial holders, as the case may be, of temporary Notes shall be entitled to all of the benefits
accorded to Holders, or beneficial holders, respectively, of Notes under this Indenture. 
 Section 2.11 Cancellation. 

The Partnership at any time may deliver Notes to the Trustee for cancellation. The Registrar and Paying Agent shall forward to the Trustee any
Notes surrendered to them for registration of transfer, exchange or payment. The Trustee or, at the direction of the Trustee, the Registrar or the Paying Agent and no one else shall cancel all Notes surrendered for registration of transfer,
exchange, payment, replacement or cancellation and shall destroy cancelled Notes in accordance with its customary procedures (subject to the record retention requirement of the Exchange Act). Certification of the destruction of all cancelled Notes
shall, upon the written request of the Partnership, be delivered to the Partnership. The Partnership may not issue new Notes to replace Notes that it has paid or that have been delivered to the Trustee for cancellation. 

Section 2.12 Defaulted Interest. 

(a) If the Partnership defaults in a payment of interest on the Notes, it shall pay the defaulted interest in any lawful manner plus, to the
extent lawful, interest payable on the defaulted interest, to the Persons who are Holders on a subsequent special record date, in each case at the rate provided in the Notes and in Section 4.01. The Partnership shall notify the Trustee in
writing of the amount of defaulted interest proposed to be paid on each Note and the date of the proposed payment, and at the same time the Partnership shall deposit with the Trustee an amount of money equal to the aggregate amount proposed to be
paid in respect of such defaulted interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to
such defaulted interest as provided in this Section 2.12. The Trustee shall fix or cause to be fixed each such special record date and payment date; provided that no such special record date shall be less than 10 days prior to the
related payment date for such defaulted interest. The Trustee shall promptly notify the Partnership of such special record date. At least 15 days before the special record date, the Partnership (or, upon the written request of the Partnership, the
Trustee in the name and at the expense of the Partnership) shall mail or deliver by electronic transmission in accordance with the applicable procedures of the Depositary, or cause to be mailed or delivered by electronic transmission in accordance
with the applicable procedures of the Depositary, to each Holder a notice that states the special record date, the related payment date and the amount of such interest to be paid. 

(b) Subject to the foregoing provisions of this Section 2.12 and for greater certainty, each Note delivered under this Indenture upon
registration of, transfer of or in exchange for or in lieu of any other Note shall carry the rights to interest accrued and unpaid, and to accrue interest, which were carried by such other Note. 

Section 2.13 CUSIP and ISIN Numbers 

The Partnership in issuing the Notes may use CUSIP or ISIN numbers (if then generally in use) and, if so, the Trustee shall use CUSIP or ISIN
numbers in notices of redemption or exchange or in offers to purchase as a convenience to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or
as contained in any notice of redemption or exchange or in offers to purchase and that reliance may be placed only on the other identification numbers printed on the Notes, and any such redemption or exchange or offer to purchase shall not be
affected by any defect in or omission of such numbers. The Partnership shall as promptly as practicable notify the Trustee in writing of any change in the CUSIP or ISIN numbers. 

  
 -17- 

 ARTICLE 3 

REDEMPTION 
 Section 3.01 Notices to
Trustee. 
 If the Partnership elects to redeem Notes of any series pursuant to Section 3.07, it shall furnish to the Trustee, at
least two Business Days before notice of redemption is required to be mailed or caused to be mailed (or delivered by electronic transmission in accordance with the applicable procedures of the Depositary) to Holders pursuant to Section 3.03
(unless a shorter notice shall be agreed to by the Trustee) but not more than 60 days before a redemption date, an Officer’s Certificate setting forth (1) the paragraph or subparagraph of such Note or Section of this Indenture pursuant to
which the redemption shall occur, (2) the redemption date, (3) the principal amount of the Notes of such series to be redeemed and (4) the redemption price, if then ascertainable. 

Section 3.02 Selection of Notes to Be Redeemed or Purchased. 

(a) If less than all of the Notes of any series are to be redeemed pursuant to Section 3.07 or purchased in an offer to purchase at any
time, the Trustee shall select the Notes to be redeemed or purchased (1) if the Notes are listed on any national securities exchange, in compliance with the requirements of the principal national securities exchange on which the Notes are
listed or (2) if the Notes are not so listed, on a pro rata basis, in accordance with the applicable procedures of the Depositary or by such other method as the Trustee in its sole discretion deems to be fair and appropriate. In the
event of partial redemption or purchase by lot, the particular Notes of such series to be redeemed or purchased shall be selected, unless otherwise provided herein, not less than 15 nor more than 60 days prior to the redemption date by the Trustee
from the then outstanding Notes not previously called for redemption or purchase. 
 (b) The Trustee shall promptly notify the Partnership in
writing of the Notes of any series selected for redemption or purchase and, in the case of any Note selected for partial redemption or purchase, the principal amount thereof to be redeemed or purchased. Notes and portions of Notes of such series
selected shall be in amounts of $1,000 or integral multiples of $1,000; provided that no Notes of $2,000 in principal amount or less shall be redeemed in part. Except as provided in the preceding sentence, provisions of this Indenture that
apply to Notes of any series called for redemption or purchase also apply to portions of such Notes called for redemption or purchase. 
 (c)
After the redemption date or purchase date, upon surrender of a Note to be redeemed or purchased in part only, a new Note or Notes in principal amount equal to the unredeemed or unpurchased portion of the original Note, representing the same Debt to
the extent not redeemed or not purchased, shall be issued in the name of the Holder of the Notes upon cancellation of the original Note (or appropriate book entries shall be made to reflect such partial redemption). 

Section 3.03 Notice of Redemption. 

(a) The Partnership shall mail or deliver by electronic transmission in accordance with the applicable procedures of the Depositary, or cause
to be mailed (or delivered by electronic transmission in accordance with the applicable procedures of the Depositary) notices of redemption of Notes of any series not less than 15 days but not more than 60 days before the redemption date to each
Holder whose Notes are to be redeemed pursuant to this Article at such Holder’s registered address or otherwise in accordance with the applicable procedures of the Depositary, except that redemption notices may be sent more than 60 days prior
to a redemption date if the notice is issued in connection with Article 8 or Article 11. Notices of redemption may not be conditional. 

  
 -18- 

 (b) The notice shall identify the Notes of any series to be redeemed (including CUSIP and
ISIN number, if applicable) and shall state: 
 (1) the redemption date; 

(2) the redemption price, including the portion thereof representing any accrued and unpaid interest; provided that in
connection with a redemption under Section 3.07(a), the notice need not set forth the redemption price but only the manner of calculation thereof; 

(3) if any Note is to be redeemed in part only, the portion of the principal amount of such Note that is to be redeemed; 

(4) the name and address of the Paying Agent; 

(5) that Notes of any series called for redemption must be surrendered to the Paying Agent to collect the redemption price;

 (6) that, unless the Partnership defaults in making such redemption payment or the Paying Agent is prohibited from making
such payment pursuant to the terms of this Indenture, interest on Notes of any series called for redemption ceases to accrue on and after the redemption date; 

(7) the paragraph or subparagraph of the Notes or Section of this Indenture pursuant to which the Notes of any series called
for redemption are being redeemed; and 
 (8) that no representation is made as to the correctness or accuracy of the CUSIP
or ISIN number, if any, listed in such notice or printed on the Notes of any series. 
 (c) At the Partnership’s request, the Trustee
shall give the notice of redemption in the Partnership’s name and at the Partnership’s expense; provided that the Partnership shall have delivered to the Trustee, at least two Business Days before notice of redemption is required to
be sent or caused to be sent to Holders pursuant to this Section 3.03 (unless a shorter notice shall be agreed to by the Trustee), an Officer’s Certificate requesting that the Trustee give such notice and setting forth the information to
be stated in such notice as provided in Section 3.03(b). 
 Section 3.04 Effect of Notice of Redemption. 

Once notice of redemption is mailed or delivered by electronic transmission in accordance with Section 3.03, Notes of any series called
for redemption become irrevocably due and payable on the redemption date at the redemption price. The notice, if mailed or delivered by electronic transmission in a manner herein provided, shall be conclusively presumed to have been given, whether
or not the Holder receives such notice. In any case, failure to give such notice or any defect in the notice to the Holder of any Note designated for redemption in whole or in part shall not affect the validity of the proceedings for the redemption
of any other Note. Subject to Section 3.05, on and after the redemption date, interest ceases to accrue on Notes of any series or portions of Notes called for redemption. 

  
 -19- 

 Section 3.05 Deposit of Redemption or Purchase Price. 

(a) No later than 11:00 a.m. (New York City time) on the redemption or purchase date (or such later time as such date to which the Trustee may
reasonably agree), the Partnership shall deposit with the Trustee or with the Paying Agent money sufficient to pay the redemption or purchase price of and accrued and unpaid interest on all Notes of any series to be redeemed or purchased on that
date. If a Note of such series is redeemed or purchased on or after a Record Date but on or prior to the related Interest Payment Date, then any accrued and unpaid interest to the redemption or purchase date in respect of such Note will be paid on
such redemption or purchase date to the Person in whose name such Note is registered at the close of business on such Record Date. The Paying Agent shall promptly send to each Holder whose Notes of such series are to be redeemed or repurchased the
applicable redemption or purchase price thereof and accrued and unpaid interest thereon. The Trustee or the Paying Agent shall promptly return to the Partnership any money deposited with the Trustee or the Paying Agent by the Partnership in excess
of the amounts necessary to pay the redemption or purchase price of, and accrued and unpaid interest on, all Notes of such series to be redeemed or purchased. 

(b) If the Partnership complies with the provisions of Section 3.05(a), on and after the redemption or purchase date, interest shall cease
to accrue on the Notes of any series or the portions of Notes called for redemption or purchase. If a Note of such series is redeemed or purchased on or after a Record Date but on or prior to the related Interest Payment Date, then any accrued and
unpaid interest to the redemption or purchase date in respect of such Note will be paid on such redemption or purchase date to the Person in whose name such Note is registered at the close of business on such Record Date. If any Note of any series
called for redemption or purchase shall not be so paid upon surrender for redemption or purchase because of the failure of the Partnership to comply with Section 3.05(a), interest shall be paid on the unpaid principal, from the redemption or
purchase date until such principal is paid, and, to the extent lawful, on any interest accrued to the redemption or purchase date not paid on such unpaid principal, in each case at the rate provided in the Notes and in Section 4.01. 

Section 3.06 Notes Redeemed or Purchased in Part. 

Upon surrender of a Note of any series that is redeemed or purchased in part, the Partnership shall issue and, upon receipt of an
Authentication Order, the Trustee shall promptly authenticate and mail to the Holder (or cause to be transferred by book entry) at the expense of the Partnership a new Note of such series equal in principal amount to the unredeemed or unpurchased
portion of the Note of such series surrendered representing the same Debt to the extent not redeemed or purchased; provided that each new Note of such series shall be in a principal amount of $2,000 or an integral multiple of $1,000 in excess
thereof. It is understood that, notwithstanding anything in this Indenture to the contrary, only an Authentication Order and not an Opinion of Counsel or Officer’s Certificate is required for the Trustee to authenticate such new Note. 

Section 3.07 Optional Redemption. 

(a) The Notes of any series are subject to redemption, in whole or in part at any time before the applicable Par Call Date, at a redemption
price equal to the greater of (1) 100% of the principal amount of the Notes of such series to be redeemed and (2) the sum of the present values of the remaining scheduled payments of principal and interest on such Notes that would have been due
if such Notes matured on the applicable Par Call Date (exclusive of interest accrued to the redemption date) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of
twelve 30-day months) at the Treasury Rate plus 50 basis points in the case of the 2029 Notes, and the Treasury Rate plus 50 basis points in the case of the 2031 Notes, plus, in each case, accrued and unpaid
interest, if any, on the principal amount being redeemed to, but excluding, such redemption date. On or after the applicable Par Call Date, the Partnership may redeem the Notes of the relevant series, in whole or in part, at a price equal to 100% of
the principal amount of such Notes to be redeemed plus accrued and unpaid interest on such Notes to be redeemed to, but excluding, the date of redemption. 

  
 -20- 

 (b) Any redemption pursuant to this Section 3.07 shall be made pursuant to the
provisions of Sections 3.01 through 3.06. 
 Section 3.08 Mandatory Redemption. 

The Partnership will not be required to make mandatory redemption or sinking fund payments with respect to the Notes. 

ARTICLE 4 
 COVENANTS 

Section 4.01 Payment of Notes. 
 (a)
The Partnership will pay, or cause to be paid, the principal, premium, if any, and interest on the Notes on the dates and in the manner provided in the Notes. Principal, premium, if any, and interest shall be considered paid on the date due if the
Paying Agent, if other than the Partnership or a Subsidiary, holds as of 11:00 a.m. (New York City) time, on the due date money deposited by the Partnership in immediately available funds and designated for and sufficient to pay the principal,
premium, if any, and interest then due. 
 (b) The Partnership shall pay interest (including post-petition interest in any proceeding under
any Bankruptcy Law) on overdue principal and premium, if any, at the rate equal to the then applicable interest rate on the Notes to the extent lawful; it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy
Law) on overdue installments of interest (without regard to any applicable grace period) at the same rate to the extent lawful. 
 Section 4.02
Maintenance of Office or Agency. 
 The Partnership shall maintain an office or agency (which may be an office of the Trustee or an
affiliate of the Trustee, Registrar or co-registrar) where Notes may be surrendered for registration of transfer or for exchange and where notices and demands to or upon the Partnership and the Subsidiary
Guarantors in respect of the Notes and this Indenture may be served. The Partnership shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Partnership shall fail
to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. 

The Partnership may also from time to time designate additional offices or agencies where the Notes may be presented or surrendered for any or
all such purposes and may from time to time rescind such designations. The Partnership shall give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency. 

The Partnership hereby designates the Corporate Trust Office of the Trustee as one such office or agency of the Partnership in accordance with
Section 2.03. 

  
 -21- 

 Section 4.03 Taxes. 

The Partnership shall pay, and shall cause each of its Subsidiaries to pay, prior to delinquency, all material taxes, assessments and
governmental levies except (a) such as are being contested in good faith and by appropriate negotiations or proceedings or (b) where the failure to effect such payment would not have a material adverse effect (1) upon the financial
condition, business or results of operations of the Partnership and its Subsidiaries taken as a whole and (2) on the ability of the Partnership and any Subsidiary Guarantors to perform their respective obligations under the Notes or this
Indenture. 
 Section 4.04 Stay, Extension and Usury Laws. 

The Partnership and each Subsidiary Guarantor covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon,
plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time hereafter in force, that may affect the covenants or the performance of this Indenture; and the
Partnership and each Subsidiary Guarantor (to the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and covenant that it shall not, by resort to any such law, hinder, delay or impede the execution
of any power herein granted to the Trustee, but shall suffer and permit the execution of every such power as though no such law has been enacted. 

Section 4.05 Existence. 
 Subject to
Article 5, the Partnership shall do or cause to be done all things necessary to preserve and keep in full force and effect (1) its limited partnership existence and the corporate, partnership, limited liability company or other existence of
each of its Subsidiaries, in accordance with the respective organizational documents (as the same may be amended from time to time) of the Partnership or any such Subsidiary and (2) the rights (charter and statutory), licenses and franchises of
the Partnership and its Subsidiaries; provided that the Partnership shall not be required to preserve any such right, license or franchise, or the corporate, partnership, limited liability company or other existence of any of its
Subsidiaries, if the Partnership in good faith shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Partnership and its Subsidiaries, taken as a whole. 

Section 4.06 Reports and Other Information. 

(a) For so long as the Partnership is subject to the requirements of Section 13 or 15(d) of the Exchange Act, the Partnership shall
furnish to the Trustee, within 15 days after the Partnership files the same with the SEC, copies of the information, documents and other reports (or copies of such portions of any of the foregoing as the SEC may by rules and regulations prescribe)
that the Partnership is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act. 
 (b) If the Partnership is
not subject to the requirements of Section 13 or 15(d) of the Exchange Act, then the Partnership may satisfy its obligations under this Section 4.06 with respect to the information that would be required in Section 4.06(a) above by
posting such information on a publicly available website maintained by the Partnership or, so long as the Partnership is a consolidated Subsidiary (direct or indirect) of Equitrans Midstream Corporation (or any other direct or indirect parent
company) for financial reporting purposes, by furnishing the corresponding reports of Equitrans Midstream Corporation (or such other parent company) within the time periods specified in the SEC’s rules and regulations for filing such
corresponding reports; provided that the financial statements and other information of Equitrans Midstream Corporation (or such other parent company) contained in such reports satisfy the requirements of Section 4.06(c) below. 

  
 -22- 

 (c) If the Partnership elects to satisfy its obligations under this Section 4.06 by
furnishing the corresponding reports of Equitrans Midstream Corporation (or such other parent company), and such financial information reflects material assets or operations of Subsidiaries of Equitrans Midstream Corporation (or such other parent
company) other than the assets or operations of the Partnership and its direct or indirect Subsidiaries, then the quarterly and annual financial information required by Section 4.06(a) and Section 4.06(b) above shall include an additional
summary presentation, either on the face of the financial statements, in the footnotes thereto, or in “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of the financial condition and results of
operations of the Partnership separate from the financial condition and results of operations of Equitrans Midstream Corporation (or such other parent company). The requirement to provide additional summary financial information required by this
Section 4.06(c) shall be deemed satisfied if such information is posted on a website in the manner described in Section 4.06(b) above. 

(d) In addition, for so long as any Notes remain outstanding, if the Partnership is not subject to the requirements of Section 13 or 15(d)
of the Exchange Act, the Partnership shall furnish to all Holders and prospective purchasers of the Notes designated by the Holders of Notes, promptly upon their request, the information required to be delivered pursuant to Rule 144A(d)(4)
promulgated under the Securities Act. The availability of the foregoing information or reports on the SEC’s website will be deemed to satisfy the foregoing delivery requirements. 

(e) Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of
such shall not constitute actual or constructive notice or knowledge of any information contained therein or determinable from information contained therein, including the Partnership’s compliance with any if its covenants hereunder (as to
which the Trustee is entitled to rely exclusively on Officer’s Certificates). 
 Section 4.07 Compliance Certificate. 

(a) The Partnership shall deliver to the Trustee, within 120 days after the end of each fiscal year of the Partnership, a statement signed by
the principal executive officer, principal financial officer or principal accounting officer of the General Partner, which need not constitute an Officer’s Certificate, stating that in the course of performance by the signing officer of his
duties as such officer of the General Partner, he would normally obtain knowledge of the keeping, observing, performing and fulfilling by the Partnership and any Subsidiary Guarantor of its obligations under this Indenture, and further stating that
to the best of his knowledge each of the Partnership and any Subsidiary Guarantor has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the
terms, provisions and conditions hereof (or, if a Default or Event of Default shall have occurred, describing all such Defaults or Events of Default of which such officer may have knowledge and what action the Partnership and any Subsidiary
Guarantor is taking or proposes to take with respect thereto). 
 (b) The Partnership shall, so long as Notes of any series are outstanding,
deliver to the Trustee, as soon as practicable, but in no event more than 30 days, after any Officer of the General Partner becoming aware of any Default or Event of Default under this Indenture, a statement specifying such Default or Event of
Default and what action the Partnership and any Subsidiary Guarantor is taking or proposes to take with respect thereto. The Trustee does not have notice of default unless a Responsible Officer for administration of trust has actual written notice.

  
 -23- 

 Section 4.08 Limitation on Liens. 

The Partnership shall not, and shall not permit any of its Principal Subsidiaries to, create, or permit to be created or to exist, any Lien
upon any Principal Property of the Partnership or any of its Principal Subsidiaries, or upon any equity interests of any Principal Subsidiary, whether such Principal Property is, or equity interests are, owned on or acquired after the Issue Date, to
secure any Debt, unless the Notes of each applicable series then outstanding are equally and ratably secured by such Lien for so long as any such Debt is so secured, other than: 

(1) purchase money mortgages, or other purchase money Liens of any kind upon property acquired by the Partnership or any Principal Subsidiary
after the Issue Date, or Liens of any kind existing on any property or any equity interests at the time of the acquisition thereof (including Liens that exist on any property or any equity interests of a Person that is consolidated with or merged
with or into the Partnership or any Principal Subsidiary or that transfers or leases all or substantially all of its properties or assets to the Partnership or any Principal Subsidiary), or conditional sales agreements or other title retention
agreements and leases in the nature of title retention agreements with respect to any property acquired after the Issue Date, so long as no such Lien shall extend to or cover any other property of the Partnership or such Principal Subsidiary; 

(2) Liens upon any property of the Partnership or any Principal Subsidiary or any equity interests of any Principal Subsidiary existing as of
the Issue Date or upon the property or any equity interests of any Person, which Liens existed at the time such Person became a Subsidiary of the Partnership; 

(3) Liens for taxes or assessments or other governmental charges or levies relating to amounts that are not yet delinquent or are being
contested in good faith; 
 (4) pledges or deposits to secure: (a) any other governmental charges or levies; (b) obligations under
workers’ compensation laws, unemployment insurance and other social security legislation; (c) performance in connection with bids, tenders, contracts (other than contracts for the payment of money) or leases to which the Partnership or any
Principal Subsidiary is a party; (d) public or statutory obligations of the Partnership or any Principal Subsidiary; and (e) surety, stay, appeal, indemnity, customs, performance or return-of-money bonds or pledges or deposits in lieu thereof; 
 (5) statutory or governmental Liens
or Liens arising by operation of law, or builders’, materialmen’s, mechanics’, carriers’, warehousemen’s, workers’, repairmen’s, operators’, landlords’ or other similar Liens in the ordinary course of
business; 
 (6) Liens created by or resulting from any litigation or proceeding that at the time is being contested in good faith by
appropriate proceedings, including Liens relating to judgments thereunder as to which the Partnership or any Principal Subsidiary has not exhausted its appellate rights; 

(7) Liens on deposits required by any Person with whom the Partnership or any Principal Subsidiary enters into forward contracts, futures
contracts, Swap Contracts or other commodities contracts in the ordinary course of business and in accordance with established risk management policies; 

(8) Liens in connection with leases (other than finance leases as defined in accordance with ASC 842-40-55 of Accounting Standards Codification 842, Leases) made, or existing on property acquired, in the ordinary course of business; and Liens, if any, in connection with leases for the operation of
pipelines, gathering systems, terminals, plants and facilities and the performance of related services; 

  
 -24- 

 (9) easements (including, without limitation, reciprocal easement agreements and utility
agreements), zoning restrictions, rights-of-way, covenants, consents, reservations, encroachments, variations and other restrictions on the use of property or minor
irregularities in title thereto, charges or encumbrances (whether or not recorded) affecting the use of real property and which are incidental to, and do not materially impair the use of such property in the operation of the business of the
Partnership and its Subsidiaries, taken as a whole, or the value of such property for the purpose of such business; 
 (10) Liens in favor of
the United States of America, any State, any foreign country or any department, agency or instrumentality or political subdivision of any such jurisdiction, to secure partial, progress, advance or other payments pursuant to any contract or statute
or to secure any Debt incurred for the purpose of financing all or any part of the purchase price or the cost of constructing or improving the property subject to such Liens, including, without limitation, Liens to secure Debt of the pollution
control, industrial development or similar revenue bond type; 
 (11) Liens of any kind upon any property acquired, constructed, developed or
improved by the Partnership or any Principal Subsidiary (whether alone or in association with others) after the Issue Date that are created prior to, at the time of, or within 12 months after such acquisition (or in the case of property constructed,
developed or improved, after the completion of such construction, development or improvement and commencement of full commercial operation of such property, whichever is later) to secure or provide for the payment of any part of the purchase price
or cost thereof; provided that in the case of such construction, development or improvement the Liens shall not apply to any property theretofore owned by the Partnership or any Principal Subsidiary other than theretofore unimproved real
property; 
 (12) Liens upon any additions, improvements, replacements, repairs, fixtures, appurtenances or component parts thereof attaching
to or required to be attached to property or assets pursuant to the terms of any mortgage, pledge agreement, security agreement or other similar instrument, creating a Lien upon such property or assets permitted by Section 4.08(1) through
Section 4.08(11) above; 
 (13) Liens in favor of the Partnership, one or more Principal Subsidiaries, one or more wholly owned
Subsidiaries of the Partnership or any of the foregoing in combination; 
 (14) the replacement, extension or renewal (or successive
replacements, extensions or renewals), as a whole or in part, of any Lien, or of any agreement, referred to in the clauses above, or the replacement, extension or renewal of the Debt secured thereby (not exceeding the principal amount of Debt
secured thereby, other than to provide for the payment of any underwriting or other fees related to any such replacement, extension or renewal, as well as any premiums owed on and accrued and unpaid interest payable in connection with any such
replacement, extension or renewal); provided that such replacement, extension or renewal is limited to all or a part of the same property that secured the Lien replaced, extended or renewed (plus improvements thereon or additions or
accessions thereto); 
 (15) Liens resulting from the deposit of moneys or evidence of indebtedness in trust for the purpose of defeasing any
Debt of the Partnership or any Principal Subsidiary, or Liens on any amounts held by a trustee under any indenture issued in escrow pursuant to customary escrow arrangements pending the release thereof; or 

(16) any Lien not excepted by the foregoing Section 4.08(1) through Section 4.08(15); provided that immediately after the
creation or assumption of such Lien the aggregate principal amount of Debt of the Partnership or any Principal Subsidiary secured by all Liens created or assumed under the provisions of this Section 4.08(16), together with all net sale proceeds
from any Sale-Leaseback Transactions, subject to certain exceptions, shall not exceed an amount equal to 15% of the Consolidated Net Tangible Assets for the fiscal quarter that was most recently completed prior to the creation or assumption of such
Lien. 

  
 -25- 

 Notwithstanding the foregoing, for purposes of making the calculation set forth in
Section 4.08(16), with respect to any such secured Debt of a non-wholly-owned Principal Subsidiary of the Partnership with no recourse to the Partnership or any wholly owned Principal Subsidiary thereof,
only that portion of the aggregate principal amount of such secured Debt reflecting the Partnership’s pro rata ownership interest in such non-wholly-owned Principal Subsidiary shall be included in
calculating compliance with this Section 4.08. 
 Section 4.09 Limitation on Sale-Leaseback Transactions. The Partnership shall not, and
shall not permit any of its Principal Subsidiaries to, engage in a Sale-Leaseback Transaction, unless: 
 (1) the Sale-Leaseback Transaction
occurs within one year from the date of acquisition of the relevant Principal Property or the date of the completion of construction, development or substantial repair or improvement, or commencement of full operations on such Principal Property,
whichever is later, and the Partnership has elected to designate, as a credit against (but not exceeding) the purchase price or cost of construction, development, repair or improvement of such Principal Property, an amount equal to all or a portion
of the net sale proceeds from such Sale-Leaseback Transaction (with any such amount not being so designated to be applied as set forth in Section 4.09(3) below); 

(2) the Partnership or such Principal Subsidiary would be entitled to incur Debt secured by a Lien on the Principal Property subject to the
Sale-Leaseback Transaction in a principal amount equal to or exceeding the net sale proceeds from such Sale-Leaseback Transaction without equally and ratably securing the Notes; or 

(3) the Partnership or such Principal Subsidiary, within a 270-day period after such Sale-Leaseback
Transaction, applies or causes to be applied an amount not less than the net sale proceeds from such Sale-Leaseback Transaction to (a) the prepayment, repayment, redemption or retirement of any unsubordinated Debt of the Partnership or any of
its Subsidiaries or (b) the investment in another Principal Property. 
 Section 4.10 Future Subsidiary Guarantors. 

(a) The Notes of each series initially shall not be entitled to the benefits of any Notes Guarantee of any Subsidiary Guarantor contemplated by
Article 10 of this Indenture. 
 (b) If any Subsidiary of the Partnership that is not then a Subsidiary Guarantor provides a guarantee under
the Credit Agreement, then the Partnership shall cause such Subsidiary to promptly execute and deliver to the Trustee a supplemental indenture in accordance with Article 10 to evidence its Note Guarantee and such Subsidiary shall be named as a
Subsidiary Guarantor with respect to the Notes of each series. 
 (c) Each Note Guarantee shall be released in accordance with the provisions
of Section 10.06. 
 Section 4.11 Offer to Repurchase Upon Change of Control. 

(a) If a Change of Control Triggering Event occurs, unless the Partnership has previously or concurrently exercised its right to redeem all of
the Notes pursuant to Sections 3.03 and 3.07, the Partnership will make an offer (a “Change of Control Offer”), and each Holder of Notes will have the right to require the Partnership to, repurchase all or any part (equal to
$2,000 or an integral multiple of $1,000 in excess of $2,000) of such Holder’s Notes. In the Change of Control Offer, the Partnership will offer a cash payment (a “Change of Control Payment”) equal to 101% of the aggregate

  
 -26- 

 
principal amount of Notes repurchased plus accrued and unpaid interest, if any, on the Notes repurchased, to, but excluding, the date of settlement (the “Change of Control Settlement
Date”), subject to the right of Holders of record on the relevant record date to receive interest due on an interest payment date that is on or prior to the Change of Control Settlement Date. Within 30 days following any Change of Control
Triggering Event, unless the Partnership has previously or concurrently exercised its right to redeem all of the Notes pursuant to Sections 3.03 and 3.07, the Partnership will send a notice to each Holder of Notes and the Trustee describing the
transaction or transactions and identification of the ratings decline that together constitute the Change of Control Triggering Event and providing the below information: 

(1) that a Change of Control Offer is being made pursuant to this Section 4.11, the expiration time for such Change of
Control Offer (which shall be no earlier than 15 days nor later than 60 days from the date such notice is mailed or otherwise delivered in accordance with the applicable procedures of the Depositary) and that all Notes properly tendered pursuant to
such Change of Control Offer will be accepted for repurchase by the Partnership at a purchase price in cash equal to 101% of the aggregate principal amount of such Notes plus accrued and unpaid interest, if any, on the Notes repurchased to, but
excluding, the Change of Control Settlement Date (subject to the right of Holders of record on the applicable Record Date to receive interest due on the Change of Control Settlement Date) pursuant to Section 4.11(d) below; 

(2) the purchase date (which shall be no later than five Business Days after the date such Change of Control Offer expires);

 (3) that Notes must be tendered in integral multiples of $1,000, and any Note not properly tendered will remain
outstanding and continue to accrue interest (subject to clause (7) below); 
 (4) that, unless the Partnership defaults
in the payment of the Change of Control Payment, any Note accepted for payment pursuant to the Change of Control Offer will cease to accrue interest on and after the Change of Control Settlement Date; 

(5) that Holders electing to have any Notes purchased pursuant to a Change of Control Offer will be required to surrender such
Notes, with the form entitled “Option of Holder to Elect Purchase” attached to such Notes completed, to the Paying Agent specified in the notice at the address specified in the notice prior to the close of business on the third Business
Day preceding the Change of Control Settlement Date; 
 (6) that Holders shall be entitled to withdraw their tendered Notes
and their election to require the Partnership to purchase such Notes; provided that the Paying Agent receives at the address specified in the notice, not later than the expiration time of such Change of Control Offer, an electronic
transmission, facsimile transmission or letter setting forth the name of the Holder of the Notes, the principal amount of Notes tendered for purchase and a statement that such Holder is withdrawing its tendered Notes and its election to have such
Notes purchased; 
 (7) that, if a Holder is tendering less than all of its Notes, such Holder will be issued new Notes equal
in principal amount to the unpurchased portion of the Notes surrendered (the unpurchased portion of the Notes must be equal to $2,000 or an integral multiple of $1,000 in excess thereof); and 

(8) the other procedures, as determined by the Partnership, consistent with this Section 4.11 that a Holder must follow.

  
 -27- 

 The notice, if mailed or otherwise delivered in a manner herein provided, shall be conclusively presumed to
have been given, whether or not the Holder receives such notice. If (A) the notice is mailed or otherwise delivered in a manner herein provided and (B) any Holder fails to receive such notice or a Holder receives such notice but it is
defective, such Holder’s failure to receive such notice or such defect shall not affect the validity of the proceedings for the purchase of the Notes as to all other Holders that properly received such notice without defect. 

(b) Promptly following the expiration of the Change of Control Offer, the Partnership will, to the extent lawful, accept for payment all Notes
or portions of Notes properly tendered and not withdrawn pursuant to the Change of Control Offer. Promptly thereafter on or before the Change of Control Settlement Date, the Partnership will: 

(1) deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Notes or portions of Notes properly
tendered; and 
 (2) deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officer’s Certificate
stating the aggregate principal amount of Notes or portions of Notes being repurchased by the Partnership. 
 (c) On the Change of Control
Settlement Date, the Paying Agent will mail to each Holder of Notes properly tendered the Change of Control Payment for such Notes (or, if all the Notes are then in global form, make such payment through the facilities of the Depository), and the
Trustee will authenticate and mail (or cause to be transferred by book entry) to each Holder a new Note equal in principal amount to any unrepurchased portion of the Notes surrendered, if any; provided, however, that each new Note will
be in a principal amount of $2,000 or an integral multiple of $1,000 in excess of $2,000. The Partnership will publicly announce the results of the Change of Control Offer on or as soon as practicable after the Change of Control Settlement Date.

 (d) If the Change of Control Settlement Date is on or after a Record Date and on or before the related Interest Payment Date, any accrued
and unpaid interest to the Change of Control Settlement Date will be paid on the Change of Control Settlement Date to the Person in whose name a Note is registered at the close of business on such Record Date. 

(e) Prior to making a Change of Control Payment, and as a condition to such payment, (1) the requisite lenders or holders of Debt incurred
or issued under a credit facility, an indenture or other agreement that may be violated by such payment shall have consented to such Change of Control Payment being made and waived the event of default, if any, caused by the Change of Control
Payment or (2) the Partnership will repay all outstanding Debt incurred or issued under a credit facility, an indenture or other agreement that may be violated by a Change of Control Payment or the Partnership will offer to repay all such Debt,
make payment to the lenders or holders of such Debt that accept such offer and obtain waivers of any event of default arising under the relevant credit facility, indenture or other agreement from the remaining lenders or holders of such Debt. The
Partnership covenants to effect such repayment or obtain such consent prior to making a Change of Control Payment, it being a default of the Change of Control provisions of this Indenture if the Partnership fails to comply with such covenant. 

(f) The Partnership will not be required to make a Change of Control Offer upon a Change of Control Triggering Event if (1) a third party
makes the Change of Control Offer in the manner, at the time and otherwise in compliance with the requirements set forth in this Section 4.11 applicable to a Change of Control Offer made by the Partnership and purchases all Notes properly
tendered and not withdrawn under the Change of Control Offer or (2) in connection with, or in contemplation of any publicly announced Change of Control, the Partnership has made an offer to purchase (an “Alternate Offer”) any
and all Notes validly tendered at a cash price equal to or higher than the Change of Control 

  
 -28- 

 
Payment and has purchased all Notes properly tendered in accordance with the terms of such Alternate Offer. Notwithstanding anything to the contrary contained in this Indenture, a Change of
Control Offer may be made in advance of a Change of Control Triggering Event, and conditioned upon the consummation of such Change of Control Triggering Event if a definitive agreement is in place for the Change of Control at the time the Change of
Control Offer is made. 
 (g) In the event that upon consummation of a Change of Control Offer or Alternate Offer less than 10% in aggregate
principal amount of the Notes (including Additional Notes, if any) that were originally issued are held by Holders other than the Partnership or its Affiliates, the Partnership will have the right, upon not less than 30 nor more than 60 days’
prior notice, given not more than 30 days following the purchase pursuant to the Change of Control Offer or Alternate Offer described in this Section 4.11, to redeem all of the Notes that remain outstanding following such purchase at a
redemption price equal to the Change of Control Payment or Alternate Offer price, as applicable, plus, to the extent not included in the Change of Control Payment, accrued and unpaid interest on the Notes that remain outstanding, to, but excluding,
the date of redemption (subject to the right of Holders of record on the relevant record date to receive interest due on an Interest Payment Date that is on or prior to the redemption date). 

(h) The Partnership will comply with the requirements of Rule 14e-1 under the Exchange Act and any
other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any
securities laws or regulations conflict with the Change of Control Triggering Event provisions of this Indenture, the Partnership will comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations
under the Change of Control Triggering Event provisions of this Indenture by virtue of such compliance. 
 (i) Other than as specifically
provided in this Section 4.11, any purchase pursuant to this Section 4.11 shall be made pursuant to the provisions of Sections 3.02, 3.05 and 3.06. 

ARTICLE 5 
 SUCCESSORS 

Section 5.01 Merger, Consolidation or Sale of All or Substantially All Assets. 

Neither the Partnership nor any Subsidiary Guarantor shall consolidate with or merge into any Person, or sell, lease, convey, assign, transfer
or otherwise dispose of, in any transaction or series of related transactions, all or substantially all of its assets to any Person (other than a consolidation or merger of the Partnership and one or more Subsidiary Guarantors or of two or more
Subsidiary Guarantors, or a sale, lease, conveyance, assignment, transfer or other disposition of all or substantially all of the assets of the Partnership to one or more Subsidiary Guarantors or of a Subsidiary Guarantor to the Partnership or one
or more other Subsidiary Guarantors), unless: 
 (1) either (a) the Partnership or such Subsidiary Guarantor, as the
case may be, shall be the continuing Person or (b) the Person (if other than the Partnership or such Subsidiary Guarantor) formed by such consolidation or into which the Partnership or such Subsidiary Guarantor is merged, or to which such sale,
lease, conveyance, assignment, transfer or other disposition shall be made (collectively, the “Successor”), is organized under the laws of the United States of America, any political subdivision thereof or any State thereof or the
District of Columbia, and expressly assumes by supplemental indenture, in the case of the Partnership, the due and punctual payment of the principal of, premium (if any) and interest on all the Notes of each series and the performance of the
Partnership’s covenants and obligations under this Indenture and such Notes, or, in the case of such Subsidiary Guarantor, the performance of the Note Guarantee and such Subsidiary Guarantor’s covenants and obligations under this Indenture
and the Notes of any series; and 

  
 -29- 

 (2) immediately after giving effect to such transaction or series of
transactions, no Default or Event of Default shall have occurred and be continuing or would result therefrom. 
 Section 5.02 Successor Entity
Substituted. 
 Upon any consolidation or merger of the Partnership or a Subsidiary Guarantor, as the case may be, or any sale, lease,
conveyance, assignment, transfer or other disposition of all or substantially all of the assets of the Partnership or such Subsidiary Guarantor in accordance with Section 5.01, the Successor formed by such consolidation or into which the
Partnership or such Subsidiary Guarantor is merged or to which such sale, lease, conveyance, assignment, transfer or other disposition is made shall succeed to, and be substituted for, and may exercise every right and power of the Partnership or
such Subsidiary Guarantor, as the case may be, under this Indenture and the Notes of each series with the same effect as if such Successor had been named as the Partnership or such Subsidiary Guarantor, as the case may be, herein and the predecessor
Partnership or Subsidiary Guarantor, in the case of a sale, conveyance, assignment, transfer or other disposition (except a lease), shall be released from all obligations under this Indenture, the Notes of each series and, in the case of a
Subsidiary Guarantor, its Note Guarantee. 
 ARTICLE 6 

DEFAULTS AND REMEDIES 
 Section 6.01
Events of Default. 
 (a) Each of the following is an “Event of Default” with respect to the Notes of each series:

 (1) default in the payment of interest on such Notes when due that continues for 30 days; 

(2) default in the payment of principal of or premium, if any, on any such Notes when due, whether at its Stated Maturity, upon
redemption or otherwise; 
 (3) failure by the Partnership or any Subsidiary Guarantor to comply for 90 days with the other
agreements with respect to such Notes contained in this Indenture after written notice by the Trustee or by the Holders of at least 25% in principal amount of the outstanding Notes of such series; 

(4) (i) the Partnership, or if the series of Notes is entitled to the benefits of a Note Guarantee by a Subsidiary Guarantor
that is a Significant Subsidiary, any such Subsidiary Guarantor, pursuant to or within the meaning of any Bankruptcy Law: 

(A) commences a voluntary case; 

(B) consents to the entry of an order for relief against it in an involuntary case; 

  
 -30- 

 (C) consents to the appointment of a Bankruptcy Custodian of it or for all
or substantially all of its property; or 
 (D) makes a general assignment for the benefit of its creditors; or 

(ii) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that remains unstayed and in effect
for 90 days and that: 
 (A) is for relief against the Partnership, or if the series of Notes is entitled to the benefits of
a Note Guarantee by a Subsidiary Guarantor that is a Significant Subsidiary, any such Subsidiary Guarantor as debtor in an involuntary case; 

(B) appoints a Bankruptcy Custodian of the Partnership or any such Subsidiary Guarantor or a Bankruptcy Custodian for all or
substantially all of the property of the Partnership or any such Subsidiary Guarantor; or 
 (C) orders the liquidation of
the Partnership or any such Subsidiary Guarantor; 
 (5) if a series of Notes is Guaranteed by a Subsidiary Guarantor that is
a Significant Subsidiary, (a) the Note Guarantee of such Subsidiary Guarantor ceases to be in full force and effect, except as otherwise provided in this Indenture; (b) the Note Guarantee of such Subsidiary Guarantor is declared null and
void in a judicial proceeding; or (c) such Subsidiary Guarantor denies or disaffirms its Obligations under this Indenture or its Note Guarantee. 
 The
term “Bankruptcy Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law. 
 However, a
Default under Section 6.01(a)(3) will not constitute an Event of Default until the Trustee or the Holders of at least 25% in principal amount of the then outstanding Notes of such series notify the Partnership of the Default and the Partnership
does not cure such Default within the time specified in Section 6.01(a)(3) after receipt of such notice. 
 Section 6.02 Acceleration. 

(a) If an Event of Default (other than an Event of Default described in Section 6.01(a)(4)) occurs and is continuing, the Trustee by
written notice to the Partnership, specifying the Event of Default, or the Holders of at least 25% in principal amount of the then outstanding Notes of any series by notice to the Partnership and the Trustee, may, and the Trustee at the request of
such Holders shall, declare the principal, premium, if any, and accrued and unpaid interest, if any, on all the Notes of such series to be due and payable. Upon such declaration, such principal, premium, if any, and accrued and unpaid interest, if
any, will be due and payable. 
 The Trustee shall have no obligation to accelerate the Notes of any series if and so long as a committee of its Responsible
Officers, in good faith, determines acceleration is not in the interest of the Holders. 
 (b) In case an Event of Default described in
Section 6.01(a)(4) occurs and is continuing, the principal of, premium, if any, and accrued and unpaid interest, if any, on all the Notes if each series will become and be immediately due and payable without any declaration or other act on the
part of the Trustee or any Holders. 

  
 -31- 

 (c) The Holders of a majority in principal amount of the outstanding Notes of each series
may waive all past Events of Default (except with respect to nonpayment of principal, premium or interest) and rescind any acceleration with respect to the Notes of such series and its consequences if (1) such rescission would not conflict with
any judgment or decree of a court of competent jurisdiction and (2) all existing Events of Default, other than the nonpayment of the principal of, premium, if any, and interest on the Notes of such series that have become due solely by such
declaration of acceleration, have been cured or waived. 
 Section 6.03 Other Remedies. 

If an Event of Default occurs and is continuing, the Trustee may pursue any available remedy to collect the payment of principal, premium, if
any, and interest on the Notes of any series or to enforce the performance of any provision of the Notes of such series or this Indenture. 

The Trustee may maintain a proceeding even if it does not possess any of the Notes of any series or does not produce any of them in the
proceeding. A delay or omission by the Trustee or any Holder of a Note of a series in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of
Default. All remedies are cumulative to the extent permitted by law. 
 Section 6.04 Waiver of Past Defaults. 

The Holders of a majority in principal amount of the outstanding Notes of each series by written notice to the Trustee may on behalf of all
Holders waive any past or existing Default and its consequences hereunder, except: 
 (1) a continuing Default in the payment
of the principal, premium, if any, or interest on any Note of such series held by a non-consenting Holder (including in connection with a Change of Control Offer); and 

(2) a Default with respect to a provision that under Section 9.02 cannot be amended without the consent of each Holder
affected, 
 provided that, subject to Section 6.02, the Holders of a majority in principal amount of the then outstanding Notes of such series
may rescind an acceleration and its consequences, including any related payment Default that resulted from such acceleration. Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have
been cured for every purpose of this Indenture, but no such waiver shall extend to any subsequent or other Default or impair any right consequent thereon. 

Section 6.05 Control by Majority. 

The Holders of a majority in principal amount of the outstanding Notes may direct the time, method and place of conducting any proceeding for
any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee. However, the Trustee may refuse to follow any direction that conflicts with law, this Indenture, the Notes or any Note Guarantee, or that the Trustee
determines in good faith is unduly prejudicial to the rights of any other Holder or that would involve the Trustee in personal liability. 

  
 -32- 

 Section 6.06 Limitation on Suits. 

Subject to Section 6.07, no Holder may pursue any remedy with respect to this Indenture or the Notes of any series unless: 

(1) the Holder gives the Trustee written notice of a continuing Event of Default for such Notes; 

(2) the Holders of at least 25% in principal amount of the outstanding Notes of such series make a written request to the
Trustee to pursue the remedy; 
 (3) the Holders offer to the Trustee security or indemnity satisfactory to the Trustee; 

(4) the Trustee fails to act for a period of 60 days after receipt of the request and offer of security or indemnity; and 

(5) during that 60-day period, the Holders of a majority in principal amount of such
Notes do not give the Trustee a direction inconsistent with the request. 
 A Holder may not use this Indenture to prejudice the rights of another Holder or
to obtain a preference or priority over another Holder. 
 Section 6.07 Rights of Holders to Receive Payment. 

Notwithstanding any other provision of this Indenture, the right of any Holder to receive payment of principal, premium, if any, and interest
on its Note of any series, on or after the respective due dates expressed or provided for in such Note (including in connection with a Change of Control Offer), or to bring suit for the enforcement of any such payment on or after such respective
dates, shall not be impaired or affected without the consent of such Holder. 
 Section 6.08 Collection Suit by Trustee. 

If an Event of Default specified in Section 6.01(a)(1) or Section 6.01(a)(2) occurs and is continuing, the Trustee may recover
judgment in its own name and as trustee of an express trust against the Partnership and any other obligor on the Notes of each series for the whole amount of principal, premium, if any, and interest remaining unpaid on such Notes, together with
interest on overdue principal and, to the extent lawful, interest and such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the
Trustee and its agents and counsel. 
 Section 6.09 Restoration of Rights and Remedies. 

If the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been
discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then and in every such case, subject to any determination in such proceedings, the Partnership, the Subsidiary Guarantors, the Trustee and
the Holders shall be restored severally and respectively to their former positions hereunder and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding has been instituted. 

  
 -33- 

 Section 6.10 Rights and Remedies Cumulative. 

Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes in Section 2.07, no
right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy are, to the extent permitted by law, cumulative and in addition to every other
right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other
appropriate right or remedy. 
 Section 6.11 Delay or Omission Not Waiver. 

No delay or omission of the Trustee or of any Holder to exercise any right or remedy accruing upon any Event of Default shall impair any such
right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article or by law to the Trustee or to the Holders may be exercised from time to time, and as often as may be deemed
expedient, by the Trustee or by the Holders, as the case may be. 
 Section 6.12 Trustee May File Proofs of Claim. 

The Trustee may file proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee
(including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders of the Notes allowed in any judicial proceedings relative to the Partnership (or any other obligor
upon the Notes, including the Subsidiary Guarantors), its creditors or its property and is entitled and empowered to participate as a member in any official committee of creditors appointed in such matter and to collect, receive and distribute any
money or other property payable or deliverable on any such claims. Any custodian in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee, and in the event that the Trustee shall consent to the making
of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee and its agents and counsel, and any other amounts due the Trustee under
Section 7.06. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.06 out of the estate in any such
proceeding, shall be denied for any reason, payment of the same shall be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that the Holders may be entitled to receive in such
proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of
reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. 

Section 6.13 Priorities. 
 If the
Trustee collects any money or property pursuant to this Article 6, it shall pay out the money in the following order: 
 (1)
to the Trustee and its agents and attorneys for amounts due under Section 7.06, including payment of all reasonable compensation, expenses and liabilities incurred, and all advances made, by the Trustee and the costs and expenses of collection;

  
 -34- 

 (3) to Holders for amounts due and unpaid on the Notes of each series for
principal, premium, if any, and interest ratably, without preference or priority of any kind, according to the amounts due and payable on such Notes for principal, premium, if any, and interest, respectively; and 

(4) to the Partnership or to such party as a court of competent jurisdiction shall direct, applicable. 

The Trustee may fix a record date and payment date for any payment to Holders pursuant to this Section 6.13. Promptly after any record date is set
pursuant to this Section 6.13, the Trustee shall cause notice of such record date and payment date to be given to the Partnership and to each Holder in the manner set forth in Section 12.01. 

Section 6.14 Undertaking for Costs. 

In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted
by it as a Trustee, a court in its discretion may require the filing by any party litigant in such suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’
fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.14 does not apply to a suit by the Trustee, a suit by a Holder pursuant to
Section 6.07, or a suit by Holders of more than 10% in aggregate principal amount of the outstanding Notes of any series. 
 ARTICLE 7

 TRUSTEE 
 Section 7.01 Duties of
Trustee. 
 (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such of the rights and powers vested in
it by this Indenture, and use the same degree of care and skill in such exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs. 

(b) Except during the continuance of an Event of Default with respect to the Notes of any series: 

(1) the Trustee need perform only those duties that are specifically set forth in this Indenture and no others, and no implied
covenants or obligations shall be read into this Indenture against the Trustee; and 
 (2) in the absence of bad faith on its
part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. However,
the Trustee shall examine such certificates and opinions to determine whether, on their face, they appear to conform to the requirements of this Indenture but need not confirm or investigate the accuracy of any such opinions and certificates. 

(c) The Trustee may not be relieved from liabilities for its own negligent action, its own negligent failure to act or its own willful
misconduct, except that: 

  
 -35- 

 (1) this paragraph does not limit the effect of Section 7.01(b); 

(2) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved
in a court of competent jurisdiction that the Trustee was negligent in ascertaining the pertinent facts; and 
 (3) the
Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05. 

(d) Whether or not therein expressly so provided, every provision of this Indenture that in any way relates to the Trustee is subject to this
Section 7.01. 
 (e) No provision of this Indenture shall require the Trustee to expend or risk its own funds or incur any liability.
The Trustee may refuse to perform any duty or exercise any right or power unless it receives indemnity satisfactory to it against any loss, liability or expense. 

(f) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Partnership.
Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. All money received by the Trustee shall, until applied as herein provided, be held in trust for the payment of the principal of, premium
(if any) and interest on the Notes of each series. 
 Section 7.02 Rights of Trustee. 

(a) The Trustee may conclusively rely on any document believed by it to be genuine and to have been signed or presented by the proper Person.
The Trustee need not investigate any fact or matter stated in the document. 
 (b) Before the Trustee acts or refrains from acting, it may
require instruction, an Officer’s Certificate or an Opinion of Counsel or both to be provided. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such instruction, Officer’s Certificate or
Opinion of Counsel. The Trustee may consult at the Partnership’s expense with counsel of its selection and the advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action
taken, suffered or omitted by it hereunder in good faith and in reliance thereon. 
 (c) The Trustee may act through its attorneys and agents
and shall not be responsible for the misconduct or negligence of any agent or attorney appointed with due care. 
 (d) The Trustee shall not
be liable for any action it takes or omits to take in good faith which it reasonably believes to be authorized or within its rights or powers conferred upon it by this Indenture. 

(e) Unless otherwise specifically provided in this Indenture, any demand, request, direction or notice from the Partnership or a Subsidiary
Guarantor shall be sufficient if signed by an Officer of the General Partner or such Subsidiary Guarantor. 
 (f) The Trustee shall not be
obligated to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other
paper or document. 

  
 -36- 

 (g) The rights, privileges, protections, immunities and benefits given to the Trustee,
including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder. 

(h) The Trustee may request that the Partnership deliver an Officer’s Certificate setting forth the names of individuals and/or titles of
officers authorized at such time to take specified actions pursuant to this Indenture, which Officer’s Certificate may be signed by any person authorized to sign an Officer’s Certificate, including any Person specified as so authorized in
any such certificate previously delivered and not superseded. 
 (i) In no event shall the Trustee be responsible or liable for special,
indirect, punitive or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of
action. 
 (j) The Trustee shall not be deemed to have notice of any Event of Default unless a Responsible Officer of the Trustee received
written notice of any event which is in fact such a default at the Corporate Trust Office of the Trustee, and such notice references the Notes and this Indenture. 

Section 7.03 May Hold Securities. 

The Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Partnership or its
Affiliates with the same rights it would have if it were not Trustee. Any Agent may do the same with like rights and duties. However, the Trustee is subject to Section 7.09. 

Section 7.04 Trustee’s Disclaimer. 

The Trustee makes no representation as to the validity or adequacy of this Indenture or the Notes, it shall not be accountable for the
Partnership’s use of the proceeds from the Notes or any money paid to the Partnership or upon the Partnership’s direction under any provision of this Indenture, it shall not be responsible for the use or application of any money received
by any Paying Agent other than the Trustee and it shall not be responsible for any statement or recital herein or any statement in the Notes other than its certificate of authentication on the Notes. 

Section 7.05 Notice of Defaults. 
 If
a Default or Event of Default with respect to the Notes of any series occurs and is continuing and it is actually known to the Trustee, the Trustee shall transmit to Holders of Notes of such series a notice of the Default or Event of Default within
90 days after it occurs. Except in the case of a Default or Event of Default in payment of principal of, premium (if any) and interest on the Notes of such series, the Trustee may withhold the notice if and so long as a committee of its Responsible
Officers in good faith determines that withholding the notice is in the interests of Holders of Notes of such series. 
 Section 7.06 Compensation
and Indemnity. 
 (a) The Partnership agrees to pay to the Trustee for its acceptance of this Indenture and services hereunder such
compensation as the Partnership and the Trustee shall from time to time agree in writing. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Partnership agrees to reimburse the
Trustee upon request for all reasonable disbursements, advances and expenses incurred by it. Such expenses shall include the reasonable compensation, disbursements and expenses of the Trustee’s agents and counsel. 

  
 -37- 

 (b) The Partnership hereby agrees to indemnify the Trustee and any predecessor Trustee
against any and all loss, liability, damage, claim or expense, including taxes (other than taxes based upon, measured by or determined by the income of the Trustee), incurred by it arising out of or in connection with the acceptance or
administration of its duties under this Indenture, except as set forth in the next following paragraph. The Trustee shall notify the Partnership promptly of any claim of which a Responsible Officer has received written notice and for which it may
seek indemnity. The Partnership shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Partnership shall pay the reasonable fees and expenses of such counsel. The Partnership need not pay
for any settlement made without its consent, which consent shall not be unreasonably withheld. 
 (c) The Partnership shall not be obligated
to reimburse any expense or indemnify against any loss or liability incurred by the Trustee as determined to have been caused by the Trustee’s own negligence, willful misconduct or bad faith. 

(d) To secure the payment obligations of the Partnership in this Section 7.06, the Trustee shall have a Lien prior to the Notes on all
money or property held or collected by the Trustee, except for money or property held in trust to pay principal of, premium (if any) and interest on Notes of any series. Such Lien and the Partnership’s obligations under this Section 7.06
shall survive the satisfaction and discharge of this Indenture. 
 (e) When the Trustee incurs expenses or renders services after an Event of
Default specified in Section 6.01(a)(4) occurs, the expenses and the compensation for the services are intended to constitute expenses of administration under any Bankruptcy Law. 

Section 7.07 Replacement of Trustee. 

(a) A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor
Trustee’s acceptance of appointment as provided in this Section 7.07. The Trustee may resign and be discharged at any time with respect to the Notes of one or more series by so notifying the Partnership. The Holders of a majority in
aggregate principal amount of the then outstanding Notes of any series may remove the Trustee with respect to the Notes of such series by so notifying the Trustee and the Partnership in writing. The Partnership may remove the Trustee if: 

(1) the Trustee fails to comply with Section 7.09; 

(2) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any
Bankruptcy Law; 
 (3) a Bankruptcy Custodian or public officer takes charge of the Trustee or its property; or 

(4) the Trustee otherwise becomes incapable of acting. 

(b) If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, with respect to the Notes of one or
more series, the Partnership shall promptly appoint a successor Trustee or Trustees with respect to the Notes of that or those series (it being understood that any such successor Trustee may be appointed with respect to the Notes of one or more or
all of such series and that at any time there shall be only one Trustee with respect to the Notes of any particular series). 

  
 -38- 

 
Within one year after the successor Trustee with respect to the Notes of any series takes office, the Holders of a majority in aggregate principal amount of the Notes of such series then
outstanding may appoint a successor Trustee to replace the successor Trustee appointed by the Partnership. 
 (c) If a successor Trustee with
respect to the Notes of any series does not take office within 30 days after the retiring or removed Trustee resigns or is removed, the retiring or removed Trustee (at the expense of the Partnership), the Partnership or the Holders of at least 10%
in aggregate principal amount of the then outstanding Notes of such series may petition any court of competent jurisdiction for the appointment of a successor Trustee with respect to the Notes of such series. 

(d) If the Trustee with respect to the Notes of a series fails to comply with Section 7.09, any Holder of Notes of such series may
petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee with respect to the Notes of such series. 

(e) In case of the appointment of a successor Trustee with respect to all Notes, each such successor Trustee shall deliver a written acceptance
of its appointment to the retiring Trustee and to the Partnership. Thereupon the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the retiring Trustee
under this Indenture. The successor Trustee shall transmit a notice of its succession to Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, upon payment of its charges hereunder and
subject to the Lien provided for in Section 7.06. 
 (f) In case of the appointment of a successor Trustee with respect to the Notes of
one or more (but not all) series, the Partnership, the retiring Trustee and each successor Trustee with respect to the Notes of one or more (but not all) series shall execute and deliver a supplemental indenture in which each successor Trustee shall
accept such appointment and that (1) shall confer to each successor Trustee all the rights, powers and duties of the retiring Trustee with respect to the Notes of that or those series to which the appointment of such successor Trustee relates,
(2) if the retiring Trustee is not retiring with respect to all Notes, shall confirm that all the rights, powers and duties of the retiring Trustee with respect to the Notes of that or those series as to which the retiring Trustee is not
retiring shall continue to be vested in the retiring Trustee and (3) shall add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one
Trustee. Nothing herein or in such supplemental indenture shall constitute such Trustees as co-trustees of the same trust, and each such Trustee shall be trustee of a trust or trusts hereunder separate and
apart from any trust or trusts hereunder administered by any other such Trustee. Upon the execution and delivery of such supplemental indenture, the resignation or removal of the retiring Trustee shall become effective to the extent provided therein
and each such successor Trustee shall have all the rights, powers and duties of the retiring Trustee with respect to the Notes of that or those series to which the appointment of such successor Trustee relates. On request of the Partnership or any
successor Trustee, such retiring Trustee shall transfer to such successor Trustee all property held by such retiring Trustee as Trustee with respect to the Notes of that or those series to which the appointment of such successor Trustee relates.
Such retiring Trustee shall, however, have the right to deduct its unpaid fees and expenses, including attorneys’ fees. 
 (g)
Notwithstanding replacement of the Trustee or Trustees pursuant to this Section 7.07, the obligations of the Partnership under Section 7.06 shall continue for the benefit of the retiring Trustee or Trustees. 

(h) As used in this Section 7.07, the term “Trustee” shall also include each Agent. 

  
 -39- 

 Section 7.08 Successor Trustee by Merger, etc. 

Subject to Section 7.09, if the Trustee consolidates, merges or converts into, or transfers all or substantially all of its corporate
trust business to, another corporation, the successor corporation without any further act shall be the successor Trustee; provided, however, that in the case of a transfer of all or substantially all of its corporate trust business to
another corporation, the transferee corporation expressly assumes all of the Trustee’s liabilities hereunder. 
 In case any Notes
shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication and deliver the Notes so authenticated; and in case at
that time any of the Notes shall not have been authenticated, any successor to the Trustee may authenticate such Notes either in the name of any predecessor hereunder or in the name of the successor to the Trustee; and in all such cases such
certificates shall have the full force which it is anywhere in the Notes or in this Indenture provided that the certificate of the Trustee shall have. 

Section 7.09 Eligibility; Disqualification. 

There shall at all times be a Trustee hereunder which shall be a corporation or banking association organized and doing business under the laws
of the United States, any State thereof or the District of Columbia and authorized under such laws to exercise corporate trust power, shall be subject to supervision or examination by federal or state (or the District of Columbia) authority and
shall have, or be a subsidiary of a bank or bank holding company having, a combined capital and surplus of at least $50 million as set forth in its most recent published annual report of condition. 

ARTICLE 8 
 LEGAL DEFEASANCE AND
COVENANT DEFEASANCE 
 Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance. 

The Partnership may, at its option and at any time, elect to have either Section 8.02 or Section 8.03 applied to all outstanding
Notes of a series upon compliance with the conditions set forth below in this Article 8. 
 Section 8.02 Legal Defeasance and Discharge. 

(a) Upon the Partnership’s exercise under Section 8.01 of the option applicable to this Section 8.02, the Partnership and the
Subsidiary Guarantors shall, subject to the satisfaction of the conditions set forth in Section 8.04, be deemed to have been discharged from their obligations with respect to the Indenture, all outstanding Notes of each series and Note
Guarantees on the date the conditions set forth below are satisfied (“Legal Defeasance”). For this purpose, Legal Defeasance means that the Partnership shall be deemed to have paid and discharged the entire Debt represented by the
outstanding Notes of such series, which shall thereafter be deemed to be “outstanding” only for the purposes of Section 8.05 and the other Sections of this Indenture referred to in clauses (1) through (4) below, and to have
satisfied all of its other obligations under such Notes and this Indenture, including that of the Subsidiary Guarantors (and the Trustee, on demand of and at the expense of the Partnership, shall execute proper instruments acknowledging the same),
except for the following provisions which shall survive until otherwise terminated or discharged hereunder: 

  
 -40- 

 (1) the rights of Holders to receive payments in respect of the principal,
premium, if any, and interest on the Notes of each series when such payments are due, solely out of the trust created pursuant to this Indenture referred to in Section 8.04; 

(2) the Partnership’s obligations with respect to such Notes concerning issuing temporary Notes, registration of Notes,
mutilated, destroyed, lost or stolen Notes and the maintenance of an office or agency for payment and money for Note payments held in trust; 

(3) the rights, powers, trusts, duties and immunities of the Trustee, and the Partnership’s obligations in connection
therewith; and 
 (4) this Section 8.02. 

(b) Following the Partnership’s exercise of its Legal Defeasance option, payment of the Notes may not be accelerated because of an Event
of Default. 
 (c) Subject to compliance with this Article 8, the Partnership may exercise its option under this Section 8.02
notwithstanding the prior exercise of its option under Section 8.03. 
 Section 8.03 Covenant Defeasance. 

Upon the Partnership’s exercise under Section 8.01 of the option applicable to this Section 8.03, the Partnership and the
Subsidiary Guarantors shall, subject to the satisfaction of the conditions set forth in Section 8.04, be released from their obligations under the covenants contained in Sections 4.06, 4.07, 4.08, 4.09, 4.10, 4.11 and 5.01 with respect to
the outstanding Notes and the Subsidiary Guarantors shall be deemed to have been discharged from their obligations with respect to all Note Guarantees, on and after the date the conditions set forth in Section 8.04 are satisfied
(“Covenant Defeasance”), and the Notes shall thereafter be deemed not “outstanding” for the purposes of any direction, waiver, consent or declaration or act of Holders (and the consequences of any thereof) in connection
with such covenants, but shall continue to be deemed “outstanding” for all other purposes hereunder (it being understood that such Notes shall not be deemed outstanding for accounting purposes). For this purpose, Covenant Defeasance means
that, with respect to this Indenture and the outstanding Notes, the Partnership may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly or indirectly, by
reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a Default or an Event of Default
under Section 6.01, but, except as specified above, the remainder of this Indenture and such Notes shall be unaffected thereby. In addition, upon the Partnership’s exercise under Section 8.01 of the option applicable to this
Section 8.03, subject to the satisfaction of the conditions set forth in Section 8.04, an Event of Default specified in Section 6.01(a)(3) (only with respect to covenants that are released as a result of such Covenant Defeasance),
Section 6.01(a)(4) (only with respect to Significant Subsidiaries) and Section 6.01(a)(5), in each case, shall not constitute an Event of Default. 

Section 8.04 Conditions to Legal or Covenant Defeasance. 

(a) The following shall be the conditions to the exercise of either the Legal Defeasance option under Section 8.02 or the Covenant
Defeasance option under Section 8.03 with respect to the Notes of each series: 

  
 -41- 

 (1) the Partnership must irrevocably deposit with the Trustee, in trust, for
the benefit of the Holders, cash in U.S. dollars, Government Securities, or a combination thereof, in amounts as will be sufficient, as confirmed, certified or attested by an Independent Financial Advisor in writing to the Trustee, without
consideration of any reinvestment of interest, to pay the principal, premium, if any, and interest due on the outstanding Notes on the Stated Maturity or on the applicable redemption date, as the case may be, and the Partnership must specify whether
the Notes are being defeased to maturity or to a particular redemption date; 
 (2) in the case of Legal Defeasance, the
Partnership has delivered to the Trustee an Opinion of Counsel reasonably acceptable to the Trustee confirming that, subject to customary assumptions and exclusions, 

(A) the Partnership has received from, or there has been published by, the U.S. Internal Revenue Service a ruling, or 

(B) since the Issue Date, there has been a change in the applicable U.S. federal income tax law, 

in either case to the effect that, and based thereon such Opinion of Counsel will confirm that the Holders will not recognize income, gain or
loss for U.S. federal income tax purposes as a result of such Legal Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not
occurred; 
 (3) in the case of Covenant Defeasance, the Partnership has delivered to the Trustee an Opinion of Counsel
reasonably acceptable to the Trustee confirming that, subject to customary assumptions and exclusions, the Holders will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance and will be
subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred; 

(4) no Default or Event of Default has occurred and is continuing on the date of such deposit or will occur as a result of such
deposit (other than a Default or an Event of Default resulting from the borrowing of funds to be applied to make such deposit and any similar and simultaneous deposit relating to other Debt and, in each case, the granting of Liens in connection
therewith) and the deposit will not result in a breach or violation of, or constitute a default under, the Credit Agreement or any other material agreement or material instrument (other than this Indenture) to which the Partnership or any Subsidiary
Guarantor is a party or by which the Partnership or any Subsidiary Guarantor is bound; 
 (5) the Partnership has delivered
to the Trustee an Officer’s Certificate stating that the deposit was not made by the Partnership with the intent of defeating, hindering, delaying or defrauding any creditors of the Partnership, any Subsidiary Guarantor or others; 

(6) the Partnership has delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel (which Opinion of
Counsel may be subject to customary assumptions and exclusions), each stating that all conditions precedent relating to the Legal Defeasance or the Covenant Defeasance, as the case may be, have been complied with; and 

(7) the Partnership has delivered irrevocable instructions to the Trustee to apply the deposited money toward the payment of
the Notes at maturity or the redemption date, as the case may be (which instructions may be contained in the Officer’s Certificate referred to in clause (6) above). 

  
 -42- 

 Section 8.05 Deposited Money and Government Securities to Be Held in Trust; Other Miscellaneous
Provisions. 
 (a) Subject to Section 8.06, all money and Government Securities (including the proceeds thereof) deposited with the
Trustee pursuant to Section 8.04 in respect of the outstanding Notes of each series shall be held in trust and applied by the Trustee, in accordance with the provisions of such Notes and this Indenture or applicable supplemental indenture, to
the payment, either directly or through any Paying Agent (including the Partnership or a Subsidiary Guarantor acting as Paying Agent) as the Trustee may determine, to the Holders of all sums due and to become due thereon in respect of principal,
premium, if any, and interest on such Notes, but such money need not be segregated from other funds except to the extent required by law. 

(b) The Partnership will pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the cash or
Government Securities deposited pursuant to Section 8.04 or the principal and interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders. 

(c) Anything in this Article 8 to the contrary notwithstanding, the Trustee will deliver or pay to the Partnership from time to time upon the
request of the Partnership any money or Government Securities held by it as provided in Section 8.04 which, in the opinion of an Independent Financial Advisor expressed in a written certification thereof delivered to the Trustee (which may be
the opinion delivered under Section 8.04(a)), are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal Defeasance or Covenant Defeasance. 

Section 8.06 Repayment to the Partnership. 

Subject to any applicable abandoned property law, any money deposited with the Trustee or any Paying Agent, or then held by the Partnership, in
trust for the payment of the principal, premium, if any, or interest on any Note of any series and remaining unclaimed for two years after such principal, premium, if any, or interest has become due and payable shall be paid to the Partnership on
its request or (if then held by the Partnership) shall be discharged from such trust; and the Holder of such Note shall thereafter look only to the Partnership for payment thereof, and all liability of the Trustee or such Paying Agent with respect
to such trust money, and all liability of the Partnership as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the
Partnership cause to be published once, in The New York Times or The Wall Street Journal (national edition) or other business periodical with national circulation, notice that such money remains unclaimed and that, after a date
specified therein, which shall not be less than 30 days from the date of such notification or publication, any unclaimed balance of such money then remaining shall be repaid to the Partnership. 

Section 8.07 Reinstatement. 
 If the
Trustee or Paying Agent is unable to apply any U.S. dollars or Government Securities in accordance with Section 8.02 or Section 8.03, as the case may be, by reason of any order or judgment of any court or governmental authority enjoining,
restraining or otherwise prohibiting such application, then the Partnership’s and the Subsidiary Guarantors’ obligations under this Indenture, the Notes of each series and the Note Guarantees shall be revived and reinstated as though no
deposit had occurred pursuant to Section 8.02 or Section 8.03 until such time as the Trustee or Paying Agent is permitted to apply all such money in accordance with Section 8.02 or Section 8.03, as the case may be;
provided that, if the Partnership makes any payment of principal, premium, if any, or interest on any such Note following the reinstatement of its obligations, the Partnership shall be subrogated to the rights of the Holders to receive such
payment from the money held by the Trustee or Paying Agent. 

  
 -43- 

 ARTICLE 9 

AMENDMENT, SUPPLEMENT AND WAIVER 

Section 9.01 Without Consent of Holders. 

(a) Notwithstanding Section 9.02, without the consent of any Holder, the Partnership, the Subsidiary Guarantors and the Trustee may amend
this Indenture, the Notes and the Note Guarantees: 
 (1) to cure any ambiguity, omission, defect or inconsistency; 

(2) to provide for the assumption of the obligations of the Partnership or any Subsidiary Guarantor under this Indenture by a
successor upon any merger, consolidation or asset transfer permitted under this Indenture; 
 (3) to provide for
uncertificated Notes of the applicable series in addition to or in place of certificated Notes of the applicable series; 

(4) to provide any security for, any Note Guarantees of or any additional obligors on the Notes or any related Note Guarantees;

 (5) to comply with any requirement to effect or maintain the qualification of this Indenture under the Trust Indenture
Act; 
 (6) to add covenants that would benefit the Holders of the Notes of the applicable series or to surrender any rights
the Partnership or any Subsidiary Guarantors have under this Indenture; 
 (7) to add Events of Default with respect to the
Notes of the applicable series; and 
 (8) to make any change that does not adversely affect any outstanding Notes of the
applicable series in any material respect. 
 (b) Upon the request of the Partnership, and upon receipt by the Trustee of the documents
described in Section 12.02, the Trustee shall join with the Partnership and the Subsidiary Guarantors in the execution of any amended or supplemental indenture authorized or permitted by the terms of this Indenture and to make any further
appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into such amended or supplemental indenture that affects its own rights, duties or immunities under this Indenture or otherwise.
Notwithstanding the foregoing, no Opinion of Counsel shall be required in connection with the addition of a Subsidiary Guarantor under this Indenture upon execution and delivery by such Subsidiary Guarantor and the Trustee of a supplemental
indenture to this Indenture, the form of which is attached as Exhibit B, and delivery of an Officer’s Certificate. 
 Section 9.02 With
Consent of Holders. 
 (a) Except as provided in Section 9.01 and this Section 9.02, the Partnership, the Subsidiary Guarantors
and the Trustee may amend or supplement this Indenture, the Notes of each series and the Note Guarantees with the consent of the Holders of a majority in principal amount of the Notes of such series then outstanding affected by such amendment or
supplement (acting as one class) (including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, Notes of such series) and, subject to Section 6.04 and Section 6.07, any past or
existing Default or 

  
 -44- 

 
Event of Default with respect to any series of Notes or all series of Notes (other than a Default or Event of Default in the payment of the principal, premium, if any, or interest on such Notes,
except a payment default resulting from an acceleration that has been rescinded) or compliance with any provision of this Indenture or such Notes may be waived with the consent of the Holders of a majority in principal amount of such Notes then
outstanding (acting as one class in the case of a waiver impacting all series of Notes) (including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, Notes of such series).
Section 2.08 and Section 2.09 shall determine which Notes are considered to be “outstanding” for the purposes of this Section 9.02. 

(b) Upon the request of the Partnership, and upon the filing with the Trustee of evidence satisfactory to the Trustee of the consent of the
Holders as aforesaid, and upon receipt by the Trustee of the documents described in Section 7.02 and Section 12.02, the Trustee shall join with the Partnership and the Subsidiary Guarantors in the execution of such amended or supplemental
indenture unless such amended or supplemental indenture directly affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter
into such amended or supplemental indenture. 
 (c) It shall not be necessary for the consent of the Holders under this Section 9.02 to
approve the particular form of any proposed amendment, supplement or waiver. It shall be sufficient if such consent approves the substance of such proposed amendment, supplement or waiver. 

(d) After an amendment, supplement or waiver under this Section 9.02 becomes effective, the Partnership will give to the Holders a notice
briefly describing such amendment, supplement or waiver. However, the failure of the Partnership to give such notice to all the Holders, or any defect in the notice, will not impair or affect the validity of any such amendment, supplement or waiver.

 (e) Without the consent of each affected Holder, an amendment, supplement or waiver under this Section 9.02 may not (with respect to
any Notes of any series held by a non-consenting Holder): 
 (1) reduce the amount of
such Notes whose Holders must consent to an amendment, a supplement or a waiver; 
 (2) reduce the rate of or change the time
for payment of interest on such Note; 
 (3) reduce the principal of such Note or change its Stated Maturity; 

(4) reduce any premium payable on the redemption of such Note or change the time at which such Note may be redeemed; 

(5) make payments on such Note payable in currency other than U.S. dollars; 

(6) impair the Holder’s right to institute suit for the enforcement of any payment on or with respect to such Note; 

(7) make any change in the percentage of principal amount of Notes of such series necessary to waive compliance with certain
provisions of this Indenture or to make any change in the provision related to modification; or 
 (8) waive a continuing
Default or Event of Default regarding any payment on the Notes of such series. 

  
 -45- 

 (f) A consent to any amendment, supplement or waiver of this Indenture, the Notes or the
Note Guarantee by any Holder given in connection with a tender of such Holder’s Notes will not be rendered invalid by such tender. 
 Section 9.03
Revocation and Effect of Consents. 
 (a) Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a
Note of any series is a continuing consent by the Holder of such Note and every subsequent Holder of such Note or portion of such Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent is not made on
any such Note. However, any such Holder of a Note or subsequent Holder of a Note may revoke the consent as to its Note if the Trustee receives written notice of revocation before the date the waiver, supplement or amendment becomes effective. An
amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder. 
 (b) The Partnership may,
but shall not be obligated to, fix a record date pursuant to Section 1.04 for the purpose of determining the Holders entitled to consent to any amendment, supplement or waiver. 

Section 9.04 Notation on or Exchange of Notes. 

(a) The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Note of any series thereafter authenticated.
The Partnership in exchange for all Notes of such series may issue and the Trustee shall, upon receipt of an Authentication Order, authenticate new Notes that reflect the amendment, supplement or waiver. 

(b) Failure to make the appropriate notation or issue a new Note shall not affect the validity and effect of such amendment, supplement or
waiver. 
 Section 9.05 Trustee to Sign Amendments, etc. 

The Trustee shall sign any amendment, supplement or waiver authorized pursuant to this Article 9 if the amendment, supplement or waiver does
not adversely affect the rights, duties, liabilities or immunities of the Trustee. In executing any amendment, supplement or waiver, the Trustee shall be entitled to receive and (subject to Section 7.01) shall be fully protected in relying
upon, in addition to the documents required by Section 12.02, an Officer’s Certificate and an Opinion of Counsel stating that the execution of such amendment, supplement or waiver is authorized or permitted by this Indenture and that such
amendment, supplement or waiver is the legal, valid and binding obligation of the Partnership and any Subsidiary Guarantor party thereto, enforceable against them in accordance with its terms, subject to customary exceptions, and complies with the
provisions hereof. 
 ARTICLE 10 

GUARANTEES 
 Section 10.01 Guarantee.

 (a) Subject to this Article 10, each of the Subsidiary Guarantors hereby, jointly and severally, irrevocably and unconditionally
guarantees, on a senior unsecured basis, to each Holder and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of this Indenture, the Notes of each series or the obligations of the Partnership hereunder or
thereunder, that: (1) the principal, premium, if any, and interest on the Notes of each series shall be promptly paid in full when due, whether at Stated Maturity, by acceleration, redemption or otherwise, and interest on the overdue

  
 -46- 

 
principal and interest on such Notes, if any, if lawful, and all other Obligations of the Partnership to the Holders or the Trustee hereunder or under such Notes shall be promptly paid in full or
performed, all in accordance with the terms hereof and thereof; and (2) in case of any extension of time of payment or renewal of any Notes of any series or any of such other obligations, that same shall be promptly paid in full when due or
performed in accordance with the terms of the extension or renewal, whether at Stated Maturity, by acceleration or otherwise collectively, the “Guaranteed Obligations”. Failing payment by the Partnership when due of any amount so
guaranteed or any performance so guaranteed for whatever reason, the Subsidiary Guarantors shall be jointly and severally obligated to pay the same immediately. Each Subsidiary Guarantor agrees that this is a guarantee of payment and not a guarantee
of collection. 
 (b) The Subsidiary Guarantors hereby agree that their obligations hereunder shall be unconditional, irrespective of the
validity, regularity or enforceability of the Notes of each series or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder with respect to any provisions hereof or thereof, the recovery of any judgment
against the Partnership, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. Each Subsidiary Guarantor hereby waives diligence, presentment, demand of
payment, filing of claims with a court in the event of insolvency or bankruptcy of the Partnership, any right to require a proceeding first against the Partnership, protest, notice and all demands whatsoever and covenants that this Note Guarantee
shall not be discharged except by complete performance of the obligations contained in the Notes of each series and this Indenture, or pursuant to Section 10.06. 

(c) Each of the Subsidiary Guarantors also agrees, jointly and severally, to pay any and all costs and expenses (including reasonable
attorneys’ fees and expenses) incurred by the Trustee or any Holder in enforcing any rights under this Section 10.01. 
 (d) If any
Holder or the Trustee is required by any court or otherwise to return to the Partnership, the Subsidiary Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to the Partnership or the Subsidiary Guarantors,
any amount paid either to the Trustee or such Holder, this Note Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect. 

(e) Each Subsidiary Guarantor agrees that it shall not be entitled to any right of subrogation in relation to the Holders in respect of any
obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. Each Subsidiary Guarantor further agrees that, as between the Subsidiary Guarantors, on the one hand, and the Holders and the Trustee, on the other hand,
(1) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 for the purposes of this Note Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the
obligations guaranteed hereby, and (2) in the event of any declaration of acceleration of such obligations as provided in Article 6, such obligations (whether or not due and payable) shall forthwith become due and payable by the Subsidiary
Guarantors for the purpose of this Note Guarantee. The Subsidiary Guarantors shall have the right to seek contribution from any non-paying Subsidiary Guarantor so long as the exercise of such right does not
impair the rights of the Holders under the Note Guarantees. 
 (f) Each Note Guarantee shall remain in full force and effect and continue to
be effective should any petition be filed by or against the Partnership for liquidation or reorganization, should the Partnership become insolvent or make an assignment for the benefit of creditors or should a receiver or trustee be appointed for
all or any significant part of the Partnership’s assets, and shall, to the fullest extent permitted by law, continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Notes of any series are,
pursuant to applicable law, rescinded or reduced 

  
 -47- 

 
in amount, or must otherwise be restored or returned by any obligee on such Notes or the Note Guarantees, whether as a “voidable preference,” “fraudulent transfer” or
otherwise, all as though such payment or performance had not been made. In the event that any payment or any part thereof, is rescinded, reduced, restored or returned, such Notes Guarantee shall, to the fullest extent permitted by law, be reinstated
and deemed reduced only by such amount paid and not so rescinded, reduced, restored or returned. 
 (g) In case any provision of any Note
Guarantee shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 

(h) Each payment to be made by a Subsidiary Guarantor in respect of its Note Guarantee shall be made without
set-off, counterclaim, reduction or diminution of any kind or nature. 
 (i) The Notes of each series
initially shall not be entitled to the benefits of any Notes Guarantee of any Subsidiary Guarantor contemplated by this Article 10. After the Issue Date, any Subsidiary Guarantors will provide a Note Guarantee in accordance with Section 4.10.

 Section 10.02 Limitation on Subsidiary Guarantor Liability. 

Each Subsidiary Guarantor, and by its acceptance of Notes of any series, each Holder, hereby confirms that it is the intention of all such
parties that the Note Guarantee of such Subsidiary Guarantor not constitute a fraudulent conveyance or a fraudulent transfer for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar
federal or state law to the extent applicable to any Note Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Subsidiary Guarantors hereby irrevocably agree that the obligations of each Subsidiary Guarantor shall be
limited to the maximum amount as will, after giving effect to such maximum amount and all other contingent and fixed liabilities of such Subsidiary Guarantor that are relevant under such laws and after giving effect to any collections from, rights
to receive contribution from or payments made by or on behalf of any other Subsidiary Guarantor in respect of the obligations of such other Subsidiary Guarantor under this Article 10, result in the obligations of such Subsidiary Guarantor under its
Note Guarantee not constituting a fraudulent conveyance or fraudulent transfer under applicable law. Each Subsidiary Guarantor that makes a payment under its Note Guarantee will be entitled upon payment in full of all Guaranteed Obligations under
this Indenture to a contribution from each other Subsidiary Guarantor in an amount equal to such other Subsidiary Guarantor’s pro rata portion of such payment based on the respective net assets of all the Subsidiary Guarantors at the
time of such payment, determined in accordance with GAAP. 
 Section 10.03 Execution and Delivery. 

A Subsidiary will become a Subsidiary Guarantor under this Indenture upon execution and delivery by such Subsidiary Guarantor and the Trustee
of a supplemental indenture to this Indenture, the form of which is attached as Exhibit B. Upon such execution, such Subsidiary Guarantor will agree that its Note Guarantee set forth in Section 10.01 shall remain in full force and effect
notwithstanding the absence of the endorsement of any notation of such Note Guarantee on the Notes of each series. 

  
 -48- 

 Section 10.04 Subrogation. 

Each Subsidiary Guarantor shall be subrogated to all rights of Holders against the Partnership in respect of any amounts paid by any Subsidiary
Guarantor pursuant to the provisions of Section 10.01; provided that, if an Event of Default has occurred and is continuing, no Subsidiary Guarantor shall be entitled to enforce or receive any payments arising out of, or based upon, such
right of subrogation until all amounts then due and payable by the Partnership under this Indenture or the Notes of each series shall have been paid in full. 

Section 10.05 Benefits Acknowledged. 

Each Subsidiary Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by this
Indenture and that the guarantee and waivers made by it pursuant to its Note Guarantee are knowingly made in contemplation of such benefits. 

Section 10.06 Release of Note Guarantees. 

(a) If no Default has occurred and is continuing under this Indenture, and to the extent not otherwise prohibited by this Indenture, a
Subsidiary Guarantor will be unconditionally released and discharged from its Note Guarantee: 
 (1) in connection with any
sale or other disposition of all or substantially all of the properties or assets of, or all of the Partnership’s direct or indirect limited partnership, limited liability company or other equity interests in, that Subsidiary Guarantor
(including by way of merger or consolidation) to a Person that is not (either before or after giving effect to such transaction) the Partnership’s Affiliate; 

(2) upon the merger of that Subsidiary Guarantor into the Partnership or any other Subsidiary Guarantor or the liquidation or
dissolution of that Subsidiary Guarantor; 
 (3) upon legal defeasance, covenant defeasance or satisfaction and discharge of
this Indenture with respect to the Notes of each applicable series in accordance with Article 8 and Article 11 of this Indenture; or 

(4) following delivery of a written notice by the Partnership to the Trustee, upon the release of all Guarantees by that
Subsidiary Guarantor under the Credit Agreement; provided that, if, at any time following any release of a Subsidiary Guarantor from its initial Note Guarantee of the Notes as described in this Section 10.06(a)(4), the Subsidiary
Guarantor again provides a Guarantee under the Credit Agreement, then the Partnership will cause the Subsidiary Guarantor to again provide a Note Guarantee in accordance with this Indenture. 

(b) At the written request of the Partnership, the Trustee shall execute and deliver any documents reasonably required in order to evidence
such release, discharge and termination in respect of the applicable Note Guarantee. 
 ARTICLE 11 

SATISFACTION AND DISCHARGE 
 Section 11.01
Satisfaction and Discharge. 
 (a) This Indenture will be discharged, and will cease to be of further effect as to all Notes of each
series, when either: 
 (1) all Notes of the applicable series that have been authenticated and delivered (except lost,
stolen or destroyed Notes that have been replaced or paid and Notes for whose payment money has been deposited in trust) have been delivered to the Trustee for cancellation; or 

  
 -49- 

 (2) (A) all Notes of the applicable series not theretofore delivered to the
Trustee for cancellation have become due and payable by reason of the giving of a notice of redemption or otherwise, will become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to
the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Partnership, and the Partnership or any Subsidiary Guarantor has irrevocably deposited or caused to be deposited with the Trustee, as trust
funds in trust solely for the benefit of the Holders, cash in U.S. dollars, Government Securities, or a combination thereof, in such amounts as will be sufficient, without consideration of any reinvestment of interest, to pay and discharge the
entire Debt on the Notes of such series not theretofore delivered to the Trustee for cancellation for principal, premium, if any, and accrued interest to the date of maturity or redemption, as the case may be; 

(B) no Default or Event of Default has occurred and is continuing on the date of such deposit or will occur as a result of such deposit (other
than a Default or an Event of Default resulting from the borrowing of funds to be applied to make such deposit and any similar and simultaneous deposit relating to other Debt and, in each case, the granting of Liens in connection therewith) and the
deposit will not result in a breach or violation of, or constitute a default under, the Credit Agreement or any other material agreement or material instrument (other than this Indenture) to which the Partnership or any Subsidiary Guarantor is a
party or by which the Partnership or any Subsidiary Guarantor is bound; 
 (C) the Partnership or any Subsidiary Guarantor has paid or caused
to be paid all sums payable by the Partnership under this Indenture; and 
 (D) the Partnership has delivered irrevocable instructions to the
Trustee to apply the deposited money toward the payment of the Notes of such series at maturity or the redemption date, as the case may be. 

(b) In addition, the Partnership shall deliver to the Trustee an Officer’s Certificate and an Opinion of Counsel (which Opinion of Counsel
may be subject to customary assumptions and exclusions) each stating that all conditions precedent to satisfaction and discharge have been satisfied. Notwithstanding the satisfaction and discharge of this Indenture, if money shall have been
deposited with the Trustee pursuant to Section 11.01(a)(2)(A), the provisions of Section 11.02 and Section 8.06 shall survive. 

Section 11.02 Application of Trust Money. 

(a) Subject to the provisions of Section 8.06, all money deposited with the Trustee pursuant to Section 11.01 shall be held in trust
and applied by it, in accordance with the provisions of the Notes of each series and this Indenture or applicable supplemental indenture, to the payment, either directly or through any Paying Agent (including the Partnership acting as its own Paying
Agent) as the Trustee may determine, to the Persons entitled thereto, of the principal, premium, if any, and interest for whose payment such money has been deposited with the Trustee, but such money need not be segregated from other funds except to
the extent required by law. 
 (b) If the Trustee or Paying Agent is unable to apply any money or Government Securities in accordance with
Section 11.01 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Partnership’s and any Subsidiary
Guarantor’s obligations under this Indenture, the Notes of each series and the Note Guarantees shall be revived and reinstated as though no deposit had occurred pursuant to Section 11.01; provided that if the Partnership has made
any payment of principal, premium, if any, or interest on any such Notes because of the reinstatement of its obligations, the Partnership shall be subrogated to the rights of the Holders of such Notes to receive such payment from the money or
Government Securities held by the Trustee or Paying Agent, as the case may be. 

  
 -50- 

 ARTICLE 12 

MISCELLANEOUS 
 Section 12.01
Notices. 
 (a) Any notice or communication to the Partnership, any Subsidiary Guarantor or the Trustee is duly given if in writing
and (1) delivered in person, (2) mailed by first-class mail (certified or registered, return receipt requested), postage prepaid, or overnight air courier guaranteeing next day delivery or (3) sent by electronic transmission, to its
address: 
 if to the Partnership or any Subsidiary Guarantor: 

c/o EQM Midstream Partners, LP 

2200 Energy Drive 
 Canonsburg,
Pennsylvania 15317 
 E-mail: treasury@equitransmidstream.com 

Attention: Treasurer 
 with a copy
to: 
 Latham & Watkins LLP 

811 Main Street, Suite 3700 

Houston, Texas 77002 
 E-mail: ryan.maierson@lw.com 
 Attention: Ryan Maierson 

if to the Trustee: 
 The Bank of
New York Mellon Trust Company, N.A. 
 500 Ross Street, 12th Floor 

Pittsburgh, PA 15262 
 Attention:
Corporate Trust 
 The Partnership, any Subsidiary Guarantor or the Trustee, by like notice, may designate additional or different addresses for subsequent
notices or communications. 
 (b) All notices and communications (other than those sent to Holders) shall be deemed to have been duly given:
at the time delivered by hand, if personally delivered; on the first date of which publication is made, if by publication; five calendar days after being deposited in the mail, postage prepaid, if mailed by first-class mail; the next Business Day
after timely delivery to the courier, if mailed by overnight air courier guaranteeing next day delivery; when receipt acknowledged, if sent by electronic transmission; provided that any notice or communication delivered to the Trustee shall
be deemed effective upon actual receipt thereof. 
 (c) Any notice or communication to a Holder shall be mailed by first-class mail
(certified or registered, return receipt requested) or by overnight air courier guaranteeing next day delivery to its address shown on the Note Register or by such other delivery system as the Trustee agrees to accept. Failure to mail a notice or
communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. 

  
 -51- 

 (d) Where this Indenture provides for notice in any manner, such notice may be waived in
writing by the Person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders shall be filed with the Trustee, but such filing shall not be a condition
precedent to the validity of any action taken in reliance upon such waiver. 
 (e) Notwithstanding any other provision herein, where this
Indenture provides for notice of any event to any Holder of an interest in a Global Note (whether by mail or otherwise), such notice shall be sufficiently given if given to the Depositary for such Note (or its designee), according to the applicable
procedures of such Depositary, if any, prescribed for the giving of such notice. 
 (f) The Trustee agrees to accept and act upon notice,
instructions or directions pursuant to this Indenture sent by unsecured electronic transmission; provided, however, that (1) the party providing such written notice, instructions or directions, subsequent to such transmission of
written instructions, shall provide the originally executed instructions or directions to the Trustee in a timely manner, and (2) such originally executed notice, instructions or directions shall be signed by an authorized representative of the
party providing such notice, instructions or directions. The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from the Trustee’s reasonable reliance upon and compliance with such notice, instructions
or directions notwithstanding such notice, instructions or directions conflict or are inconsistent with a subsequent notice, instructions or directions. 

(g) If a notice or communication is sent in the manner provided above within the time prescribed, it is duly given, whether or not the
addressee receives it. 
 (h) If the Partnership mails a notice or communication to Holders, it shall mail a copy to the Trustee and each
Agent at the same time. 
 Section 12.02 Certificate and Opinion as to Conditions Precedent. 

Upon any request or application by the Partnership or any Subsidiary Guarantor to the Trustee to take any action under this Indenture, the
Partnership or such Subsidiary Guarantor, as the case may be, shall furnish to the Trustee: 
 (1) an Officer’s
Certificate in form and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 12.03) stating that, in the opinion of the signer(s), all conditions precedent and covenants, if any, provided for
in this Indenture relating to the proposed action have been complied with; and 
 (2) an Opinion of Counsel in form and
substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 12.03) stating that, in the opinion of such counsel, all such conditions precedent and covenants have been complied with; provided
that (A) no Opinion of Counsel shall be required in connection with the addition of a Subsidiary Guarantor under this Indenture upon execution and delivery by such Subsidiary Guarantor and the Trustee of a supplemental indenture to this
Indenture, the form of which is attached as Exhibit B, and (B) no Opinion of Counsel pursuant to this Section 12.02 shall be required in connection with the issuance of Notes on the Issue Date. 

  
 -52- 

 Section 12.03 Statements Required in Certificate or Opinion. 

Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate
provided pursuant to Section 4.07) shall include: 
 (1) a statement that the Person making such certificate or opinion
has read such covenant or condition; 
 (2) a brief statement as to the nature and scope of the examination or investigation
upon which the statements or opinions contained in such certificate or opinion are based; 
 (3) a statement that, in the
opinion of such Person, he or she has made such examination or investigation as is necessary to enable him or her to express an informed opinion as to whether or not such covenant or condition has been complied with (and, in the case of an Opinion
of Counsel, may be limited to reliance on an Officer’s Certificate as to matters of fact); and 
 (4) a statement as to
whether or not, in the opinion of such Person, such condition or covenant has been complied with. 
 Section 12.04 Rules by Trustee and Agents.

 The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar or Paying Agent may make reasonable rules
and set reasonable requirements for its functions. 
 Section 12.05 No Personal Liability of Directors, Officers, Employees, Members, Partners and
Stockholders. 
 No past, present or future director, officer, employee, incorporator, member, manager, partner or stockholder of the
General Partner, the Partnership or any Subsidiary Guarantor, as such, shall have any liability for any obligations of the Partnership or any Subsidiary Guarantor under the Notes, the Note Guarantees or this Indenture or for any claim based on, in
respect of, or by reason of, such obligations or their creation. 
 Each Holder by accepting a Note agrees to the foregoing sentence and
waives and releases all such liability of any past, present or future director, officer, employee, incorporator, member, manager, partner or stockholder of the General Partner, the Partnership or any Subsidiary Guarantor. The waiver and release are
part of the consideration for issuance of the Notes. 
 Section 12.06 Governing Law. 

THIS INDENTURE, THE NOTES AND ANY NOTE GUARANTEE WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH
OF THE PARTIES HERETO AGREES TO SUBMIT TO THE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE GUARANTEES. 

Section 12.07 Waiver of Jury Trial. 

EACH OF THE PARTNERSHIP, THE SUBSIDIARY GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES, THE NOTE GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

  
 -53- 

 Section 12.08 Force Majeure. 

In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations under this Indenture
arising out of or caused by, directly or indirectly, forces beyond its reasonable control, including without limitation strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or
acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software or hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices in the
banking industry to resume performance as soon as practicable under the circumstances. 
 Section 12.09 No Adverse Interpretation of Other
Agreements. 
 This Indenture may not be used to interpret any other indenture, loan or debt agreement of the Partnership or its
Subsidiaries or of any other Person. Any such indenture, loan or debt agreement may not be used to interpret this Indenture. 
 Section 12.10
Successors. 
 All agreements of the Partnership in this Indenture and the Notes shall bind its successors. All agreements of the
Trustee in this Indenture shall bind its successors. All agreements of each Subsidiary Guarantor in this Indenture shall bind its successors, except as otherwise provided in Section 10.06. 

Section 12.11 Severability. 
 In case
any provision in this Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 

Section 12.12 Counterpart Originals. 

The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of them together represent the same
agreement. The word “execution,” “executed,” “signed,” “signature,” “delivery” and words of like import in or relating to this Indenture or any document to be signed in connection with this Indenture
shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof of the
use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means. 

Section 12.13 Table of Contents, Headings, etc. 

The Table of Contents, Cross-Reference Table and headings of the Articles and Sections of this Indenture have been inserted for convenience of
reference only, are not to be considered a part of this Indenture and shall in no way modify or restrict any of the terms or provisions hereof. 

  
 -54- 

 Section 12.14 PDF Delivery of Signature Pages. 

The exchange of copies of this Indenture and of signature pages by portable document format (“PDF”) transmission shall
constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted PDF shall be deemed to be their original
signatures for all purposes. 
 Section 12.15 U.S.A. PATRIOT Act. 

The parties hereto acknowledge that in accordance with Section 326 of the U.S.A. PATRIOT Act, the Trustee is required to obtain, verify,
and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such information as it may request
in order for the Trustee to satisfy the requirements of the U.S.A. PATRIOT Act. 
 Section 12.16 Payments Due on
Non-Business Days. 
 In any case where any Interest Payment Date, redemption date or repurchase
date or the Stated Maturity of the Notes of any series shall not be a Business Day, then (notwithstanding any other provision of this Indenture or of such Notes) payment of principal, premium, if any, or interest on such Notes need not be made on
such date, but may be made on the next succeeding Business Day with the same force and effect as if made on the Interest Payment Date, redemption date or repurchase date, or at the Stated Maturity of such Notes; provided that no interest will
accrue for the period from and after such Interest Payment Date, redemption date, repurchase date or Stated Maturity, as the case may be. 

[Signatures on following pages] 

  
 -55- 

 
			
	EQM MIDSTREAM PARTNERS, LP
	
	By: EQGP Services, LLC, its general partner
		
	By:	 	/s/ Kirk. R. Oliver
		 	Name: Kirk R. Oliver
		 	Title: Senior Vice President and Chief Financial Officer

 [Signature Page to Indenture] 

 
			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	/s/ Lawrence M. Kusch
		 	Name: Lawrence M. Kusch
		 	Title: Vice President

 [Signature Page to Indenture] 

 APPENDIX A 

PROVISIONS RELATING TO INITIAL NOTES AND 

ADDITIONAL NOTES 
 Section 1.1
Definitions. 
 (a) Capitalized Terms. 

Capitalized terms used but not defined in this Appendix A have the meanings given to them in this Indenture. The following capitalized terms
have the following meanings: 
 “Applicable Procedures” means, with respect to any transfer or transaction involving a
Global Note or beneficial interest therein, the rules and procedures of the Depositary for such Global Note, Euroclear or Clearstream, in each case to the extent applicable to such transaction and as in effect from time to time. 

“Clearstream” means Clearstream Banking, Société Anonyme, or any successor securities clearing agency. 

“Distribution Compliance Period,” with respect to any Note, means the period of 40 consecutive days beginning on and
including the later of (a) the day on which such Note is first offered to persons other than distributors (as defined in Regulation S) in reliance on Regulation S, notice of which day shall be promptly given by the Partnership to the
Trustee, and (b) the date of issuance with respect to such Note or any predecessor of such Note. 
 “Euroclear” means
Euroclear Bank SA/NV, as operator of Euroclear systems Clearance System or any successor securities clearing agency. 

“QIB” means a “qualified institutional buyer” as defined in Rule 144A. 

“Regulation S” means Regulation S promulgated under the Securities Act. 

“Rule 144” means Rule 144 promulgated under the Securities Act. 

“Rule 144A” means Rule 144A promulgated under the Securities Act. 

“Unrestricted Global Note” means any Note in global form that does not bear or is not required to bear the Restricted Notes
Legend. 
 “U.S. person” means a “U.S. person” as defined in Regulation S. 

(b) Other Definitions. 
  

			
	 Term:
	  	Defined in
Section:
	 “Agent Members”
	  	2.1(c)
	 “Definitive Notes Legend”
	  	2.2(e)
	 “ERISA Legend”
	  	2.2(e)
	 “Global Note”
	  	2.1(b)
	 “Global Notes Legend”
	  	2.2(e)
	 “Regulation S Global Note”
	  	2.1(b)
	 “Regulation S Notes”
	  	2.1(a)
	 “Restricted Notes Legend”
	  	2.2(e)
	 “Rule 144A Global Note”
	  	2.1(b)
	 “Rule 144A Notes”
	  	2.1(a)

 Section 2.1 Form and Dating 

(a) The Initial Notes issued on the date hereof shall be (i) offered and sold by the Partnership to the initial purchasers thereof
and (ii) resold, initially only to (1) QIBs in reliance on Rule 144A (“Rule 144A Notes”) and (2) Persons other than U.S. persons in reliance on Regulation S (“Regulation S Notes”). Additional
Notes may also be considered to be Rule 144A Notes or Regulation S Notes, as applicable. 
 (b) Global Notes. Rule 144A Notes
shall be issued initially in the form of one or more permanent global Notes in definitive, fully registered form, numbered RA-1 upward (collectively, the “Rule 144A Global
Note”) and Regulation S Notes shall be issued initially in the form of one or more global Notes, numbered RS-1 upward (collectively, the “Regulation S Global Note”), in each case
without interest coupons and bearing the Global Notes Legend and Restricted Notes Legend, which shall be deposited on behalf of the purchasers of the Notes represented thereby with the Custodian, and registered in the name of the Depositary or a
nominee of the Depositary, duly executed by the Partnership and authenticated by the Trustee as provided in the Indenture. The Rule 144A Global Note, the Regulation S Global Note and any Unrestricted Global Note are each referred to herein
as a “Global Note” and are collectively referred to herein as “Global Notes.” Each Global Note shall represent such of the outstanding Notes as shall be specified in the “Schedule of Exchanges of Interests in
the Global Note” attached thereto and each shall provide that it shall represent the aggregate principal amount of Notes from time to time endorsed thereon and that the aggregate principal amount of outstanding Notes represented thereby may
from time to time be reduced or increased, as applicable, to reflect exchanges and redemptions. Any endorsement of a Global Note to reflect the amount of any increase or decrease in the aggregate principal amount of outstanding Notes represented
thereby shall be made by the Trustee or the Custodian, at the direction of the Trustee, in accordance with instructions given by the Holder thereof as required by Section 2.06 of this Indenture and Section 2.2(c) of this Appendix A. 

(c) Book-Entry Provisions. This Section 2.1(c) shall apply only to a Global Note deposited with or on behalf of the Depositary.

 The Partnership shall execute and the Trustee shall, in accordance with this Section 2.1(c) and Section 2.02 of this Indenture
and pursuant to an order of the Partnership signed by one Officer of the Partnership, authenticate and deliver initially one or more Global Notes that (i) shall be registered in the name of the Depositary for such Global Note or Global Notes or
the nominee of such Depositary and (ii) shall be delivered by the Trustee to such Depositary or pursuant to such Depositary’s instructions or held by the Trustee as Custodian. 

Members of, or participants in, the Depositary (“Agent Members”) shall have no rights under the Indenture with respect to any
Global Note held on their behalf by the Depositary or by the Trustee as Custodian or under such Global Note, and the Depositary may be treated by the Partnership, the Trustee and any agent of the Partnership or the Trustee as the absolute owner of
such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Partnership, the Trustee or any agent of the Partnership or the Trustee from giving effect to any written certification, proxy or other
authorization furnished by the Depositary or impair, as between the Depositary and its Agent Members, the operation of customary practices of such Depositary governing the exercise of the rights of a holder of a beneficial interest in any Global
Note. 

  
 2 

 (d) Definitive Notes. Except as provided in Section 2.2 or Section 2.3 of
this Appendix A, owners of beneficial interests in Global Notes shall not be entitled to receive physical delivery of Definitive Notes. 
 Section 2.2
Transfer and Exchange. 
 (a) Transfer and Exchange of Definitive Notes for Definitive Notes. When Definitive Notes are
presented to the Registrar with a request: 
 (i) to register the transfer of such Definitive Notes; or 

(ii) to exchange such Definitive Notes for an equal principal amount of Definitive Notes of other authorized
denominations, 
 the Registrar shall register the transfer or make the exchange as requested if its reasonable requirements for such transaction are met;
provided, however, that the Definitive Notes surrendered for transfer or exchange: 
 (1) shall be duly
endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Partnership and the Registrar, duly executed by the Holder thereof or his attorney duly authorized in writing; and 

(2) in the case of Transfer Restricted Notes, they are being transferred or exchanged pursuant to an effective
registration statement under the Securities Act or pursuant to Section 2.2(b) of this Appendix A or otherwise in accordance with the Restricted Notes Legend, and are accompanied by a certification from the transferor in the form provided on the
reverse side of the Form of Note in Exhibit A-1 and Exhibit A-2 for exchange or registration of transfers and, as applicable, delivery of such legal opinions,
certifications and other information as may be requested pursuant thereto. 
 (b) Restrictions on Transfer of a Definitive Note for a
Beneficial Interest in a Global Note. A Definitive Note may not be exchanged for a beneficial interest in a Global Note except upon satisfaction of the requirements set forth below. Upon receipt by the Trustee of a Definitive Note, duly endorsed
or accompanied by a written instrument of transfer in form reasonably satisfactory to the Partnership and the Registrar, together with: 

(i) a certification from the transferor in the form provided on the reverse side of the Form of Note in Exhibit A-1 and Exhibit A-2 for exchange or registration of transfers and, as applicable, delivery of such legal opinions, certifications and other information as may be requested
pursuant thereto; and 
 (ii) written instructions directing the Trustee to make, or to direct the Custodian to make, an
adjustment on its books and records with respect to such Global Note to reflect an increase in the aggregate principal amount of the Notes represented by the Global Note, such instructions to contain information regarding the Depositary account to
be credited with such increase, 

  
 3 

 the Trustee shall cancel such Definitive Note and cause, or direct the Custodian to cause, in accordance
with the standing instructions and procedures existing between the Depositary and the Custodian, the aggregate principal amount of Notes represented by the Global Note to be increased by the aggregate principal amount of the Definitive Note to be
exchanged and shall credit or cause to be credited to the account of the Person specified in such instructions a beneficial interest in the Global Note equal to the principal amount of the Definitive Note so canceled. If the applicable Global Note
is not then outstanding, the Partnership shall issue and the Trustee shall authenticate, upon an Authentication Order, a new applicable Global Note in the appropriate principal amount. 

(c) Transfer and Exchange of Global Notes. 

(i) The transfer and exchange of Global Notes or beneficial interests therein shall be effected through the Depositary, in accordance with
the Indenture (including applicable restrictions on transfer set forth in Section 2.2(d) of this Appendix A, if any) and the procedures of the Depositary therefor. A transferor of a beneficial interest in a Global Note shall deliver to the
Registrar a written order given in accordance with the Depositary’s procedures containing information regarding the participant account of the Depositary to be credited with a beneficial interest in such Global Note, or another Global Note and
such account shall be credited in accordance with such order with a beneficial interest in the applicable Global Note and the account of the Person making the transfer shall be debited by an amount equal to the beneficial interest in the Global Note
being transferred. 
 (ii) If the proposed transfer is a transfer of a beneficial interest in one Global Note to a beneficial interest
in another Global Note, the Registrar shall reflect on its books and records the date and an increase in the principal amount of the Global Note to which such interest is being transferred in an amount equal to the principal amount of the interest
to be so transferred, and the Registrar shall reflect on its books and records the date and a corresponding decrease in the principal amount of the Global Note from which such interest is being transferred. 

(iii) Notwithstanding any other provisions of this Appendix A (other than the provisions set forth in Section 2.3 of this Appendix
A), a Global Note may not be transferred except as a whole and not in part if the transfer is by the Depositary to a nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the
Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary. 
 (d) Restrictions on Transfer of
Global Notes; Voluntary Exchange of Interests in Transfer Restricted Global Notes for Interests in Unrestricted Global Notes. 
 (i)
Transfers by an owner of a beneficial interest in a Rule 144A Global Note to a transferee who takes delivery of such interest through another Transfer Restricted Global Note shall be made in accordance with the Applicable Procedures and the
Restricted Notes Legend and only upon receipt by the Trustee of a certification from the transferor in the form provided on the reverse side of the Form of Note in Exhibit A-1 and Exhibit A-2 for exchange or registration of transfers and, as applicable, delivery of such legal opinions, certifications and other information as may be requested pursuant thereto. 

(ii) During the Distribution Compliance Period, beneficial ownership interests in the Regulation S Global Note may only be sold, pledged or
transferred through Euroclear or Clearstream in accordance with the Applicable Procedures, the Restricted Notes Legend on such Regulation S Global Note and any applicable securities laws of any state of the U.S. Prior to the expiration of the
Distribution Compliance Period, transfers by a Beneficial Owner in the Regulation S Global Note to a transferee who takes delivery of such interest through a Rule 144A Global Note shall be made only in accordance with the Applicable Procedures
and the Restricted Notes Legend and upon receipt by the Trustee of a written certification from the transferor of the beneficial interest in the form provided on the reverse side of the Form of Note in
Exhibit A-1 and Exhibit A-2 for exchange or registration of transfers. Such written certification shall no longer be required after the expiration of the
Distribution Compliance Period. Upon the expiration of the Distribution Compliance Period, beneficial ownership interests in the Regulation S Global Note shall be transferable in accordance with applicable law and the other terms of the Indenture.

  
 4 

 (iii) Upon the expiration of the Distribution Compliance Period, beneficial interests in the
Regulation S Global Note may be exchanged for beneficial interests in an Unrestricted Global Note upon certification in the form provided on the reverse side of the Form of Note in Exhibit A-1 and
Exhibit A-2 for an exchange from a Regulation S Global Note to an Unrestricted Global Note. 
 (iv)
Beneficial interests in a Transfer Restricted Note that is a Rule 144A Global Note may be exchanged for beneficial interests in an Unrestricted Global Note if the Holder certifies in writing to the Registrar that its request for such exchange is in
respect of a transfer made in reliance on Rule 144 (such certification to be in the form set forth on the reverse side of the Form of Note in Exhibit A-1 and Exhibit
A-2) and/or upon delivery of such legal opinions, certifications and other information as the Partnership or the Trustee may reasonably request. 

(v) If no Unrestricted Global Note is outstanding at the time of a transfer contemplated by the preceding clauses (iii) and (iv), the
Partnership shall issue and the Trustee shall authenticate, upon an Authentication Order, a new Unrestricted Global Note in the appropriate principal amount. 

(e) Legends. 

(i) Except as permitted by Section 2.2(d) and this Section 2.2(e) of this Appendix A, each Note certificate evidencing the
Global Notes and the Definitive Notes (and all Notes issued in exchange therefor or in substitution thereof) shall bear a legend in substantially the following form (each defined term in the legend being defined as such for purposes of the legend
only) (“Restricted Notes Legend”): 
 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF
IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS SECURITY, BY ITS ACCEPTANCE HEREOF, AGREES ON ITS OWN BEHALF AND ON BEHALF OF ANY INVESTOR ACCOUNT FOR WHICH IT
HAS PURCHASED SECURITIES, TO OFFER, SELL OR OTHERWISE TRANSFER SUCH SECURITY, PRIOR TO THE DATE (THE “RESALE RESTRICTION TERMINATION DATE”) THAT IS [IN THE CASE OF RULE 144A NOTES: SIX MONTHS AFTER THE LATER OF THE ORIGINAL ISSUE
DATE HEREOF, THE ORIGINAL ISSUE DATE OF THE ISSUANCE OF ANY ADDITIONAL NOTES AND THE LAST DATE ON WHICH THE PARTNERSHIP OR ANY AFFILIATE OF THE PARTNERSHIP WAS THE OWNER OF THIS SECURITY (OR ANY PREDECESSOR OF SUCH SECURITY),] [IN THE CASE OF
REGULATION S NOTES: 40 DAYS AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF, THE ORIGINAL ISSUE DATE OF THE ISSUANCE OF ANY ADDITIONAL NOTES AND THE DATE ON WHICH THIS SECURITY (OR ANY PREDECESSOR OF SUCH SECURITY) WAS FIRST OFFERED TO PERSONS
OTHER THAN DISTRIBUTORS (AS DEFINED IN RULE 902 OF REGULATION S) IN RELIANCE ON REGULATION S], ONLY (A) TO THE PARTNERSHIP OR ANY SUBSIDIARY THEREOF, (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE
SECURITIES ACT, (C) 

  
 5 

 
FOR SO LONG AS THE SECURITIES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT (“RULE 144A”), TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL
BUYER” AS DEFINED IN RULE 144A THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (D) PURSUANT TO OFFERS AND SALES TO NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF REGULATION S UNDER THE SECURITIES ACT OR (E) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT, SUBJECT TO THE PARTNERSHIP’S AND THE TRUSTEE’S RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER PURSUANT TO CLAUSES (D) OR (E) TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION AND/OR OTHER INFORMATION
SATISFACTORY TO EACH OF THEM. THIS LEGEND WILL BE REMOVED UPON THE REQUEST OF THE HOLDER AFTER THE RESALE RESTRICTION TERMINATION DATE. [IN THE CASE OF REGULATION S NOTES: BY ITS ACQUISITION HEREOF, THE HOLDER HEREOF REPRESENTS THAT IT IS NOT
A U.S. PERSON NOR IS IT PURCHASING FOR THE ACCOUNT OF A U.S. PERSON AND IS ACQUIRING THIS SECURITY IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH REGULATION S UNDER THE SECURITIES ACT.] 

Each Definitive Note shall bear the following additional legend (“Definitive Notes Legend”): 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 
 Each Global Note shall bear
the following additional legend (“Global Notes Legend”): 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE PARTNERSHIP OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE
NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER,
PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF
OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 

  
 6 

 Each Note shall bear the following additional legend (“ERISA Legend”): 

BY ITS ACQUISITION OF THIS SECURITY, THE HOLDER THEREOF WILL BE DEEMED TO HAVE REPRESENTED AND WARRANTED THAT EITHER (1) NO PORTION OF THE
ASSETS USED BY SUCH HOLDER TO ACQUIRE OR HOLD THIS SECURITY CONSTITUTES THE ASSETS OF AN EMPLOYEE BENEFIT PLAN THAT IS SUBJECT TO TITLE I OF THE U.S. EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), OF A PLAN,
INDIVIDUAL RETIREMENT ACCOUNT OR OTHER ARRANGEMENT THAT IS SUBJECT TO SECTION 4975 OF THE U.S. INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”) OR PROVISIONS UNDER ANY OTHER FEDERAL, STATE, LOCAL,
NON-U.S. OR OTHER LAWS OR REGULATIONS THAT ARE SIMILAR TO SUCH PROVISIONS OF ERISA OR THE CODE (“SIMILAR LAWS”), OR OF AN ENTITY WHOSE UNDERLYING ASSETS ARE CONSIDERED TO INCLUDE “PLAN
ASSETS” OF ANY SUCH PLAN, ACCOUNT OR ARRANGEMENT, OR (2) THE ACQUISITION AND HOLDING OF THIS SECURITY WILL NOT CONSTITUTE A NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA OR SECTION
4975 OF THE CODE OR A SIMILAR VIOLATION UNDER ANY APPLICABLE SIMILAR LAWS. 
 (ii) Upon any sale or transfer of a Transfer Restricted
Note that is a Definitive Note, the Registrar shall permit the Holder thereof to exchange such Transfer Restricted Note for a Definitive Note that does not bear the Restricted Notes Legend and the Definitive Notes Legend and rescind any restriction
on the transfer of such Transfer Restricted Note if the Holder certifies in writing to the Registrar that its request for such exchange is in respect of a transfer made in reliance on Rule 144 (such certification to be in the form set forth on
the reverse side of the Form of Note in Exhibit A-1 and Exhibit A-2) and provides such legal opinions, certifications and other information as the Partnership or the
Trustee may reasonably request. 
 (iii) Any Additional Notes sold in a registered offering shall not be required to bear the Restricted
Notes Legend. 
 (f) Cancellation or Adjustment of Global Note. At such time as all beneficial interests in a Global Note have either
been exchanged for Definitive Notes, transferred in exchange for an interest in another Global Note, redeemed, repurchased or canceled, such Global Note shall be returned by the Depositary to the Trustee for cancellation or retained and canceled by
the Trustee. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged for Definitive Notes, transferred in exchange for an interest in another Global Note, redeemed, repurchased or canceled, the principal
amount of Notes represented by such Global Note shall be reduced and an adjustment shall be made on the books and records of the Registrar (if it is then the Custodian for such Global Note) with respect to such Global Note, by the Registrar or the
Custodian, to reflect such reduction. 
 (g) Obligations with Respect to Transfers and Exchanges of Notes. 

(i) To permit registrations of transfers and exchanges, the Partnership shall execute and the Trustee shall authenticate, Definitive Notes
and Global Notes at the Registrar’s request. 
 (ii) No service charge shall be imposed in connection with any registration of transfer
or exchange, but the Partnership may require payment of a sum sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such transfer taxes or similar governmental charge
payable upon exchange or transfer pursuant to Sections 2.10, 3.06 and 9.04 of the Indenture). 

  
 7 

 (iii) Prior to the due presentation for registration of transfer of any Note, the
Partnership, the Trustee, the Paying Agent or the Registrar may deem and treat the person in whose name a Note is registered as the absolute owner of such Note for the purpose of receiving payment of principal, premium, if any, and interest on such
Note and for all other purposes whatsoever, whether or not such Note is overdue, and none of the Partnership, the Trustee, the Paying Agent or the Registrar shall be affected by notice to the contrary. 

(iv) All Notes issued upon any transfer or exchange pursuant to the terms of this Indenture shall evidence the same debt and shall be
entitled to the same benefits under this Indenture as the Notes surrendered upon such transfer or exchange. 
 (v) In order to effect
any transfer or exchange of an interest in any Transfer Restricted Note for an interest in a Note that does not bear the Restricted Notes Legend and has not been registered under the Securities Act, if the Registrar so requests or if the Applicable
Procedures so require, an Opinion of Counsel, in form reasonably acceptable to the Registrar to the effect that no registration under the Securities Act is required in respect of such exchange or transfer or the
re-sale of such interest by the beneficial holder thereof, shall be required to be delivered to the Registrar and the Trustee. 

(h) No Obligation of the Trustee. 

(i) The Trustee shall have no responsibility or obligation to any Beneficial Owner of a Global Note, a member of, or a participant in the
Depositary or any other Person with respect to the accuracy of the records of the Depositary or its nominee or of any participant or member thereof, with respect to any ownership interest in the Notes or with respect to the delivery to any
participant, member, Beneficial Owner or other Person (other than the Depositary) of any notice (including any notice of redemption or repurchase) or the payment of any amount, under or with respect to such Notes. All notices and communications to
be given to the Holders and all payments to be made to Holders under the Notes shall be given or made only to the registered Holders (which shall be the Depositary or its nominee in the case of a Global Note). The rights of Beneficial Owners in any
Global Note shall be exercised only through the Depositary subject to the applicable rules and procedures of the Depositary. The Trustee may rely and shall be fully protected in relying upon information furnished by the Depositary with respect to
its members, participants and any Beneficial Owners. 
 (ii) The Trustee shall have no obligation or duty to monitor, determine or
inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Note (including any transfers between or among Depositary participants, members or
Beneficial Owners in any Global Note) other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by, the terms of the Indenture, and to examine
the same to determine substantial compliance as to form with the express requirements hereof. 
 Section 2.3 Definitive Notes. 

(a) A Global Note deposited with the Depositary or with the Trustee as Custodian pursuant to Section 2.1 may be transferred to the
Beneficial Owners thereof in the form of Definitive Notes in an aggregate principal amount equal to the principal amount of such Global Note, in exchange for such Global Note, only if such transfer complies with Section 2.2 of this Appendix A
and (i) the Depositary notifies the Partnership that it is unwilling or unable to continue as a Depositary for such Global Note or if at any time the Depositary ceases to be a “clearing agency” registered under the Exchange Act and,
in each case, a successor depositary is not appointed by the Partnership within 90 days of such notice or after the Partnership becomes aware of such cessation or (ii) an Event of Default has occurred and is continuing and the Registrar
has received a request from the Depository. In addition, any 

  
 8 

 
Affiliate of the Partnership or any Subsidiary Guarantor that is a Beneficial Owner of all or part of a Global Note may have such Affiliate’s beneficial interest transferred to such
Affiliate in the form of a Definitive Note by providing a written request to the Partnership and the Trustee and such Opinions of Counsel, certificates or other information as may be required by the Indenture or the Partnership or Trustee. 

(b) Any Global Note that is transferable to the Beneficial Owners thereof pursuant to this Section 2.3 shall be surrendered by the
Depositary to the Trustee, to be so transferred, in whole or from time to time in part, without charge, and the Trustee shall authenticate and deliver, upon such transfer of each portion of such Global Note, an equal aggregate principal amount of
Definitive Notes of authorized denominations. Any portion of a Global Note transferred pursuant to this Section 2.3 shall be executed, authenticated and delivered only in denominations of $2,000 and integral multiples of $1,000 in excess
thereof and registered in such names as the Depositary shall direct. Any Definitive Note delivered in exchange for an interest in a Global Note that is a Transfer Restricted Note shall, except as otherwise provided by Section 2.2(e) of this
Appendix A, bear the Restricted Notes Legend. 
 (c) The registered Holder of a Global Note may grant proxies and otherwise authorize
any Person, including Agent Members and Persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under this Indenture or the Notes. 

(d) In the event of the occurrence of any of the events specified in Section 2.3(a) of this Appendix A, the Partnership shall
promptly make available to the Trustee a reasonable supply of Definitive Notes in fully registered form without interest coupons. 

  
 9 

 EXHIBIT A-1 

[FORM OF FACE OF 2029 NOTE] 

[Insert the Restricted Notes Legend, if applicable, pursuant to the provisions of the Indenture] 

[Insert the Global Notes Legend, if applicable, pursuant to the provisions of the Indenture] 

[Insert the Definitive Notes Legend, if applicable, pursuant to the provisions of the Indenture] 

[Insert the ERISA Legend, if applicable, pursuant to the provisions of the Indenture.] 

  
 A-1 

 APPENDIX A 

CUSIP [                ] 

ISIN [                 ]1 
 [RULE 144A][REGULATION S] NOTE 

4.50% Senior Notes due 2029 
  

			
	No. [RA-__] [RS-__]	  	[Up to]2  [$______________]

 EQM MIDSTREAM PARTNERS, LP 

promises to pay to [CEDE & CO.]3 [_______________] or registered assigns the principal sum [set
forth on the Schedule of Exchanges of Interests in the Global Note attached hereto]4 [of $_______ (_______ Dollars)]5 on January 15, 2029.

 Interest Payment Dates: January 15 and July 15 

Record Dates: January 1 and July 1 

 

	1	 Rule 144A Note CUSIP: 26885BAK6 

Rule 144A Note ISIN:    US26885BAK61 

Regulation S Note CUSIP: U26886AC2 

Regulation S Note ISIN: USU26886AC29 

	2 	 Include in Global Notes. 

	3 	 Include in Global Notes 

	4 	 Include in Global Notes 

	5 	 Include in Definitive Notes 

 IN WITNESS HEREOF, the Partnership has caused this instrument to be duly executed. 

Dated: 
  

			
	EQM MIDSTREAM PARTNERS, LP
	
	By: EQGP Services, LLC, its general partner
		
	By:	 	 
		 	Name: Kirk R. Oliver
		 	Title: Senior Vice President and Chief Financial Officer

  
 A-1-2 

 CERTIFICATE OF AUTHENTICATION 

This is one of the Notes referred to in the within-mentioned Indenture: 

 

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	                
		 	Authorized Signatory

 Dated: 

  
 A-1-3 

 [Reverse Side of Note] 

4.50% Senior Notes due 2029 

Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated. 

1. INTEREST. EQM Midstream Partners, LP, a Delaware limited partnership (the “Partnership”), promises to pay interest on the
principal amount of this Note at 4.50% per annum until but excluding maturity. The Partnership shall pay interest semi-annually in arrears on January 15 and July 15 of each year, or if any such day is not a Business Day, on the next
succeeding Business Day (each, an “Interest Payment Date”). Interest on the Notes shall accrue from the most recent date to which interest has been paid or, if no interest has been paid, from and including [the date of original
issuance] 6 [[__________] [__], 20[__]]7; provided that the first Interest Payment
Date shall be July 15, 2021. The Partnership shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and premium, if any, from time to time on demand at the interest rate on the
Notes to the extent lawful; it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest (without regard to any applicable grace periods) from time to time on demand at the
interest rate on the Notes to the extent lawful. Interest shall be computed on the basis of a 360-day year comprised of twelve 30-day months. 

2. METHOD OF PAYMENT. The Partnership shall pay interest on the Notes to the Persons who are registered holders of Notes at the close of
business on the January 1 or July 1 (whether or not a Business Day), as the case may be, immediately preceding the related Interest Payment Date, even if such Notes are canceled after such Record Date and on or before such Interest Payment
Date, except as provided in Section 2.12 of the Indenture with respect to defaulted interest. Principal, premium, if any, and interest on the Notes shall be payable at the office or agency of the Partnership maintained for such purpose or, at
the option of the Partnership, payment of interest and premium, if any, may be made by check mailed to the Holders at their respective addresses set forth in the Note Register; provided that payment by wire transfer of immediately available
funds shall be required with respect to principal, premium, if any, and interest on all Global Notes and all other Notes the Holders of which shall have provided wire transfer instructions to the Partnership or the Paying Agent at least five
Business Days prior to the applicable payment date. Such payment shall be in such coin or currency of the United States as at the time of payment is legal tender for payment of public and private debts. 

3. PAYING AGENT AND REGISTRAR. Initially, The Bank of New York Mellon Trust Company, N.A., the Trustee under the Indenture, shall act as Paying
Agent and Registrar. The Partnership may change any Paying Agent or Registrar without notice to the Holders. The Partnership or any of its Subsidiaries may act in any such capacity. 

4. INDENTURE. The Partnership issued the Notes under an Indenture, dated as of January 8, 2021 (as amended or supplemented from time to
time, the “Indenture”), between EQM Midstream Partners, LP and the Trustee. This Note is one of a duly authorized issue of notes of the Partnership designated as its 4.50% Senior Notes due 2029. The Partnership shall be entitled to
issue Additional Notes pursuant to Section 2.01 of the Indenture. The Notes and any Additional Notes issued under the Indenture shall be treated as a single class of securities under the Indenture. The terms of the Notes include those stated in
the Indenture. The Notes are subject to all such terms, and Holders are referred to the Indenture for a statement of such terms. To the extent any provision of this Note conflicts with the express provisions of the Indenture, the provisions of the
Indenture shall govern and be controlling. 
  

	6 	 With respect to the Initial Notes. This may need to be a specified date if the Notes are not issued on the
expected closing date. 

	7 	 With respect to Notes other than the Initial Notes. Fill in date of last interest payment.

  
 A-1-4 

 5. REDEMPTION AND REPURCHASE. The Notes are subject to optional redemption, and may be the
subject of an offer to purchase, as further described in the Indenture. The Partnership shall not be required to make mandatory redemption or sinking fund payments with respect to the Notes. 

6. DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of
$1,000 in excess thereof. The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer
documents, and Holders shall be required to pay any taxes and fees required by law or permitted by the Indenture. The Partnership need not exchange or register the transfer of any Note or portion of a Note selected for redemption or tendered for
repurchase in connection with a Change of Control Offer, except for the unredeemed portion of any Note being redeemed or repurchased in part. 

7. PERSONS DEEMED OWNERS. The registered Holder of a Note may be treated as its owner for all purposes. 

8. AMENDMENT, SUPPLEMENT AND WAIVER. The Indenture, the Note Guarantees, to the extent applicable, or the Notes may be amended or supplemented
as provided in the Indenture. 
 9. DEFAULTS AND REMEDIES. The Events of Default relating to the Notes are defined in Section 6.01 of
the Indenture. Upon the occurrence of an Event of Default, the rights and obligations of the Partnership, the Subsidiary Guarantors, the Trustee and the Holders shall be as set forth in the applicable provisions of the Indenture. 

10. AUTHENTICATION. This Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose until
authenticated by the manual, facsimile or electronic signature of the Trustee. 
 11. GOVERNING LAW. THIS NOTE WILL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 12. CUSIP AND ISIN NUMBERS. Pursuant to a recommendation promulgated by
the Committee on Uniform Security Identification Procedures, the Partnership has caused CUSIP and ISIN numbers to be printed on the Notes, and the Trustee may use CUSIP and ISIN numbers in notices of redemption as a convenience to Holders. No
representation is made as to the accuracy of such numbers either as printed on the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 

The Partnership shall furnish to any Holder upon written request and without charge a copy of the Indenture. Requests may be made to the
Partnership at the following address: 
 c/o EQM Midstream Partners, LP 

2200 Energy Drive 
 Canonsburg,
Pennsylvania 15317 
 E-mail: tnelson@equitransmidstream.com 

Attention: Corporate Secretary 

  
 A-1-5 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 

(I) or (we) assign and transfer this Note to:
                                        
                                         
                                         
                   
 (Insert
assignee’s legal name) 
  
  

(Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably appoint
                                        
                                         
                                         
                                         
          
 to transfer this Note on the books of the Partnership. The agent may substitute another to act
for him. 
 Date: _____________________ 
  

			
	Your Signature:	 	  

		 	(Sign exactly as your name appears on the face of this Note)

 Signature Guarantee*: __________________________________ 

 

	*	 Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to
the Trustee). 

  
 A-1-6 

 CERTIFICATE TO BE DELIVERED UPON EXCHANGE OR 

REGISTRATION OF TRANSFERS OF TRANSFER RESTRICTED NOTES 

This certificate relates to $_________ principal amount of Notes held in (check applicable space) ____ book-entry or _____ definitive form by the undersigned.

 The undersigned (check one box below): 
  

	☐	 has requested the Trustee by written order to deliver in exchange for its beneficial interest in a Global Note
held by the Depositary a Note or Notes in definitive, registered form of authorized denominations and an aggregate principal amount equal to its beneficial interest in such Global Note (or the portion thereof indicated above) in accordance with the
Indenture; or 

  

	☐	 has requested the Trustee by written order to exchange or register the transfer of a Note or Notes.

 In connection with any transfer of any of the Notes evidenced by this certificate, the undersigned confirms that such Notes are being
transferred in accordance with its terms: 
 CHECK ONE BOX BELOW 
  

	 	(1)      ☐	 to the Partnership or subsidiary thereof; or 

 

	 	(2)      ☐	 to the Registrar for registration in the name of the Holder, without transfer; or 

 

	 	(3)      ☐	 pursuant to an effective registration statement under the Securities Act of 1933, as amended (the
“Securities Act”); or 

  

	 	(4)      ☐	 to a Person that the undersigned reasonably believes is a “qualified institutional buyer” (as defined
in Rule 144A under the Securities Act (“Rule 144A”)) that purchases for its own account or for the account of a qualified institutional buyer and to whom notice is given that such transfer is being made in reliance on Rule
144A, in each case pursuant to and in compliance with Rule 144A; or 

  

	 	(5)      ☐	 pursuant to offers and sales to non-U.S. persons that occur outside the
United States within the meaning of Regulation S under the Securities Act (and if the transfer is being made prior to the expiration of the Distribution Compliance Period, the Notes shall be held immediately thereafter through Euroclear or
Clearstream); or 

  

	 	(6)      ☐	 pursuant to Rule 144 under the Securities Act; or 

 

	 	(7)      ☐	 pursuant to another available exemption from registration under the Securities Act. 

Unless one of the boxes is checked, the Trustee will refuse to register any of the Notes evidenced by this certificate in the name of any
Person other than the registered Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Partnership or the Trustee may require, prior to registering any such transfer of the Notes, such legal opinions,
certifications and other information as the Partnership or the Trustee has reasonably requested to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the
Securities Act. 

  
 A-1-7 

			
		  	  
 Your Signature

	Date:______________________	  	  

		  	 Signature of Signature
 Guarantor

 TO BE COMPLETED BY PURCHASER IF (4) ABOVE IS CHECKED. 

The undersigned represents and warrants that it is purchasing this Note for its own account or an account with respect to which it exercises
sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A, and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it
has received such information regarding the Partnership as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon the undersigned’s
foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

			
	Dated:____________________	  	  

		  	 NOTICE: To be executed by

an executive officer
 Name:

Title:

 Signature Guarantee*: __________________________________ 

 

	*	 Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to
the Trustee). 

  
 A-1-8 

 TO BE COMPLETED IF THE HOLDER REQUIRES AN EXCHANGE FROM A 

REGULATION S GLOBAL NOTE TO AN UNRESTRICTED GLOBAL NOTE, 

PURSUANT TO SECTION 2.2(d)(iii) OF APPENDIX A TO THE INDENTURE8 

The undersigned represents and warrants that either: 
  

	☐	 the undersigned is not a dealer (as defined in the Securities Act) and is a
non-U.S. person (within the meaning of Regulation S under the Securities Act); or 

  

	☐	 the undersigned is not a dealer (as defined in the Securities Act) and is a U.S. person (within the meaning of
Regulation S under the Securities Act) who purchased interests in the Notes pursuant to an exemption from, or in a transaction not subject to, the registration requirements under the Securities Act; or 

 

	☐	 the undersigned is a dealer (as defined in the Securities Act) and the interest of the undersigned in this Note
does not constitute the whole or a part of an unsold allotment to or subscription by such dealer for the Notes. 

  

			
	Dated:________________________	  	  

		  	Your Signature

  

	8 	 Include only for Regulation S Global Notes. 

  
 A-1-9 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Partnership pursuant to Section 4.11 of the Indenture, check the appropriate box
below: 
 [    ] Section 4.11 

If you want to elect to have only part of this Note purchased by the Partnership pursuant to Section 4.11 of the Indenture, state the
amount you elect to have purchased: 
  

					
		  	$_______________	  	(integral multiples of $1,000, provided that the unpurchased portion must be in a minimum principal amount of $2,000)

 Date: _____________________ 
  

					
		  	Your Signature: 	  	  

		  		  	(Sign exactly as your name appears on the face of this Note)
		  	Tax Identification No.:	  	  

 Signature Guarantee*: __________________________________ 

 

	*	 Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to
the Trustee). 

  
 A-1-10 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE* 

The initial outstanding principal amount of this Global Note is $____. The following exchanges of a part of this Global Note for an interest
in another Global Note or for a Definitive Note, or exchanges of a part of another Global Note or Definitive Note for an interest in this Global Note, have been made: 
  

									
	 Date of Exchange
	  	 Amount of Decrease

in Principal Amount of this
Global Note
	  	 Amount of

Increase
 in Principal

Amount of
 this

Global Note
	  	 Principal

Amount of
 this Global

Note
 following

such
 Decrease or

Increase
	  	 Signature of

Authorized
 Signatory of
Trustee,
Depositary or Custodian

  
  

	*	 This schedule should be included only if the Note is issued in global form.  

  
 A-1-11 

 EXHIBIT A-2 

[FORM OF FACE OF 2031 NOTE] 

[Insert the Restricted Notes Legend, if applicable, pursuant to the provisions of the Indenture] 

[Insert the Global Notes Legend, if applicable, pursuant to the provisions of the Indenture] 

[Insert the Definitive Notes Legend, if applicable, pursuant to the provisions of the Indenture] 

[Insert the ERISA Legend, if applicable, pursuant to the provisions of the Indenture.] 

  
 A-2-1 

 CUSIP
[                ] 
 ISIN
[                 ]9 

[RULE 144A][REGULATION S] NOTE 

4.75% Senior Notes due 2031 
  

			
	No. [RA-__] [RS-__]	  	[Up to]10  [$______________]

 EQM MIDSTREAM PARTNERS, LP 

promises to pay to [CEDE & CO.]11 [_______________] or registered assigns the principal sum [set
forth on the Schedule of Exchanges of Interests in the Global Note attached hereto]12 [of $_______ (_______ Dollars)]13 on January 15,
2031. 
 Interest Payment Dates: January 15 and July 15 

Record Dates: January 1 and July 1 

 

	9 	 Rule 144A Note CUSIP: 26885BAL4 

Rule 144A Note ISIN:    US26885BAL45 

Regulation S Note CUSIP: U26886AD0 

Regulation S Note ISIN: USU26886AD02 

	10 	 Include in Global Notes. 

	11 	 Include in Global Notes 

	12 	 Include in Global Notes 

	13 	 Include in Definitive Notes 

  
 A-2-2 

 IN WITNESS HEREOF, the Partnership has caused this instrument to be duly executed. 

Dated: 

			
	
	 EQM MIDSTREAM PARTNERS, LP
  

By: EQGP Services, LLC, its general partner

		
	By:	 	  

		 	Name: Kirk R. Oliver
		 	Title: Senior Vice President and Chief Financial Officer

  
 A-2-3 

 CERTIFICATE OF AUTHENTICATION 

This is one of the Notes referred to in the within-mentioned Indenture: 

 

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	 
		 	Authorized Signatory

 Dated: 

  
 A-2-4 

 [Reverse Side of Note] 

4.75% Senior Notes due 2031 

Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated. 

1. INTEREST. EQM Midstream Partners, LP, a Delaware limited partnership (the “Partnership”), promises to pay interest on the
principal amount of this Note at 4.75% per annum until but excluding maturity. The Partnership shall pay interest semi-annually in arrears on January 15 and July 15 of each year, or if any such day is not a Business Day, on the next
succeeding Business Day (each, an “Interest Payment Date”). Interest on the Notes shall accrue from the most recent date to which interest has been paid or, if no interest has been paid, from and including [the date of original
issuance] 14 [[__________] [__], 20[__]]15; provided that the first Interest
Payment Date shall be July 15, 2021. The Partnership shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and premium, if any, from time to time on demand at the interest rate on
the Notes to the extent lawful; it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest (without regard to any applicable grace periods) from time to time on demand at
the interest rate on the Notes to the extent lawful. Interest shall be computed on the basis of a 360-day year comprised of twelve 30-day months. 

2. METHOD OF PAYMENT. The Partnership shall pay interest on the Notes to the Persons who are registered holders of Notes at the close of
business on the January 1 or July 1 (whether or not a Business Day), as the case may be, immediately preceding the related Interest Payment Date, even if such Notes are canceled after such Record Date and on or before such Interest Payment
Date, except as provided in Section 2.12 of the Indenture with respect to defaulted interest. Principal, premium, if any, and interest on the Notes shall be payable at the office or agency of the Partnership maintained for such purpose or, at
the option of the Partnership, payment of interest and premium, if any, may be made by check mailed to the Holders at their respective addresses set forth in the Note Register; provided that payment by wire transfer of immediately available
funds shall be required with respect to principal, premium, if any, and interest on all Global Notes and all other Notes the Holders of which shall have provided wire transfer instructions to the Partnership or the Paying Agent at least five
Business Days prior to the applicable payment date. Such payment shall be in such coin or currency of the United States as at the time of payment is legal tender for payment of public and private debts. 

3. PAYING AGENT AND REGISTRAR. Initially, The Bank of New York Mellon Trust Company, N.A., the Trustee under the Indenture, shall act as Paying
Agent and Registrar. The Partnership may change any Paying Agent or Registrar without notice to the Holders. The Partnership or any of its Subsidiaries may act in any such capacity. 

4. INDENTURE. The Partnership issued the Notes under an Indenture, dated as of January 8, 2021 (as amended or supplemented from time to
time, the “Indenture”), between EQM Midstream Partners, LP and the Trustee. This Note is one of a duly authorized issue of notes of the Partnership designated as its 4.75% Senior Notes due 2031. The Partnership shall be entitled to
issue Additional Notes pursuant to Section 2.01 of the Indenture. The Notes and any Additional Notes issued under the Indenture shall be treated as a single class of securities under the Indenture. The terms of the Notes include those stated in
the Indenture. The Notes are subject to all such terms, and Holders are referred to the Indenture for a statement of such terms. To the extent any provision of this Note conflicts with the express provisions of the Indenture, the provisions of the
Indenture shall govern and be controlling. 
  

	14 	 With respect to the Initial Notes. This may need to be a specified date if the Notes are not issued on the
expected closing date. 

	15 	 With respect to Notes other than the Initial Notes. Fill in date of last interest payment.

  
 A-2-5 

 5. REDEMPTION AND REPURCHASE. The Notes are subject to optional redemption, and may be the
subject of an offer to purchase, as further described in the Indenture. The Partnership shall not be required to make mandatory redemption or sinking fund payments with respect to the Notes. 

6. DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of
$1,000 in excess thereof. The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer
documents, and Holders shall be required to pay any taxes and fees required by law or permitted by the Indenture. The Partnership need not exchange or register the transfer of any Note or portion of a Note selected for redemption or tendered for
repurchase in connection with a Change of Control Offer, except for the unredeemed portion of any Note being redeemed or repurchased in part. 

7. PERSONS DEEMED OWNERS. The registered Holder of a Note may be treated as its owner for all purposes. 

8. AMENDMENT, SUPPLEMENT AND WAIVER. The Indenture, the Note Guarantees, to the extent applicable, or the Notes may be amended or supplemented
as provided in the Indenture. 
 9. DEFAULTS AND REMEDIES. The Events of Default relating to the Notes are defined in Section 6.01 of
the Indenture. Upon the occurrence of an Event of Default, the rights and obligations of the Partnership, the Subsidiary Guarantors, the Trustee and the Holders shall be as set forth in the applicable provisions of the Indenture. 

10. AUTHENTICATION. This Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose until
authenticated by the manual, facsimile or electric signature of the Trustee. 
 11. GOVERNING LAW. THIS NOTE WILL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 12. CUSIP AND ISIN NUMBERS. Pursuant to a recommendation promulgated by
the Committee on Uniform Security Identification Procedures, the Partnership has caused CUSIP and ISIN numbers to be printed on the Notes, and the Trustee may use CUSIP and ISIN numbers in notices of redemption as a convenience to Holders. No
representation is made as to the accuracy of such numbers either as printed on the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 

The Partnership shall furnish to any Holder upon written request and without charge a copy of the Indenture. Requests may be made to the
Partnership at the following address: 
 c/o EQM Midstream Partners, LP 

2200 Energy Drive 
 Canonsburg,
Pennsylvania 15317 
 E-mail: tnelson@equitransmidstream.com 

Attention: Corporate Secretary 

  
 A-2-6 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 

(I) or (we) assign and transfer this Note to:
                                        
                                         
                                         
                   
 (Insert
assignee’s legal name) 
  
  

(Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably appoint
                                        
                                         
                                         
                                         
          
 to transfer this Note on the books of the Partnership. The agent may substitute another to act
for him. 
 Date: _____________________ 
  

			
	Your Signature:	 	
                     
        

		 	(Sign exactly as your name appears on the face of this Note)

 Signature Guarantee*: __________________________________ 

 

	*	 Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to
the Trustee). 

  
 A-2-7 

 CERTIFICATE TO BE DELIVERED UPON EXCHANGE OR 

REGISTRATION OF TRANSFERS OF TRANSFER RESTRICTED NOTES 

This certificate relates to $_________ principal amount of Notes held in (check applicable space) ____ book-entry or _____ definitive form by the undersigned.

 The undersigned (check one box below): 
  

	☐	 has requested the Trustee by written order to deliver in exchange for its beneficial interest in a Global Note
held by the Depositary a Note or Notes in definitive, registered form of authorized denominations and an aggregate principal amount equal to its beneficial interest in such Global Note (or the portion thereof indicated above) in accordance with the
Indenture; or 

  

	☐	 has requested the Trustee by written order to exchange or register the transfer of a Note or Notes.

 In connection with any transfer of any of the Notes evidenced by this certificate, the undersigned confirms that such Notes are being
transferred in accordance with its terms: 
 CHECK ONE BOX BELOW 
  

	 	(1)        ☐	 to the Partnership or subsidiary thereof; or 

 

	 	(2)        ☐	 to the Registrar for registration in the name of the Holder, without transfer; or 

 

	 	(3)        ☐	 pursuant to an effective registration statement under the Securities Act of 1933, as amended (the
“Securities Act”); or 

  

	 	(4)        ☐	 to a Person that the undersigned reasonably believes is a “qualified institutional buyer” (as defined
in Rule 144A under the Securities Act (“Rule 144A”)) that purchases for its own account or for the account of a qualified institutional buyer and to whom notice is given that such transfer is being made in reliance on Rule
144A, in each case pursuant to and in compliance with Rule 144A; or 

  

	 	(5)        ☐	 pursuant to offers and sales to non-U.S. persons that occur outside the
United States within the meaning of Regulation S under the Securities Act (and if the transfer is being made prior to the expiration of the Distribution Compliance Period, the Notes shall be held immediately thereafter through Euroclear or
Clearstream); or 

  

	 	(6)        ☐	 pursuant to Rule 144 under the Securities Act; or 

 

	 	(7)        ☐	 pursuant to another available exemption from registration under the Securities Act. 

Unless one of the boxes is checked, the Trustee will refuse to register any of the Notes evidenced by this certificate in the name of any
Person other than the registered Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Partnership or the Trustee may require, prior to registering any such transfer of the Notes, such legal opinions,
certifications and other information as the Partnership or the Trustee has reasonably requested to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the
Securities Act. 

  
 A-2-8 

			
		  	  
 Your Signature

	Date:___________________	  	  

		  	 Signature of Signature
 Guarantor

 TO BE COMPLETED BY PURCHASER IF (4) ABOVE IS CHECKED. 

The undersigned represents and warrants that it is purchasing this Note for its own account or an account with respect to which it exercises
sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A, and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it
has received such information regarding the Partnership as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon the undersigned’s
foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

			
	Dated:_______________________	  	  

		  	 NOTICE: To be executed by

an executive officer
 Name:

Title:

 Signature Guarantee*: __________________________________ 

 

	*	 Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to
the Trustee). 

  
 A-2-9 

 TO BE COMPLETED IF THE HOLDER REQUIRES AN EXCHANGE FROM A 

REGULATION S GLOBAL NOTE TO AN UNRESTRICTED GLOBAL NOTE, 

PURSUANT TO SECTION 2.2(d)(iii) OF APPENDIX A TO THE INDENTURE16 

The undersigned represents and warrants that either: 
  

	☐	 the undersigned is not a dealer (as defined in the Securities Act) and is a
non-U.S. person (within the meaning of Regulation S under the Securities Act); or 

  

	☐	 the undersigned is not a dealer (as defined in the Securities Act) and is a U.S. person (within the meaning of
Regulation S under the Securities Act) who purchased interests in the Notes pursuant to an exemption from, or in a transaction not subject to, the registration requirements under the Securities Act; or 

 

	☐	 the undersigned is a dealer (as defined in the Securities Act) and the interest of the undersigned in this Note
does not constitute the whole or a part of an unsold allotment to or subscription by such dealer for the Notes. 

  

			
	Dated: ______________________________	  	  

		  	Your Signature

  

	16 	 Include only for Regulation S Global Notes. 

  
 A-2-10 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Partnership pursuant to Section 4.11 of the Indenture, check the appropriate box
below: 
 [    ] Section 4.11 

If you want to elect to have only part of this Note purchased by the Partnership pursuant to Section 4.11 of the Indenture, state the
amount you elect to have purchased: 
  

					
		  	$_______________	  	(integral multiples of $1,000, provided that the unpurchased portion must be in a minimum principal amount of $2,000)

 Date: _____________________ 
  

					
		  	Your Signature: 	  	
                     
                        

		  		  	(Sign exactly as your name appears on the face of this Note)
		  	Tax Identification No.:	  	  

 Signature Guarantee*: __________________________________ 

 

	*	 Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to
the Trustee). 

  
 A-2-11 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE* 

The initial outstanding principal amount of this Global Note is $____. The following exchanges of a part of this Global Note for an interest
in another Global Note or for a Definitive Note, or exchanges of a part of another Global Note or Definitive Note for an interest in this Global Note, have been made: 
  

									
	 Date of Exchange
	  	 Amount of Decrease

in Principal Amount of this
Global Note
	  	 Amount of Increase

in Principal
 Amount of this

Global Note
	  	 Principal Amount of

this Global Note
 following such

Decrease or Increase
	  	 Signature of Authorized
Signatory of Trustee,
Depositary or
Custodian

  
  

	*	 This schedule should be included only if the Note is issued in global form. 

  
 A-2-12 

 EXHIBIT B 

FORM OF SUPPLEMENTAL INDENTURE 
 TO
BE DELIVERED BY SUBSEQUENT GUARANTORS 
 Supplemental Indenture (this “Supplemental Indenture”), dated as of [__________]
[__], 20[__], among __________________ (the “Guaranteeing Subsidiary”), a subsidiary of EQM Midstream Partners, LP, a Delaware limited partnership (the “Partnership”), and The Bank of New York Mellon Trust Company,
N.A., as Trustee (the “Trustee”). 
 W I T N E S E T H 

WHEREAS, the Partnership has heretofore executed and delivered to the Trustee an indenture (the “Indenture”), dated as of
January 8, 2021, providing for the issuance of an unlimited aggregate principal amount of 4.50% Senior Notes due 2029 and 4.75% Senior Notes due 2031 (together, the “Notes”); 

WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary shall execute and deliver to the Trustee a
supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally Guarantee all of the Partnership’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture;
and 
 WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental
Indenture. 
 NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby
acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders as follows: 
 1. Capitalized
Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture. 
 2. Subsidiary
Guarantor. The Guaranteeing Subsidiary hereby agrees to be a Subsidiary Guarantor under the Indenture and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors, including Article 10 thereof. 

3. Governing Law. THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

 4. Waiver of Jury Trial. EACH OF THE GUARANTEEING SUBSIDIARY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE NOTE GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. 

5. Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but
all of them together represent the same agreement. The word “execution,” “executed,” “signed,” “signature,” “delivery” and words of like import in or relating to this Supplemental Indenture or any
document to be signed in connection with this Supplemental Indenture shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or
enforceability as a manually executed signature, physical delivery thereof of the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means.

  
 B-1 

 6. Headings. The headings of the Sections of this Supplemental Indenture have been
inserted for convenience of reference only, are not to be considered a part of this Supplemental Indenture and shall in no way modify or restrict any of the terms or provisions hereof. 

  
 B-2 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed, all as of the date first above written. 
  

			
	[NAME OF GUARANTEEING SUBSIDIARY]
		
	By:	 	 
		 	Name:
		 	Title:
	
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	 
		 	Name:
		 	Title:

  
 B-3Exhibit 10.5

 

 

 

 

 

 

 

ASSET Purchase
Agreement

 

by and among

 

PREVACUS,
INC.;

 

Michael
Lewandowski;

 

Jacob
VanLandingham, Ph.D.;

 

and

 

Odyssey
Group International, INC.

 

January 8, 2021

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

TABLE OF
CONTENTS

 

 

 

Page

	Article 1 SALE OF ASSETS	1
	Section 1.1.   Purchase and Sale of Assets	1
	Section 1.2.   Excluded Assets	3
	Section 1.3.   Assumed Liabilities	3
	Section 1.4.   Excluded Liabilities	4
	Section 1.5.   Method of Conveyance	5
	Article 2 CONSIDERATION	6
	Section 2.1.   Consideration	6
	Section 2.2.   Delivery of Closing Share Consideration and Escrow Purchaser Shares	6
	Section 2.3.   Escrow Agreement	6
	Section 2.4.   Milestone Consideration	6
	Section 2.5.   Withholding Rights	8
	Section 2.6.   Provisions Related to the Issuance of Purchaser Common Stock	8
	Section 2.7.   Setoff Rights	9
	Section 2.8.   Allocation	9
	Section
    2.9    Leak-Out Terms	9
	Section
    2.10  Adjustments to Milestone Compensation	9
	Article 3 CLOSING; CLOSING DELIVERIES	10
	Section 3.1.   Closing	10
	Section 3.2.   Deliveries by the Company	10
	Section 3.3.   Deliveries by Additional Parties	12
	Section 3.4.   Deliveries by Purchaser at Closing	12
	Article 4 REPRESENTATIONS AND WARRANTIES OF THE ADDITIONAL PARTIES AND THE COMPANY	13
	Section 4.1.   Organization; Good Standing	13
	Section 4.2.   Subsidiaries	13
	Section 4.3.   Power and Authority	14
	Section 4.4.   No Conflict	14
	Section 4.5.   Restrictions	15
	Section 4.6.   Title to and Adequacy of Tangible Assets	15
	Section 4.7.   Financial Statements; Indebtedness.	15
	Section 4.8.   Tax Matters	15
	Section 4.9.   Litigation	17
	Section 4.10.   Intellectual Property	17
	Section 4.11.   Contracts	18
	Section 4.12.   Regulatory Matters	19
	Section 4.13.   Environmental Matters	19
	Section 4.14.   Inventory	20
	Section 4.15.   Labor and Employment Matters	21
	Section 4.16.   Governmental Authorizations; Compliance with Laws; Permits	23
	Section 4.17.   Licenses	23
	Section 4.18.   Insurance Policies	23
	Section 4.19.   Vendors/Agents	23
	Section 4.20.   No Real Property	23

 

 

 

 

    	 	i	 

     

    

 

	Section 4.21.   Acquired Accounts Receivable	24
	Section 4.22.   No Other Agreement	24
	Section 4.23.   No Brokers	24
	Section 4.24.   Product and Service Warranties	24
	Section 4.25.   Product or Service Liability	24
	Section 4.26.   Transactions with Affiliates	24
	Section 4.27.   Import/Export Activities	24
	Section 4.28.   Operation of Business	25
	Section 4.29.   Absence of Undisclosed Liabilities	25
	Section 4.30.   Absence of Certain Changes	25
	Section 4.31.   Fraudulent Conveyance	26
	Section 4.32.   Powers of Attorney	26
	Section 4.33.   Representations Regarding Consideration	27
	Section 4.34.   Statements and Other Documents Not Misleading	27
	Section 4.35.   Anti-Terrorism Laws	27
	Section 4.36.   Anti-Bribery	28
	Article 5 REPRESENTATIONS AND WARRANTIES OF PURCHASER	29
	Section 5.1.   Organization and Standing	29
	Section 5.2.   Authority	29
	Section 5.3.   Conflict with other Instruments; Absence of Restrictions	29
	Section 5.4.   Government Approvals	29
	Section 5.5.   No Brokers	29
	Section 5.6.   Purchaser SEC Documents	29
	Section 5.7.   Valid Issuance of Purchaser Shares	30
	Section 5.8.   No Additional Representations	30
	Article 6 ADDITIONAL COVENANTS	30
	Section 6.1.   Further Assurances	30
	Section 6.2.   Fulfillment of Agreements	30
	Section 6.3.   Standstill	30
	Section 6.4.   Conduct of Business Pending Closing	30
	Section 6.5.   Employees	33
	Section 6.6.   Access to Information	33
	Section 6.7.   Public Announcements	34
	Section 6.8.   Supplemental Information	34
	Section 6.9.   Restrictive Covenants	34
	Section 6.10.   Judicial Modification of Covenants	35
	Section 6.11.   Tax Matters	35
	Section 6.12.   Transfer Taxes	35
	Section 6.13.   Cooperation on Tax Matters	35
	Section 6.14.   Bulk Sales Laws	35
	Section 6.15.   Customer and Supplier Inquiries; Accounts Receivable; Name; Dissolution.	36
	Section 6.16.   Company Stockholder Approval	36
	Section 6.17.   Restricted Securities	36
	Section 6.18.   Future Purchaser Financings	36
	Section 6.19.   Product Books and Record	37
	Section 6.20.   Regulatory Matters	37
	Section 6.21.   Incentive Plan	37
	Section 6.22    Restrictive Covenant Agreement	37

 

 

 

 

 

    	 	ii	 

     

    

 

	Article 7 CONDITIONS TO THE CLOSING	38
	Section 7.1.   Conditions to Obligations of the Additional Parties and the Company	38
	Section 7.2.   Conditions to Obligations of Purchaser	38
	Section 7.3.   Termination	39
	Article 8 INDEMNIFICATION	40
	Section 8.1.   Survival of Representations and Warranties	40
	Section 8.2.   Indemnification by the Company and the Additional Parties	40
	Section 8.3.   Indemnification by Purchaser	40
	Section 8.4.   Third Party Claims	40
	Section 8.5.   Recovery From Escrow Account	41
	Section 8.6.   Distribution of Escrow Fund	42
	Section 8.7.   Adjustments to Consideration	42
	Article 9 GENERAL PROVISIONS	42
	Section 9.1.   Assignment	42
	Section 9.2.   Notices	42
	Section 9.3.   Interpretation	43
	Section 9.4.   Severability	44
	Section 9.5.   No Third-Party Beneficiaries	44
	Section 9.6.   Expenses	44
	Section 9.7.   Amendment; Waiver	44
	Section 9.8.   Governing Law	45
	Section 9.9.   Counterparts	45
	Section 9.10.   Construction of Agreement	45
	Section 9.11.   Entire Agreement	45
	Section 9.12.   Calculation of Time	46
	Section 9.13.   Expenses, Costs, Attorneys’ Fees	46
	Section 9.14.   Specific Performance	46

 

 

 

 

    	 	iii	 

     

    

 

Asset Purchase
Agreement

 

THIS ASSET PURCHASE
AGREEMENT (this “Agreement”) is made this ____ day of January, 2021 by and among Odyssey Group International,
Inc., a Nevada corporation (“Purchaser”); Prevacus, Inc., a Delaware corporation (the “Company”);
Michael Lewandowski, an adult individual (“Mr. Lewandowski”); and Jacob VanLandingham, Ph.D., an adult individual
(“Dr. VanLandingham”, and each of Mr. Lewandowski and Dr. VanLandingham, an “Additional Party”,
and collectively, the “Additional Parties”). Capitalized terms not otherwise defined herein have the respective
meanings assigned to such terms in Exhibit A hereto.

 

BACKGROUND

 

WHEREAS, the
Company is engaged in the development of treatments for mild traumatic brain injuries and brain related diseases (the “Business”);

 

WHEREAS, the
Company and Purchaser previously entered into that certain Master Agreement for a Joint Venture and Intellectual Property Purchase
Agreement, dated as of June 26, 2019 (the “Master Agreement for a Joint Venture”), whereby Purchaser purchased
and the Company sold fifty percent of certain of the Company’s assets in exchange for, inter alia, (i) 2,000,000 shares
of Purchaser Common Stock, and (ii) the execution by the Company and Purchaser of that certain Share Exchange Agreement, dated
as of June 26, 2019 (the “Share Exchange Agreement”);

 

WHEREAS, the
Company desires to sell and assign to Purchaser, and Purchaser desires to purchase and assume, substantially all of the assets,
and certain specified liabilities, of the Business, subject to the terms and conditions set forth herein;

 

WHEREAS, the
Additional Parties desire to cause the consummation of the Contemplated Transactions and to perform the obligations of the Additional
Parties in accordance with the terms hereof and acknowledge that the consummation of the Contemplated Transactions will benefit
the Additional Parties, directly and/or indirectly, as the case may be; and

 

WHEREAS, to
induce Purchaser to enter into this Agreement and consummate the purchase of substantially all of the assets, and certain specified
liabilities, of the Business, and the other Contemplated Transactions, each of the Additional Parties agrees to be bound by this
Agreement, including the Restrictive Covenants applicable to such Persons contained herein.

 

AGREEMENT

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be
legally bound, hereby agree as follows:

 

Article
1

SALE OF ASSETS

 

Section 1.1.        
Purchase and Sale of Assets. Subject to the terms
and conditions of this Agreement, at the Closing, the Company will sell, assign, transfer, deliver and convey good and marketable
title to Purchaser, and Purchaser shall purchase from the Company, free and clear of any Encumbrances, all of the Company’s
right, title and interest in, to and under all of the assets, properties and rights of every kind and nature, whether real, personal
or mixed, tangible or intangible (including goodwill), wherever located and whether now existing or hereafter acquired (other than
the Excluded Assets), which relate to, or are used or held for use in connection with, the PRV-002 Program, the Delivery Device
or the Business (collectively, the “Purchased Assets”), including, without limitation, the following (in each
case to the extent related to, or derived from, the Business):

 

 

 

    	 	 	 

     

    

 

1.1.1.       all
accounts receivable held by the Company, and any security, claim, remedy or other right related to any of the foregoing (“Acquired
Accounts Receivable”);

 

1.1.2.       all
inventory, finished goods, raw materials, work in progress, packaging, supplies, parts and other inventories owned by the Company
and used exclusively in the Business or held for sale exclusively to customers of the Business, including spare parts, containers,
packaging and packaging supplies (“Inventory”);

 

1.1.3.       all
Contracts, including Intellectual Property Licenses and Contracts related to, PRV-002 and the Delivery Device, set forth on Schedule
1.1.3 (the “Assigned Contracts”);

 

1.1.4.       all
Intellectual Property Assets for PRV-002 and the Delivery Device listed on Schedule 1.1.4.

 

1.1.5.       all
furniture, fixtures, equipment, machinery, tools, vehicles, office equipment, supplies, computers, telephones and other tangible
personal property (the “Tangible Personal Property”);

 

1.1.6.       all
Licenses and Permits, including Environmental Permits, which are held by the Company and required for the conduct of the Business
as currently conducted or for the ownership and use of the Purchased Assets, including those listed on Schedule 1.1.6 (any
such Licenses and Permits, including Environmental Permits, issued by any Governmental Authority, the “Transferred Governmental
Authorizations”);

 

1.1.7.       all
rights to any Claims of any nature available to or being pursued by the Company to the extent related to the Business, the Purchased
Assets or the Assumed Liabilities, whether arising by way of counterclaim or otherwise;

 

1.1.8.       all
prepaid expenses, credits, advance payments, claims, security, refunds, rights of recovery, rights of set-off, rights of recoupment,
deposits, charges, sums and fees (including any such item relating to the payment of Taxes);

 

1.1.9.       all
of the Company’s rights under warranties, indemnities and all similar rights against Third Parties to the extent related
to any Purchased Assets;

 

1.1.10.       all
insurance benefits, including rights and proceeds, arising from or relating to the Business, the Purchased Assets or the Assumed
Liabilities;

 

1.1.11.       the
Regulatory Information; provided, however, that the Company may retain copies of the Regulatory Information (i) to
the extent necessary to demonstrate compliance with Applicable Law or pursuant to internal compliance or document retention procedures
in the ordinary course of business consistent in all material respects with past practice or (ii) to the extent related to any
Excluded Assets or Excluded Liabilities;

 

1.1.12.       subject
to Section 6.19 and Section 6.20 (and other than the items set forth in Section 1.2.3), the following current and historical records
and files (whether in hard copy format, electronic format or otherwise) primarily relating to the products of the Company, the
Purchased Assets, or the Assumed Liabilities, including but not limited to, the PRV-002 Program and the Delivery Device, and in
the possession of the Company or any of its Affiliates (but excluding records or files not reasonably separable from documents
or databases that do not relate exclusively to the Purchased Assets) and solely to the extent relating to the Business (including,
if applicable, supporting Transferred Governmental Authorizations in the United States): (i) development, quality control, quality
assurance, regulatory, and pharmacovigilance records, and (ii) other business records and information relating exclusively to the
Purchased Assets (the foregoing records and documents, in each case to the extent not already in the possession or control of Purchaser,
being referred to herein collectively as the “Product Books and Records”); provided, however,
that the Company may retain copies of the Product Books and Records (x) to the extent necessary to demonstrate compliance with
Applicable Law or pursuant to internal compliance or document retention procedures in the ordinary course of business consistent
in all material respects with past practice or (y) to the extent related to any Excluded Assets or Excluded Liabilities; and

 

 

 

 

    	 	2	 

     

    

 

1.1.13.       all
goodwill and the going concern value of the Business.

 

Section 1.2.        
Excluded Assets. Notwithstanding the foregoing,
the Purchased Assets shall not include the following assets (collectively, the “Excluded Assets”):

 

1.2.1.       Cash
and Cash Equivalents;

 

1.2.2.       Contracts
that are not Assigned Contracts (the “Excluded Contracts”);

 

1.2.3.       (i)
the corporate books and records of the Company and its Affiliates that are not Product Books and Records, (ii) all personnel records,
(iii) any attorney work product, attorney-client communications and other items protected by attorney-client or similar privilege,
(iv) Tax Returns, Tax information, and Tax records related to the Company or its Affiliates for any Tax period ending prior to
the Closing date (provided that Purchaser shall be provided with copies of such Tax Returns and other Tax books and records), and
(v) any documents (other than any non-disclosure or confidentiality agreements that constitute Material Contracts) that were received
from third parties in connection with their proposed acquisition of the Purchased Assets or that were prepared by the Company or
any of its Affiliates in connection therewith;

 

1.2.4.       all
Employee Plans of the Company;

 

1.2.5.       the
assets, properties and rights specifically set forth on Schedule 1.2.5; and

 

1.2.6.       the
rights which accrue or will accrue to the Company under the Transaction Documents.

 

1.2.7.       the
rights which accrue or will accrue to the Company through its involvement in PreSolMD, LLC, the Intellectual Property of PreSolMD,
LLC, or any equity derived therefrom.

 

Section 1.3.        
Assumed Liabilities. Subject to the terms and
conditions set forth herein, Purchaser shall assume and agree to pay, perform and discharge only the following Liabilities of the
Company (collectively, the “Assumed Liabilities”), and no other Liabilities:

 

1.3.1.       liabilities
and obligations relating to employee benefits, compensation or other arrangements with respect to any Transferred Employee solely
arising after the Closing and relating to facts and circumstances that occurred after the Closing; and

 

1.3.2.       all
Liabilities in respect of the Assigned Contracts but only to the extent that such Liabilities thereunder are required to be performed
after the Closing Date, were incurred in the ordinary course of business and do not relate to any failure to perform, improper
performance, warranty or other breach, default or violation by the Company on or prior to the Closing.

These liabilities shall
be set forth on Schedule 1.3.

 

 

 

 

    	 	3	 

     

    

 

Section 1.4.        
Excluded Liabilities. Notwithstanding the provisions
of Section 1.3 or any other provision in this Agreement to the contrary, Purchaser shall not assume and shall not be responsible
to pay, perform or discharge any Liabilities of the Company or any of its Affiliates of any kind or nature whatsoever other than
the Assumed Liabilities (the “Excluded Liabilities”). The Company shall,
and shall cause each of its Affiliates to, pay and satisfy in due course all Excluded Liabilities which they are obligated to pay
and satisfy. Without limiting the generality of the foregoing, the Excluded Liabilities shall include, but not be limited to, the
following:

 

1.4.1.       any
Liabilities of the Company arising or incurred in connection with the negotiation, preparation, investigation and performance of
this Agreement, the other Transaction Documents and the transactions contemplated hereby and thereby, including, without limitation,
Transaction Fees and expenses of counsel, accountants, consultants, advisers and others;

 

1.4.2.       any
Liability for (i) Taxes of the Company (or any equity holder or Affiliate of the Company); (ii) Taxes relating to the Business,
the Purchased Assets or the Assumed Liabilities that arise in or is allocable to any Tax period or portion thereof ending on or
prior to the Closing Date (including the amount of any Taxes computed for any Interim Period pursuant to Section 6.11); (iii)
Taxes that arise out of the consummation of the transactions contemplated hereby or that are the responsibility of the Company
pursuant to Section 6.12; or (iv) other Taxes of the Company (or any equity holder or Affiliate of the Company) of any kind or
description, including any Liability for Taxes of the Company (or any equity holder or Affiliate of the Company) that becomes
a Liability of Purchaser under any common law doctrine of de facto merger or transferee or successor liability or otherwise by
operation of contract or Applicable Law;

 

1.4.3.       any
Liabilities relating to or arising out of the Excluded Assets or Excluded Liabilities;

 

1.4.4.       any
Liabilities in respect of any pending or threatened Claim arising out of, relating to or otherwise in respect of the operation
of the Business or the Purchased Assets to the extent such Claim relates to such operation on or prior to the Closing Date;

 

1.4.5.       any
product Liability or similar claim for injury to a Person or property which arises out of or is based upon any express or implied
representation, warranty, agreement or guaranty made by the Company, or by reason of the improper performance or malfunctioning
of a product, improper design or manufacture, failure to adequately package, label or warn of hazards or other related product
defects of any products at any time manufactured or sold or any service performed by the Company;

 

1.4.6.       any
recall, design defect or similar claims of any products manufactured or sold or any service performed by the Company;

 

1.4.7.       any
Liabilities of the Company arising under or in connection with any Employee Plan with respect to any present or former employee
of the Company, including without limitation any Excluded Employee Liabilities;

 

1.4.8.       any
Liabilities of the Company for any present or former employees, agents or independent contractors of the Company, including, without
limitation, any Liabilities associated with any claims for wages or other benefits, workers’ compensation, severance, retention,
termination or other payments, except for those Liabilities set forth in Section 1.3.1;

 

 

 

 

    	 	4	 

     

    

 

1.4.9.       any
Environmental Claims, or Liabilities under Environmental Laws, to the extent arising out of or relating to facts, circumstances
or conditions existing on or prior to the Closing or otherwise to the extent arising out of any actions or omissions of the Company;

 

1.4.10.       any
Indebtedness of the Company, including, trade and other accounts payable of the Company;

 

1.4.11. any Liabilities
from any liens against the Company or any Acquired Asset, including, but not limited to, Tax liens in favor of the United States
(the “Tax Liens”), and liens in favor of American Express Company (the “Amex Lien”), Institute
for Commercialization of Florida Technology, Inc., Creditors Adjustment Bureau, or any Affiliates thereof;

 

1.4.12.       any
Liabilities to indemnify, reimburse or advance amounts to any officer, director, employee or agent of the Company (including with
respect to any breach of fiduciary obligations by same), except for indemnification of same pursuant to Section 8.3 as the Company
Indemnified Parties;

 

1.4.13.       any
Liabilities under the Excluded Contracts or any other Contracts (i) which are not validly and effectively assigned to Purchaser
pursuant to this Agreement; (ii) which do not conform to the representations and warranties with respect thereto contained in this
Agreement; or (iii) to the extent such Liabilities arise out of or relate to a breach by the Company of such Contracts prior to
Closing;

 

1.4.14       any
Liabilities which arise out of or relate to the matters listed on Schedule 4.9;

 

1.4.15       any
Liabilities of, Claims by, or Claims against (i) PreSolMD, LLC, (ii) any Subsidiary, or (iii) or any other Person in which the
Company or any of the Additional Parties has an interest.

 

1.4.16.       any
Liabilities arising in connection with (i) the due authorization and approval of the Contemplated Transactions by the Company,
(ii) the governance of the Company, (iii) any distributions of Excluded Assets or proceeds from the Contemplated Transactions to
the Company Stockholders, or (iv) any other Claims of Company Stockholders;

 

1.4.17.       any
Liabilities associated with debt, loans or credit facilities of the Company and/or the Business owing to financial institutions;
and any Liabilities arising out of, in respect of or in connection with the failure by the Company or any of its Affiliates to
comply with any Applicable Law or Governmental Order; and

 

1.4.18.       any
Liabilities not explicitly enumerated in Section 1.3 and detailed by the Company in the Schedules accompanying Section 1.3.

 

Section 1.5.        
Method of Conveyance.

 

1.5.1.       The
sale, assignment, transfer, delivery and conveyance by the Company to Purchaser in accordance with this Article 1 shall be effected
by the Company’s delivery of the items specified in Section 3.2 in accordance therewith, at the Closing.

 

1.5.2.       To
the extent that the assignment by the Company to Purchaser pursuant to the terms hereof of any Purchased Asset is not permitted
without the consent of another Person or Persons or would otherwise constitute a breach or other contravention under any Contract
or Law to which the Company is a party or by which it is bound, or in any way adversely affects rights of the Company or, upon
transfer, Purchaser with respect to such Purchased Asset, this Agreement and the Assignment and Assumption Agreement shall not
be deemed to constitute an assignment of any such Purchased Asset if such consent is not obtained, and such asset (a “Contingent
Asset”) shall only become a Purchased Asset if and when such consent is obtained. The Company shall use its commercially
reasonable efforts to obtain any consents or waivers required to assign to Purchaser any Contingent Asset, without any conditions
to such transfer (including the making of any payments) or changes or modifications of terms thereunder. If any such consent is
not obtained prior to Closing, the Company and Purchaser will cooperate in the negotiation of a mutually agreeable arrangement
pursuant to which it is intended that Purchaser would obtain all of the benefits and assume all of the obligations and Liabilities
thereunder to the fullest extent legally possible as determined by Purchaser in its sole discretion.

 

 

 

    	 	5	 

     

    

 

Article
2

CONSIDERATION

 

Section 2.1.        
Consideration. As consideration for the sale
and transfer of the Purchased Assets and Assumed Liabilities, and the Restrictive Covenants, Purchaser shall pay and deliver, or
cause to be paid and delivered on Purchaser’s behalf:

 

2.1.1.       to
the Company an amount equal to (i) 7,000,000 shares of Purchaser Common Stock (the “Closing Share Consideration”);
plus (ii) the Milestone Consideration (as set forth in Section 2.4), if any; and

 

2.1.2.       to
the Escrow Agent deposit certificates representing the Escrow Purchaser Shares, to be held in the Escrow Account pursuant to the
Escrow Agreement.

 

Section 2.2.        
Delivery of Closing Share Consideration and Escrow Purchaser
Shares. At Closing, Purchaser will (i) issue the Closing Share Consideration to the Company, and (ii) issue the Escrow
Purchaser Shares in the name of the Company to be held by the Escrow Agent in the Escrow Account pursuant to the Escrow Agreement.

 

Section 2.3.        
Escrow Agreement. At the Closing, Purchaser,
the Company and the Escrow Agent will enter into an Escrow Agreement a form mutually agreed to by the parties (the “Escrow
Agreement”) pursuant to which, among other things, Purchaser will deposit an amount of deposit certificates representing
the Escrow Purchaser Shares to be held in an escrow account (the “Escrow Account”), with such Escrow Account
to be used to compensate the Purchaser Indemnified Parties for any Damages incurred or sustained by them for which they are entitled
to recovery pursuant to Article 8 hereof.

 

Section 2.4.        
Milestone Consideration.

 

2.4.1.       Subject
to the satisfaction of the conditions precedent set forth in this Section 2.4 (each, a “Milestone Event”) and
adjustment pursuant to Section 8.7, Purchaser or an Affiliate of Purchaser shall deliver to the Company shares of Purchaser Common
Stock (each, a “Milestone Payment” and together, the “Milestone Payments”), in such amounts
and at such times as is set forth in this Section 2.4, subject at all times to any offset thereto in accordance with Section 8.5.3.
All Milestone Payments shall only be paid once, upon the initial achievement of the particular Milestone Event. The Purchaser,
at its sole and absolute discretion shall determine if a Milestone Event has occurred. Purchaser shall notify the Company within
ten (10) Business Days from when a Milestone Event has occurred. Within ten (10) Business Days from the Company’s receipt
of such notice from Purchaser, Purchaser shall deliver the following Milestone Payments to the Company:

 

 

 

    	 	6	 

     

    

 

(a)       2,000,000
shares of Purchaser Common Stock when the United States Patents for PRV-002 are revived in the name of Purchaser as set forth on
Exhibit B by the U.S. Patent and Trademark Office and any international patents that have lapsed as set forth on Exhibit
C as revived in the name of the Purchaser by the respective country’s patent offices; provided, however, that
the Company and each Additional Party shall cooperate with Purchaser in all Patent prosecutions related thereto, including revivals
and reissuances of such Patents; The value of 2,000,000 shares of Purchaser Common Stock when
the United States Patents for PRV-002 are revived in the name of Purchaser shall not exceed Six Million Dollars ($6,000,000) based
on the ask price on the date the payment is due.

 

(b)       1,000,000
shares of Purchaser Common Stock upon successful first dosing in a Phase I Clinical Trial for PRV-002
for which Purchaser or one of its Affiliates is the sponsor, as determined by Purchaser in
its sole and reasonable discretion;

 

(c)       2,000,000
shares of Purchaser Common Stock upon the grant and issuance to Purchaser of Patent for the drug-device combination for PRV-002
and the Delivery Device from the U.S. Patent and Trademark Office; The value of 2,000,000 shares
of Purchaser Common Stock when the Patents for PRV-002 are revived in the name of Purchaser shall not exceed Ten Million Dollars
($10,000,000) based on the ask price on the date the payment is due.

 

(d)       1,000,000
shares of Purchaser Common Stock upon Purchaser’s receipt of net proceeds to Purchaser of at
least $1,000,000 in a Non-Dilutive Financing; The Non-Dilutive Financing must relate directly to the development of PRV-002 and
the Delivery Device. This milestone will expire (i) one (1) year after the Closing Date or (ii) for any grant Non-Dilutive Financing
submitted prior to the one year anniversary of the Closing Date the milestone will stay effective until the second year anniversary
of the Closing Date. After two (2) years after the closing of the transaction, Purchaser will have no further liability under this
subsection;

 

(e)       2,000,000
shares of Purchaser Common Stock if Purchaser sells PRV-002, after a Phase Ib Clinical Trial
for which Purchaser or one of its Affiliates, is the sponsor is complete, but prior
to completion of a Phase II Clinical Trial (as determined by Purchaser in its sole and reasonable discretion), to a Third Party
resulting in net proceeds to Purchaser of at least $50,000,000; The value of 2,000,000 shares
of Purchaser Common Stock when sold, and so long as the sale is for more than $50,000,000 dollars, shall not exceed Twenty Five
Million Dollars ($25,000,000) based on the ask price on the date the payment is due; and

 

(f)       4,000,000
shares of Purchaser Common Stock upon, as determined by Purchaser in its sole and reasonable discretion, the successful completion
of a Phase II Clinical Trial for PRV-002 that leads to (i) Purchaser’s sale of PRV-002 to a Third Party
resulting in net proceeds to Purchaser of at least $50,000,000, or (ii) the administration of the first dose of to a human
being in a Phase III Clinical Trial for PRV-002 for which Purchaser or one of its Affiliates or licensees is the sponsor.

 

(g)        2,000,000
shares of Purchaser Common Stock after the first dosing in a human as part of a Phase 2 clinical trial and the successful completion
of a Phase 1B human clinical trial, as determined by Purchaser in its sole discretion.

 

2.4.2.       Once
Purchaser (or its Affiliates) has made any particular Milestone Payment under this Section 2.4, Purchaser shall not be obligated
to make any payment under this Section 2.4 with respect to the re-occurrence of the same or similar Milestone Event, whether or
not such re-occurrence is with respect to a different or the same product. Notwithstanding anything in this Agreement to the contrary,
a Change of Control or sale of a Purchased Asset by Purchaser shall not constitute a Milestone Event nor trigger any Milestone
Payment unless expressly specified in Section 2.4.1.

 

 

 

 

    	 	7	 

     

    

2.4.3       Notwithstanding
anything to the contrary contained in this Agreement or any Transaction Document, Purchaser shall not make any Milestone Payment
for so long as Purchaser determines, in its sole and absolute discretion, that any facts or circumstances exist that could form
that basis of a Claim under Article 8, or any such Claim remains outstanding.

 

2.4.4       Notwithstanding
anything to the contrary contained in this Agreement or any Transaction Document, the above-mentioned Milestone Payments will terminate
and cease to exist, and Purchaser will no longer be liable thereunder, if said Milestone is not completed within Four (4) year
after the Closing Date.

 

Section 2.5.        
Withholding Rights. Notwithstanding anything
in this Agreement to the contrary, Purchaser or its agent, as applicable, shall be entitled to deduct and withhold from any amounts
required to be paid pursuant to this Agreement such amounts as Purchaser or its agent, as applicable, are required to deduct and
withhold with respect to the making of such payments under the Code or any applicable provision of state, local or foreign Tax
law. To the extent that amounts are so deducted or withheld by Purchaser or its agent, such deducted or withheld amounts shall
be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding
was made. Purchaser or its agent, as applicable, shall timely disburse such deducted or withheld amounts to the applicable Tax
authority.

 

Section 2.6.        
Provisions Related to the Issuance of Purchaser Common Stock.

 

2.6.1.       The
applicable amount of the Purchaser Common Stock to be issued in connection with this Agreement to the Company may be either (i)
registered securities pursuant to the Securities Act, or (ii) issued in a transaction exempt from registration under the Securities
Act, by reason of Section 4(a)(2) thereof and/or Regulation D promulgated under the Securities Act and may not be re-offered or
resold other than in conformity with the registration requirements of the Securities Act and such other laws or pursuant to an
exemption therefrom (with the certificates issued by Purchaser with respect to such Purchaser Common Stock legended to the effect
described above and shall include such additional legends as necessary to comply with applicable U.S. federal securities laws and
Blue-Sky laws).

 

2.6.2.       The
Company shall use commercially reasonable efforts to provide such information, take such further actions and execute such documents
as Purchaser may determine to be necessary to ensure that the Purchaser Common Stock to be issued in connection with this Agreement
are issued in a transaction exempt from registration under the Securities Act, by reason of Section 4(a)(2) thereof and/or Regulation
D promulgated under the Securities Act, including requiring that the Company make the representations to Purchaser set forth in
Section 4.35 hereof as of the date(s) of issuance of the Purchaser Common Stock to be issued in connection with this Agreement.

 

2.6.3.       Purchaser
shall deliver any Purchaser Common Shares it is obligated to deliver upon the occurrence of a Milestone Event in book-entry form
with Purchaser’s transfer agent.

 

2.6.4.       Nothing
contained in this Agreement shall constitute an agreement, nor shall the Purchaser be otherwise required, to remain a reporting
company under the Exchange Act or maintain any public market or listing of its securities.

 

 

 

 

 

    	 	8	 

     

    

 

Section 2.7.        
Setoff Rights. Purchaser may
setoff any amount to which it may be entitled under this Agreement or any other agreement, document, instrument or certificate
executed in connection with the consummation of the transactions contemplated by this Agreement against amounts otherwise due to
the Company or the Additional Parties under this Agreement or any other agreement, document, instrument or certificate executed
in connection with the consummation of the transactions contemplated by this Agreement, including. Neither the exercise of nor
the failure to exercise such right of setoff will constitute an election of remedies or limit Purchaser in any way in the enforcement
of any other remedies that may be available to it.

 

Section 2.8.        
Allocation. Not later than 90 days following
the Closing Date, Purchaser shall prepare or cause to be prepared and shall provide to the company a statement (the “Allocation
Statement”) allocating the Consideration for the Purchased Assets (including all Assumed Liabilities and any other amounts
to the extent they are required to be treated as consideration for federal income Tax purposes), as adjusted pursuant to this Agreement,
among such Purchased Assets and the restrictive covenants set forth in Section 6.9. Thereafter, Purchaser shall prepare or caused
to be prepared and shall provide to the Company from time to time revised copies of the Allocation Statement (the “Revised
Statements”) so as to report any matters on any Allocation Statement that require revision as a result of the Consideration
adjustment provisions of Article 8, with an explanation of the basis for such allocation. The Allocation Statement and any Revised
Statements shall be prepared in accordance with the provisions of Section 1060 of the Code and the Treasury Regulations thereunder.
The Parties shall not take any position inconsistent with the Allocation Statement or any Revised Statement in any Tax Return or
in any administrative or judicial proceeding relating to Taxes, unless otherwise required pursuant to a final determination (as
defined in Section 1313 of the Code).

 

Section 2.9.        
Leak-Out TermsSection 2.10.. No Shareholder
receiving shares under this Agreement shall sell on any one (1) trading day more than five percent (5%) of the average trading
volume of the Company’s Common Stock. These selling restrictions shall apply in addition to the restrictive selling provisions
under Rule 144 as either an insider or an affiliate of the Purchaser. In the event that a Shareholder transfers its shares of capital
stock in the Company to a third party outside of the trading into the market pursuant to the limitations set forth in this Section
2.9, such transferee shall hold such shares subject to the above percentage restrictions and shall agree to same in a writing the
consideration of which shall be acknowledged and on which the Purchaser’s Transfer Agent may rely to enforce such leak-out.

 

Section 2.10.    
Adjustments to Milestone Compensation. The number of shares issuable as Milestone Compensation under this Agreement
shall be proportionately adjusted if the Purchaser shall declare a dividend of capital stock on its capital stock, conduct a “reverse”
stock split, or subdivide its outstanding capital stock into a larger number of shares by reclassification, stock split or otherwise,
which adjustment shall be made effective immediately after the record date in the case of a dividend, and after the effective date
in the case of a subdivision or consolidation. The number of shares issuable upon satisfying a condition precedent of any particular
Milestone Compensation provision shall be proportionately adjusted in the amount of securities for which the shares have been changed
or exchanged in another transaction for other stock or securities, cash and/or any other property pursuant to a merger, consolidation
or other combination. The Purchaser shall provide the Company with notice of any events mandating an adjustment to the conversion
ratio, or for any planned merger, consolidation, share exchange or sale of the Purchaser, signed by the President and Chief Executive
Officer of Purchaser.

 

 

 

 

    	 	9	 

     

    

 

Article
3

CLOSING; CLOSING DELIVERIES

 

Section 3.1.        
Closing. Subject to the terms and conditions
of this Agreement, the closing of the Contemplated Transactions (the “Closing”) will take place at a mutually
agreeable location, or by such other means, including but not limited to the delivery of the relevant documents by means of facsimile,
email, mail or courier as Purchaser the Company may mutually agree, at 12:01 AM, New York, New York Time on the first Business
that is at least five (5) Business Days following the satisfaction of the conditions set forth in Article 7, other than (i) those
conditions which are waived in accordance with the terms of this Agreement by the party or parties for whose benefit such conditions
exist, and (ii) any such conditions, which by their terms, are not capable of being satisfied until the Closing (the day on
which the Closing takes place being referred to herein as the “Closing Date”).

 

Section 3.2.        
Deliveries by the Company. At or prior to the
Closing, the Company shall deliver the following to Purchaser:

 

3.2.1.       a
bill of sale in a form mutually agreed to by the parties (the “Bill of Sale”)
and duly executed by the Company, transferring the tangible personal property included in the Purchased Assets to Purchaser;

 

3.2.2.       an
assignment and assumption agreement in a form mutually agreed to by the parties (the “Assignment
and Assumption Agreement”) and duly executed by the Company, effecting the assignment to and assumption by Purchaser
of the Purchased Assets and the Assumed Liabilities;

 

3.2.3.       assignments
in a form determined by Purchaser in its sole discretion (the “Intellectual Property Assignments”)
and duly executed by the Company, transferring all of the Company’s right, title and interest in and to the Intellectual
Property Assets and the Intellectual Property Licenses to Purchaser;

 

3.2.4.       with
respect to each Company Stockholder, an agreement with Purchaser in a form determined by Purchaser in its sole discretion setting
forth (i) that, absent more restrictive selling provisions under Rule 144 of the Securities Act, such Company Stockholder shall
not sell on any one trading day more than 5% of the average trading volume of any of Purchaser’s Securities it might receive
as a result of the Contemplated Transactions or otherwise, and (ii) in the event that such Company Stockholder transfers its shares
of Purchaser’s Securities to a third-party, that such transferee shall hold such shares subject to the above percentage restrictions;

 

3.2.5.       a
power of attorney in a form determined by Purchaser in its sole discretion and duly executed by the Company;

 

3.2.6.       the
Product Books and Records;

 

3.2.7.       as
to the Company, a certificate dated as of the Closing Date and signed on its behalf by its secretary to the effect that: (A) (1)
the copies of Charter Documents of the Company attached to the certificate all of the Charter Documents and are true and complete,
(2) such Charter Documents have been in full force and effect in the form attached to the certificate since the date of the adoption
of the resolutions referred to in clauses (3) and (4) below and no amendment to such Charter Documents has occurred since the date
of the last amendment annexed thereto, (3) the resolutions of the board of directors of the Company authorizing the actions taken
in connection with the Contemplated Transactions (i) were duly adopted at a duly convened meeting thereof, at which a quorum was
present and acting throughout, or by unanimous written consent, (ii) remain in full force and effect, and (iii) have not been amended,
rescinded or modified, (4) the resolutions of the Company Stockholders authorizing the actions taken in connection with the Contemplated
Transactions (i) were duly adopted at a duly convened meeting thereof, at which a quorum was present and acting throughout, or
by written consent in accordance with the Charter Documents, (ii) remain in full force and effect, and (iii) have not been amended,
rescinded or modified, and (5) a certificate of good standing with respect to the Company certified by the Secretary of State or
other appropriate officials of the state of the Company’s incorporation, dated as of a date not more than 10 days prior to
the Closing Date; (B) each officer or other individual executing this Agreement and each of the Transaction Documents to which
the Company is a party is an incumbent officer or otherwise duly authorized to execute such agreements and documents on behalf
of the Company; (C) the Company has fulfilled or Purchaser has waived all conditions set forth in Section 7.2 that are required
to be fulfilled by it or them on or prior to the Closing Date; and (D) the Company is in good standing in all relevant jurisdictions;

 

 

 

    	 	10	 

     

    

 

3.2.8.       all
Required Consents (all such Required Consents shall be in form and substance reasonably satisfactory to Purchaser, and none of
such Required Consents shall have been revoked);

 

3.2.9.       evidence
in form and substance reasonably acceptable to Purchaser of termination of all Related Party Agreements;

 

3.2.10.       INTENTIONALLY
DELETED.

 

3.2.11.       evidence
in form and substance reasonably acceptable to Purchaser of compliance with Section 6.12;

 

3.2.12.       a
Restrictive Covenant Agreement between Purchaser and the Company restricting the Company from competing with, and soliciting from,
Purchaser in the drug treatment of neurology market for ten 10 years following the Closing, in a form determined by Purchaser in
its sole discretion (the “Company Restrictive Covenant Agreement”), duly executed by an authorized officer of
the Company;

 

3.2.13.       the
Escrow Agreement, duly executed by the Company;

 

3.2.14.       
confidentiality, non-solicitation, non-competition and invention assignment agreements in form and substance reasonably acceptable
to Purchaser with each officer, director and employee of the Company, as Purchaser reasonably deems to be appropriate, and such
agreements shall be in full force and effect;

 

3.2.15.       original
copies of all insurance policies covering any Purchased Asset purchased by or for the benefit of the Company;

 

3.2.16.       duly
executed copies of a letter from the site administrator listed with the site registrar for the Company’s website changing
the site administrator to an agent of Purchaser to be designated by Purchaser;

 

3.2.17.       evidence,
reasonably satisfactory to Purchaser that all Transaction Fees have been paid, in full, to each party entitled to such payment;

 

3.2.18.       evidence
in form and substance reasonably acceptable to Purchaser that due authorization and approval of the Contemplated Transactions has
been obtained by the Company;

 

3.2.19.       (i)
the VanLandingham Employment Agreement, (ii) the VanLandingham Incentive Agreement, (iii) the VanLandingham Finder Agreement, (iv)
the VanLandingham Restrictive Covenant Agreement, and (v) a Release, each duly executed by Dr. VanLandingham;

 

 

 

 

 

    	 	11	 

     

    

 

3.2.20.       the
Lewandowski Agreement, Lewandowski Restrictive Covenant Agreement, and Lewandowski Non-Restricted Stock Agreement, each duly executed
by Mr. Lewandowski;

 

3.2.21. a termination
agreement in a form determined by Purchaser in its sole discretion, duly executed by the Company, regarding certain provisions
of the Share Exchange Agreement and the Master Agreement for a Joint Venture (the “Termination Agreement”);
and

 

3.2.22.       all
such other documents and instruments as Purchaser or its counsel shall reasonably request in connection with the consummation of
the Contemplated Transactions.

 

Section 3.3.        
Deliveries by Additional Parties. At or prior
to the Closing:

 

3.3.1.       Dr.
VanLandingham shall execute and deliver to Purchaser, each in a form determined by Purchaser in its sole discretion, (i) an employment
agreement with Purchaser (the “VanLandingham Employment Agreement”), (ii) an equity incentive agreement granting
Dr. VanLandingham the option to purchase up to 1,000,000 of Purchaser’s Securities issued pursuant to the Incentive Plan
(the “VanLandingham Incentive Agreement”), (iii) a finder agreement (the “VanLandingham Finder Agreement”),
(iv) Restrictive Covenant Agreement limiting future work outside of the Purchaser on brain-related drugs (“VanLandingham
Noncompete Agreement”); and (v) a release (the “Release”); and

 

3.3.2.       Mr.
Lewandowski shall execute and deliver to Purchaser, each in a form determined by Purchaser in its sole discretion, (i) a consulting
agreement with Purchaser (the “Lewandowski Agreement”), (ii) a Release, (iii) a restricted stock agreement (the
“Lewandowski Restricted Stock Agreement”); and (iv) Restrictive Covenant Agreement limiting future work outside
of the Purchaser on brain-related drugs (“Lewandowski Noncompete Agreement”).

 

Section 3.4.        
Deliveries by Purchaser at Closing. At or prior
to the Closing, Purchaser shall:

 

3.4.1.       deliver
to the Company the Closing Share Consideration, in accordance with Section 2.1.1;

 

3.4.2.       issue
and deposit certificates representing the Escrow Purchaser Shares with the Escrow Agent;

 

3.4.3.       deliver
to the Company and the Escrow Agent, the Escrow Agreement, executed on Purchaser’s behalf by an authorized officer of Purchaser;

 

3.4.4.       deliver
to the Company evidence reasonably satisfactory to the Company that the certificates representing the Escrow Purchaser Shares have
been delivered to the Escrow Agent to be held in the Escrow Account pursuant to the Escrow Agreement;

 

3.4.5.       the
Assignment and Assumption Agreement duly executed by Purchaser;

 

3.4.6.       deliver
to Dr. VanLandingham (i) the VanLandingham Employment Agreement, (ii) the VanLandingham Incentive Agreement; and (iii) the VanLandingham
Restrictive Covenant Agreement, each executed on Purchaser’s behalf by an authorized officer of Purchaser;

 

3.4.7        deliver
to the Company the Termination Agreement duly executed by Purchaser; and

 

3.4.8.       deliver
to Mr. Lewandowski the Lewandowski Agreement and Lewandowski Restrictive Covenant Agreement, executed on Purchaser’s behalf
by an authorized officer of Purchaser.

 

 

 

    	 	12	 

     

    

 

Article
4

REPRESENTATIONS AND WARRANTIES OF THE ADDITIONAL PARTIES AND THE COMPANY

 

Each Additional Party
and the Company hereby make each of the following representations and warranties to Purchaser as of the date hereof and as of the
Closing Date. The representations and warranties set forth in this Article 4 (as qualified by the disclosure schedules hereto)
are separate from and independent of any diligence or other investigations conducted by Purchaser and Purchaser shall be entitled
to rely on these representations and warranties (as qualified by the disclosure schedules hereto) without reference to or qualification
by any diligence or other investigations.

 

Section 4.1.        
Organization; Good Standing. The Company is a
Delaware corporation duly incorporated, validly existing and in good standing under the laws of the jurisdiction of its organization,
having full power and authority to own its property and carry on the Business as it has been and is now being conducted. The Company
is duly qualified to do business and is in good standing in every jurisdiction in which the character of the Business requires
such qualification, which jurisdictions are set forth on Schedule 4.1. The Company has heretofore furnished to Purchaser
a complete and correct copy of its Charter Documents, each as amended to date. The Company’s Charter Documents are in full
force and effect and the Company is not in violation, nor has the Company ever violated of any provision of its Charter Documents.
The name and role(s) of each of the Company’s officers and directors as of the date hereof and at any time during the six-year
period preceding the date hereof is listed on Schedule 4.1 (including whether such person is a current or former officer
and/or director, as applicable).

 

Section 4.2.        
Subsidiaries.

 

4.2.1.       Except
as set forth on Schedule 4.2, the Company does not have any Subsidiaries. Each Subsidiary is duly organized, validly existing
and in good standing under the laws of its jurisdiction of organization as reflected on Schedule 4.2, with full corporate
power and authority to conduct its business as it is presently being conducted and to own or lease, as applicable, its assets.
Each Subsidiary is duly qualified to transact business as a foreign entity and is in good standing in each jurisdiction where the
character of its properties owned or leased or the nature of its activities make such qualification necessary, except where the
failure to be so qualified or in good standing would not have, individually or in the aggregate, a Material Adverse Effect. Copies
of the certificate of incorporation and bylaws (or other similar organizational documents and agreements) of each Subsidiary, and
all amendments thereto, heretofore delivered or otherwise made available to Purchaser, are true and correct as of the date hereof.
No Subsidiary is in violation of its respective organizational or governing documents in any material respect.

 

4.2.2.       The
Securities of each of the Subsidiaries consist of the shares of common stock and membership interests listed on Schedule 4.2,
all of which are owned by the Company or a Subsidiary and are issued and outstanding. All of the outstanding shares of common stock
and membership interests of each of the Subsidiaries have been duly authorized and validly issued and are fully paid, nonassessable
and free of preemptive rights and Encumbrances.

 

4.2.3.       None
of the Subsidiaries has granted any outstanding options, warrants, rights or other securities convertible into or exchangeable
or exercisable for shares of common stock or membership interests of such Subsidiary or any other commitments or agreements providing
for the issuance of additional shares or membership interests, the sale of treasury shares or for the repurchase or redemption
of shares of such Subsidiary’s equity interests. There are no (i) agreements of any kind which obligate any of the Subsidiaries
to issue, purchase, redeem or otherwise acquire any of its equity interests, (ii) equity appreciation rights, phantom equity or
similar plans or rights pursuant to which any Subsidiary of the Company has any obligations, (iii) voting trusts, proxies, or similar
agreements to which the Company or any Subsidiary is a party with respect to the equity interests of any Subsidiary or (iv) outstanding
bonds, debentures, notes or other indebtedness or other securities of any Subsidiary having the right to vote. The Company has
no Liability for accrued and unpaid dividends.

 

 

 

    	 	13	 

     

    

 

Section 4.3.        
Power and Authority.

 

4.3.1.       The
Company has the full right, power, legal capacity and authority to enter into and perform its obligations under this Agreement
and the other Transaction Documents, and to consummate the Contemplated Transactions. The execution, delivery, carrying out and
performance by the Company of this Agreement and the other Transaction Documents, the consummation of the Contemplated Transactions
on the terms and conditions set forth herein have been duly and validly authorized by the board of directors of the Company, and
the Company has taken all actions necessary to secure all approvals required in connection therewith (which actions and approvals
have been obtained and carried out in compliance with all Applicable Laws, the Company’s Charter Documents, each as amended
to date, and all Contracts binding on the Company), except for the Company Stockholder Approval. This Agreement has been duly and
validly executed and delivered by the Company and, assuming the due authorization, execution and delivery hereof by Purchaser and
the Additional Parties, this Agreement constitutes, and the other Transaction Documents will constitute, valid and legally binding
obligations of the Company enforceable against it in accordance with their respective terms, except as such enforceability may
be limited by applicable bankruptcy, insolvency, moratorium or similar Applicable Laws affecting the rights of creditors generally
and general equity principles (regardless of whether enforceability is considered in a proceeding at or in equity) (the “Bankruptcy
and Equity Exceptions”).

 

4.3.2.       Each
Additional Party has the legal capacity to enter into and perform its obligations under this Agreement, and the other Transaction
Documents to which it is a party. The execution, delivery, carrying out and performance by each Additional Party of this Agreement
and the other Transaction Documents to which it is a party and each Additional Party has taken all actions necessary to secure
all approvals required in connection therewith (which actions and approvals have been obtained and carried out in compliance with
all Applicable Laws and all Contracts binding on the applicable Additional Party). This Agreement has been duly and validly executed
and delivered by each Additional Party and this Agreement constitutes, and the other Transaction Documents to which each Additional
Party is a party will constitute, valid and legally binding obligations of such Additional Party enforceable against it in accordance
with their respective terms, except as such enforceability may be limited by the Bankruptcy and Equity Exceptions.

 

4.3.3.       The
affirmative vote of the holders of a majority of the outstanding shares of the Company’s stock entitled to vote thereon are
the only votes necessary to be obtained from the holders of any class or series of the capital stock of the Company to approve
this Agreement and the Contemplated Transactions, whether at a meeting of stockholders of the Company, however called, or in connection
with any written consent of the stockholders of the Company, shall herein be referred to as “Company Stockholder Approval”).

 

4.3.4.       The
board of directors of the Company, at a meeting duly called and held, has unanimously duly adopted resolutions (i) determining
that this Agreement and the Contemplated Transactions are advisable and are fair to and in the best interest of the Company Stockholders,
(ii) approving this Agreement and the Contemplated Transactions, which approval satisfies in full the requirements of Applicable
Law that the Agreement be approved by the board of directors of the Company, and (iii) resolving to recommend approval and adoption
of this Agreement by the Company Stockholders in connection with the Company Stockholder Approval.

 

Section 4.4.        
No Conflict. Except for the consents set forth
on Schedule 4.4 (each, a “Required Consent”), the execution, delivery and performance of this Agreement
and the Transaction Documents by the Additional Parties and the Company and the consummation of the Contemplated Transactions will
not (i) conflict with, result in or constitute a breach or an event that, with notice or lapse of time or both, would be a
default, breach or other violation of the Charter Documents of the Company; (ii) violate, or require any consent, approval,
filing or notice under, any Applicable Law, or with any Governmental Authority; (iii) require any Court Order, or any registration,
declaration or filing with, or notice to, any Governmental Authority or other Person by or with respect to the Company; (iv) violate
or conflict with, require any consent, waiver, approval, filing or notice under, or result in the breach, suspension or termination
of any provision of, or constitute a default under, or result in the acceleration of the performance of the obligations of the
Company under any Contract to which the Company is a party or by which the Company or the Business is bound, or (v) result
in the creation of any Encumbrances upon all or any portion of the properties, assets or Business of the Company pursuant to the
Charter Documents of the Company, or any Contract to which the Company is a party or by which the Company or the properties of
the Company bound.

 

 

 

    	 	14	 

     

    

 

Section 4.5.        
Restrictions. None of the Company or any Additional
Party is party to any Contract (including but not limited to any Customer Contract) or subject to any restriction or any Court
Order or Applicable Laws which adversely affects the Company, the Purchased Assets or the Business or affects or restricts the
ability of any Additional Party or the Company to consummate the Contemplated Transactions.

 

Section 4.6.        
Title to and Adequacy of Tangible Assets. The
Company has good, valid and marketable title to, or in the case of leased properties and assets, valid leasehold interests in,
all of the tangible properties and assets, real, personal and mixed, used or held for use in its Business (the “Property”),
free and clear of any and all Encumbrances other than Permitted Encumbrances or as set forth on Schedule 4.6. The tangible
personal property included in such Property (including equipment), taken as a whole, is in good working order and fit for its intended
use, reasonable wear and tear excepted. The Property, taken as a whole, is sufficient to conduct the Business as now conducted.
No Property used by the Company in connection with the Business is held under any lease or Encumbrance or is located other than
in the possession of the Company. All of the Property is in the possession or under control of the Company and consists of all
of the assets that are incremental or related to, or used in connection with, the operation of the Business. All of the leases
of personal property to which the Company is a party are valid and in effect and afford the Company peaceful and undisturbed possession
of the subject matter of such leases. Since July 1, 2017, there has not been any material interruption of the operation of the
business of the Company due to the condition of any of the tangible Company Assets other than planned shut-downs for routine maintenance.

 

Section 4.7.        
Financial Statements; Indebtedness. 

 

4.7.1.       The Company
heretofore has delivered or otherwise made available to Purchaser true and correct copies of the Financial Statements. The Financial
Statements (a) have been prepared in accordance with the books and records of the Company, (b) have been prepared in accordance
with GAAP and (c) fairly present in all material respects the financial position, statements of operations, changes in stockholders’
equity and cash flow of the Company for the periods covered and as of the respective dates thereof (except, in each case, that
the Interim Financial Statements may not contain all the footnote disclosures required by GAAP and are subject to normal year-end
adjustments (none of which, individually or in the aggregate, are material)). The management of the Company has disclosed to the
Company’s outside auditors any fraud or possible fraud, whether or not material, that to the Knowledge of the Company, involves
any member, officer, employee, auditor or representative of the Company. Neither the Company nor to the Knowledge of the Company,
any member, officer, employee, auditor or representative of the Company has received written notice of any material complaint,
allegation or claim, whether written or oral, regarding the accounting and auditing practices, procedures or methodologies of the
Company or its internal accounting controls. The Company does not have any Indebtedness other than Indebtedness, if any, that has
been taken into consideration in calculating the Closing Share Consideration.

 

Section 4.8.        
Tax Matters

 

4.8.1.       All
Tax Returns required to have been filed by or with respect to the Company and the Acquired Assets have been duly and timely filed
(taking into account applicable extensions of time to file), and each such Tax Return correctly and completely reflects liability
for Taxes and all other information required to be reported thereon. All Taxes owed by the Company and with respect to the Acquired
Assets (whether or not shown on any Tax Return) have been timely paid. The Company has adequately provided for, in its books of
account and related records, liability for all unpaid Taxes of the Company, being current Taxes not yet due and payable. The Company
is not and has not been a member of a Relevant Group.

 

4.8.2.       There
is no action, audit, dispute or Claim now in process or pending or, to the Knowledge of the Company, proposed or threatened against,
or with respect to, the Company in respect of any Taxes. The Company is not the beneficiary of any extension of time within which
to file any Tax Return that has not been filed. No Claim has been made by an authority in a jurisdiction where the Company does
not file Tax Returns that such entity is, or may be, subject to taxation by that jurisdiction.

 

 

 

 

    	 	15	 

     

    

 

4.8.3        Except
as set forth in Schedule 4.8.3, there are no Encumbrances on the stock or assets of the Company with respect to Taxes other
than Permitted Encumbrances.

 

4.8.4.       The
Company has withheld and timely paid to the appropriate taxing authority all Taxes required to have been withheld and paid and
has complied with all information reporting and backup withholding requirements.

 

4.8.5.       Schedule
4.8.5 lists all Tax Returns filed with respect to the Company, indicates those Tax Returns that have been audited, and indicates
those Tax Returns that currently are the subject of an audit. The Company has delivered to Purchaser correct and complete copies
of all Tax Returns, examination reports, and statements of deficiencies assessed against or agreed to by it.

 

4.8.6       The
Company is not subject to a waiver of any statute of limitations in respect of Taxes or any extension of time with respect to a
Tax assessment or deficiency.

 

4.8.7.       None
of the Company Stockholders is a “foreign person” within the meaning of Section 1445 of the Code.

 

4.8.8.        None
of the Acquired Assets constitutes a debt, equity or other interest in any other Person.

 

4.8.9.       The
Company has not been the “distributing corporation” or the “controlled corporation” with respect to a transaction
described in Section 355 of the Code. The Company is not subject to any private ruling from any taxing authority or any agreement
with a taxing authority.

 

4.8.10.     The
Company is not a party to any Tax allocation or sharing agreement. The Company do not have any Liability for the Taxes of any Person
(other than itself) (i) as a transferee or successor, (ii) by Contract, (iii) under Section 1.1502-6 of the Treasury Regulations
(or any similar provision of state, local or foreign Law), or (iv) otherwise.

 

4.8.11.     The
Company will not be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable
period (or portion thereof) ending after the Closing Date as a result of any: (i) installment sale or open transaction disposition
made on or prior to the Closing Date; (ii) prepaid amount received or accrued on or prior to the Closing Date; (iii) cancellation
of debt income or (iv) method of accounting that defers the recognition of income to any period (or portion thereof) ending after
the Closing Date or accelerates any deduction to any period (or portion thereof) ending on or before the Closing Date.

 

4.8.12.     The
Company has validly been treated at all times since its inception and is currently treated for income Tax purposes as a C-corporation.
The Company will not be liable for any Taxes pursuant to Sections 1374 or 1375 of the Code (or any corresponding provision of state,
local or non-US Tax law) as a result of the transactions contemplated by this Agreement

 

4.8.13.     There
is no power of attorney in effect with respect to the Company with respect to Taxes.

 

4.8.14.      The
Company has not engaged in any transaction that is, or is substantially similar to, any listed or reportable transaction within
the meaning of Treasury Regulation Section 1.6011-4.

 

4.8.15       All
Taxes of the Company and any Taxes with respect to the Acquired Assets accrued following the Interim Balance Sheet Date have been
accrued in the ordinary course of business and do not exceed comparable amounts incurred in similar periods in prior years (taking
into account any changes in the operating results of the Company).

 

 

 

 

    	 	16	 

     

    

 

Section 4.9.      Litigation.
Except as set forth on Schedule 4.9: (i) there is no Litigation pending or threatened against the Business, the
Company or any of its Affiliates (or against any officer, director, member, stockholder, employee, agent or other similar representative
of the Company or any of its Affiliates in his or her capacity as such or relating to his or her employment, services or relationship
with the Company) before any Governmental Authority or arbitrator, (ii) there is no Litigation pending or threatened related
in any way to this Agreement, the Business, the Purchased Assets, the Assumed Liabilities or the Contemplated Transactions, (iii) there
is no Court Order outstanding against the Company relating to this Agreement, the Business, the Purchased Assets, the Assumed
Liabilities or the Contemplated Transactions, (iv) there is no dispute or disagreement pending or threatened between the
Company and any of its customers or suppliers of the Business, (v) to Company’s Knowledge, no event has occurred, nor
has any Claim been asserted, that might result in Litigation against the Company or the Business, and (vi) there is no reasonable
basis for any such Claim. All pending or threatened Litigation is fully covered by insurance except to the extent described on
Schedule 4.9.

 

Section 4.10.    
Intellectual Property.

 

4.10.1.      Set
forth in Schedule 4.10.1 is a true and complete list of all (i) Registered Intellectual Property of the Company; and (ii)
un-registered Intellectual Property of the Company or its Affiliates that is material to the Business, including, a brief description
of each listed Intellectual Property item, including, the owner, including the chain of title as evidenced by reel/frame numbers
of recorded assignments, or by non-recorded assignments, from each inventor to owner; the applicable jurisdiction; the registration
number; the application number; the patent number or issuance number; and the filing date of the application or registration.

 

4.10.2.      The
Company owns all Intellectual Property that may be necessary for the operation of the Business and the research, development, manufacture
or commercialization of PRV-001, PRV-002 or the Delivery Device. The Company has, and Purchaser will have after Closing, the right
to bring actions for the infringement or other violations of all Intellectual Property owned or exclusively licensed by the Company,
or purported by the Company to be owned or exclusively licensed by the Company.

 

4.10.3.      The
operation of the Business does not infringe, dilute, or otherwise violate the intellectual property rights of any Third Party.
No Claim is pending or, to the Knowledge of the Company, threatened, and the Company has not received written notice to the effect
that: (i) the Company infringes upon, misappropriates or conflicts with the rights of any Third Party intellectual property; or
(ii) the Company’s interest in any Intellectual Property owned or licensed by the Company or which the Company otherwise
has the right to use, is invalid or unenforceable by the Company. To the Knowledge of the Company, no Third Party is infringing
upon, misappropriating or using in any unauthorized manner, any of the Company’s Intellectual Property or Proprietary Information.
No Third Party has exercised any rights to indemnification granted by the Company against infringement of Intellectual Property
rights.

 

4.10.4.      The
Company has complied and is in compliance with all Applicable Laws of all Governmental Entities, or any self-regulating organization,
regarding privacy, security and/or data protection (collectively, “Privacy Laws”), in each case in all material
respects. The Company has maintained, enforce and have enforced and complied with in all respects written privacy, security and
data protection policies (the “Privacy Policies”) with respect to any Proprietary Information providing for,
without limitation: (i) clear and conspicuous disclosure of the Company’s privacy, security and data protection practices,
including the Company’s collection, storage, use and disclosure of, and provision of access and corrections to any Proprietary
Information, and (ii) protection from loss, misappropriation, disclosure or corruption of, and unauthorized access to any Proprietary
Information. Neither this Agreement nor the Contemplated Transactions violate or will violate the terms and conditions of any Privacy
Policies, any applicable Privacy Laws or the privacy rights of any Person. The current and former consultants and contractors of
the Company have executed proprietary information and confidentiality agreements, none of which will be terminated as a result
of the Contemplated Transactions and all of which shall be enforceable by or on behalf of the Company after the Closing.

 

4.10.5.      To
the Knowledge of the Company, no Proprietary Information has been subject to any breach, misappropriation, unauthorized disclosure,
or unauthorized access or use by any Person. There are no Claims pending or threatened, or complaints filed, against the Company,
and the Company is not subject to any settlement agreements, directives or orders, at law or in equity before or by a Governmental
Authority or self-regulating organization, regarding the Company’s Privacy Policies and/or Proprietary Information.

 

 

 

 

 

    	 	17	 

     

    

 

4.10.6.     Set
forth in Schedule 4.10.6 is a true and correct list of all Contracts (including licenses and sublicenses) pertaining to
any Company Intellectual Property. None of the Company or any other party is in breach of or Default under any such license or
other Contract, and each such license and other Contract is valid and in full force and effect. The Company owns and has owned
all licenses necessary to use the COTS Software as actually used in the operation of the Business without Claims of infringement
or other violation of rights of the owner of the COTS Software. The Company has not received any written notice claiming that any
of them is, was or could be using any COTS Software in violation of the rights of any Third Party or been the subject of an investigation
or audit by any Third Party in relation to their respective use of COTS Software. The Company is not in breach or Default under
any Contract governing the use of COTS Software, and each such Contract is valid and in full force and effect.

 

4.10.7.      All
Intellectual Property developed by or for the Company was conceived, invented, reduced to practice, reduced to tangible form, written
or otherwise created solely by either (i) employees of the Company acting within the scope of their employment; or (ii) persons
or entities who have executed a written confidentiality and assignment agreement that irrevocably assigns and transfers all right,
title and interest in and to such intellectual property (including the right to seek past and future damages with respect to such
intellectual property) to the Company, and the Company is the sole and exclusive owner of such intellectual property. Each past
or present employee and independent contractor performing activities related to the Business, including the manufacture, use, sale,
offer for sale or importation of products or services marketed by or under development by the Company, such as PRV-001 and PRV-002,
or the Delivery Device has entered into a proprietary information and confidentiality agreement. The Company has made available
to Purchaser’s legal advisor copies of such agreements.

 

4.10.8.      None
of the Registered Intellectual Property is subject to the payment of any registration, maintenance or renewal fees or Taxes or
actions and/or responses falling due within 90 calendar days following the Closing Date, and none of the Registered Intellectual
Property has expired, been cancelled or abandoned.

 

4.10.9.     The
Company has never agreed to indemnify any Person for or against any interference, proceeding with the Patent Trial and Appeal Board
(PTAB) of the U.S. Patent and Trademark Office, opposition, infringement, misappropriation, or other conflict with respect to Intellectual
Property.

 

4.10.10.    The
Company has taken commercially reasonable steps to provide for the archival, back-up, recovery and restoration of their critical
business data.

 

4.10.11.   Schedule
4.10.11 describes all instances in which the Company (i) has received government funding; and (ii) has contracted for the use
of facilities of a university, college, other educational institution or research center in the development of any Intellectual
Property of the Company where, as a result of such funding or the use of such facilities, the government or any university, college,
other educational institution or research center has any rights in such Intellectual Property of the Company.

 

Section 4.11.    
Contracts.

 

4.11.1.     Set
forth in Schedule 4.11.1 is a true and complete list (organized by subclause) of all Contracts to which the Company is a
party, or by which any of its property or assets are bound (each, a “Material Contract”).

 

4.11.2.     The
Company has provided to Purchaser true and correct copies of all Material Contracts (or descriptions thereof, in the case of oral
Contracts). Each Material Contract (or description) sets forth the entire agreement and understanding between the parties thereto.
The Company is not (with or without the lapse of time or the giving of notice or both) in Default under any Material Contract and,
to the Knowledge of the Company, no other party to any such Material Contract is (with or without the lapse of time or the giving
of notice or both) in Default thereunder. No party to any Material Contract has threatened, or provided notice to the Company of
its intent to terminate or withdraw its participation in any such Material Contract. To the Company’s Knowledge there is
no event or condition which has occurred or exists which would cause the acceleration of any obligations or loss of any rights
of any party to any Material Contract or give rise to any right of termination or cancellation thereof. All of the Material Contracts
are in full force and effect and are valid and binding obligations of the Company (to the extent binding obligations of the other
parties thereto) enforceable in accordance with their respective terms, except as such enforceability may be limited by the Bankruptcy
and Equity Exceptions.

 

 

    	 	18	 

     

    

 

4.11.3.      The
execution, delivery and performance of this Agreement and the other Transaction Documents and the consummation of the Contemplated
Transactions will not result in or give to any Person any additional rights or entitlement to increased, additional, accelerated
or guaranteed payments under any Material Contract. None of such Material Contracts contain any provisions that would cause the
Company to be liable to any other party thereto for any amount (or any increased price for goods or services being provided by
the other party thereto) as a result of the consummation of the Contemplated Transactions.

 

Section 4.12.    
Regulatory Matters.

 

4.12.1.      As
of the date of this Agreement there are no NDAs or INDs of the Company, including but not limited to any NDAs or INDs relating
to PRV-001, PRV-002 or the Delivery Device.

 

4.12.2.       With
respect to the Business, neither the Company nor, to the Knowledge of the Company, any officer, employee or agent of the Company,
has made an untrue statement of a material fact or a fraudulent statement to the FDA or other Governmental Authority, failed to
disclose a material fact required to be disclosed to the FDA or other Governmental Authority or committed an act, made a statement,
or failed to make a statement that, at the time such disclosure was made, would reasonably be expected to provide a basis for the
FDA to invoke its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities policy set forth in the FDA’s
Compliance Policy Guide Sec. 120.100 (CPG 7150.09).

 

4.12.3.       Neither
the Company, its Affiliates nor any officer, director, employee or, to the Knowledge of the Company, any agent has, under any Health
Law, been debarred, excluded, suspended or otherwise determined to be ineligible to participate in any health care programs of
any Governmental Authority, or convicted of any crime, or, to the Knowledge of the Company, engaged in any conduct that has resulted,
or would reasonably be expected to result, in any such debarment, exclusion, suspension, ineligibility or conviction in a manner
that would reasonably be expected to adversely affect the Business.

 

4.12.4.       With
the respect to the Business, the Company has not received from the FDA or any other Governmental Authority any notification, inspection
reports, notices of adverse findings, warning or untitled letters, Form 483, or other correspondence alleging or asserting a failure
to comply with Applicable Laws, including any Health Laws.

 

4.12.5.       All
clinical trials, pre-clinical trials, studies, tests and research for the products of the Company that have been or are being conducted
by or on behalf of the Company or its Affiliates were conducted, and are being conducted, in all material respects in accordance
with all Applicable Laws, including Health Laws. To the Knowledge of the Company, there is no Claim pending or threatened by any
Governmental Authority to suspend, investigate or terminate any ongoing clinical trials or studies for any product of the Company.

 

4.12.6.       All
Regulatory Information or other documentation, correspondence, reports, data, analysis, certifications or other information relating
to or regarding the Purchased Assets filed by or on behalf of the Company or its Affiliates, or delivered by or on behalf of the
Company or its Affiliates to, any Governmental Authority were true and accurate when so filed or delivered (or, if amended, as
of the date for which such amendment speaks) and remain, to the extent required by any Applicable Laws, including any Health Laws,
true and accurate.

 

Section 4.13.    
Environmental Matters. Except as disclosed on
Schedule 4.13 hereto (by corresponding subsection):

 

4.13.1.       No
releases of Hazardous Materials in violation of any Environmental Law or that would reasonably be expected to result in Damages
against the Company or the Business have occurred at or from any property during the period it was owned, leased or otherwise used
by the Company or, to Company’s Knowledge, at any other time;

 

4.13.2.       There
are no past, pending, or, to Company’s Knowledge, threatened Environmental Claims against the Company;

 

 

 

 

    	 	19	 

     

    

 

4.13.3.       There
are no underground storage tanks owned by the Company, or located at any facility owned or operated by the Company;

 

4.13.4.       The
Company has obtained all Environmental Permits required to operate the Business as it is currently operated and all such Environmental
Permits are in full force and effect. There are no facts, circumstances, or conditions that could reasonably be expected to restrict,
under any Environmental Law or Environmental Permit in effect prior to or at the Closing Date, the ownership, occupancy, use or
transferability of any Environmental Permit or any property now owned, operated, leased or otherwise used by the Company, or to
give rise to any legal liability of the Company under any Environmental Law pertaining to any property now or, to Company’s
Knowledge, at any other time owned, operated, leased or otherwise used by the Company;

 

4.13.5.       The
Company has not received (i) any request under any Environmental Law or from any Governmental Authority for information relating
to any of the property now or at any time owned, operated, leased or otherwise used by the Company, or (ii) a notice of Claim,
demand or notification that the Company is or that the Company may be a “potentially responsible party” with respect
to any investigation or remediation of any threatened or actual release of any Hazardous Materials;

 

4.13.6.       There
are no unsatisfied financial assurance or closure requirements under any Environmental Law pertaining to any property on account
of the Company’s use or ownership of such property;

 

4.13.7.       Any
contaminant levels resulting from any releases of Hazardous Materials at or from the properties now or, to Company’s Knowledge,
at any other time owned, operated, leased or otherwise used by the Company meet applicable remediation standards under any applicable
Environmental Law;

 

4.13.8.       None
of the properties owned, operated, leased or otherwise used by the Company are now or have in the past been listed on the National
Priorities List of sites under CERCLA, the CERCLA Information System, or any comparable state or local environmental database;

 

4.13.9.       There
is no asbestos-containing material, lead-based paint or equipment containing polychlorinated biphenyls located at any of the facilities
or properties now used by the Company;

 

4.13.10.     The
Company has not provided information to any Governmental Authority of any actual, threatened or suspected releases of Hazardous
Materials or any violation of an Environmental Permit or any other requirement of any Environmental Law;

 

4.13.11.     There
is no liability with respect to the cleanup or investigation at any facility or property, including but not limited to any off-site
location, resulting from the storage, disposal or treatment (with a transporter or otherwise) of Hazardous Materials by the Company,
or to Company’s Knowledge, by any other party;

 

4.13.12.       The
Company is now and at all time since its incorporation has been in compliance with all applicable Environmental Laws and Environmental
Permits; and

 

4.13.13.       The
Company has not, by agreement or by operation of law, assumed or is otherwise responsible or liable for, liabilities of any Third
Party pursuant to Environmental Laws.

 

Section 4.14.    
Inventory. Attached as Schedule 4.14 is
a true and correct copy of the Company’s report of Inventory, dated as of the date of this Agreement, which was prepared
by the Company in a manner consistent with the past custom and practice of the Company with respect to the preparation of its reports
of Inventory. The Inventory is of good and merchantable quality, is usable and salable in the ordinary course of business with
respect to the Business, is in the physical possession of the Company or in transit to or from a supplier of the Company, and no
Inventory has been pledged as collateral or otherwise subject to any Encumbrance or held on consignment from others. The Inventory
is fully paid for. All of the Inventory is free of material defects (including defects in packaging, labeling and storage) and
systematic or chronic problems and comply in all material respects with all applicable specifications and all Applicable Laws,
including all Health Laws and Environmental Laws. All Inventories that have been returned, have expired or have been deemed unusable
or not fit for sale, have been or will be destroyed in accordance with the policies of the Company and Applicable Law.

 

 

 

 

    	 	20	 

     

    

 

Section 4.15.    
Labor and Employment Matters.

 

4.15.1.       Schedule 4.15.1
lists each employee of the Business (collectively, the “Business Employees”), his/her date of hire by the Company,
his/her (i) base salary and (ii) bonus arrangements, if any, each for calendar year 2019 and as of the date hereof, and
the date on which the most recent salary increase went into effect for each of the Business Employees and the amount of each such
increase. There are no agreements, contracts or collective bargaining agreements, work rules or practices covering or applicable
to any of the Business Employees, except as set forth on Schedule 4.15.1. Except as set forth on Schedule 4.15.1,
none of the Business Employees or Independent Contractors of the Company is represented by any labor union or organization. No
union claims to represent any Business Employee or Independent Contractor nor has any union made such a claim to the Company within
the last 5 years, and there is no question concerning union representation as to such Business Employees or Independent Contractors.
There have been no labor union organization activities or other concerted activities among the Business Employees or Independent
Contractors within the last five years. No labor strike, dispute, slowdown, work stoppage or lockout involving any Business Employee
or Independent Contractor (in so far as such activities impact each Independent Contractor’s ability to perform services
for the Company) of, or affecting, the Company or the Business, is pending, or to Company’s Knowledge, threatened, nor has
there been any such activity in the last 5 years. The Company is not engaged in any unfair labor practice with regard to any of
the Business Employees, Independent Contractors or any other Person providing services to the Company. The Company has no obligation
to continue the employment or engagement of any of the Business Employees or Independent Contractors. The Company has not agreed
to increase the compensation level of any of the Business Employees nor is there any obligation or understanding respecting such
an increase. The Company has no workers’ compensation penalties or assessments pending. To Company’s Knowledge, no
Governmental Authority responsible for the enforcement of labor or employment laws or wage and hour laws intends to conduct an
investigation with respect to or relating to the Company and no such investigation is in progress or threatened. The Company has
paid all wages and wage supplements including, without limitation, salaries, commissions, bonuses, vacation pay, overtime pay,
severance pay, sick pay, expense reimbursements, and other compensation, if any, earned by any of the Business Employees or due
and owing to any Business Employees in the ordinary course of business consistent with the Company’s past practices. Any
wages and wage supplements including, without limitation, salaries, commissions, bonuses, vacation pay, overtime pay, severance
pay, sick pay, expense reimbursements, and other compensation, if any, earned by any of the Business Employees which remain unpaid
as of the Closing Date have been incurred in the ordinary course of business consistent with the Company’s past practices.
The Company has properly classified its employees in accordance with Applicable Laws governing wages and working hours. The employment
of any Business Employee by the Company will not constitute a breach of, or otherwise contravene, the terms of any employment agreement
or other agreement or policy to which such Business Employee is a party or otherwise bound. Except as expressly set forth in Schedule
4.15.1, the Company does not have any oral or written severance policy or other severance obligation involving any Business
Employee or former employee of the Company. Schedule 4.15.1 contains a list of each Business Employee or former employee
of the Company for which the Company is currently providing health or welfare benefits pursuant to COBRA.

 

4.15.2.       Schedule 4.15.2
contains a list of the names of each current independent contractor retained by the Company who performs services for the Business
(“Independent Contractors”) and the current rate of compensation paid to each such Independent Contractor. Schedule 4.15.2
specifies the site at which each such Independent Contractor performs services for the Company. The Independent Contractors, and
all other independent contractors who have previously rendered services to the Company, have in the past and continue to be legally,
properly and appropriately treated as non-employees for all federal, state, local and foreign tax purposes, as well as all ERISA
and employee benefit purposes. There has been no determination by any Governmental Authority, or by any tribunal or commission
that any Independent Contractor constitutes an employee of the Company. There has been no investigation or Claim made by or threatened
by any Person or Governmental Authority that any Independent Contractor constitutes an employee of the Company. The Company has
paid all compensation and all other monetary amounts earned by any independent contractors engaged by the Company or due and owing
to any independent contractors engaged by the Company in the ordinary course of business consistent with the Company’s past
practices. Any compensation or other monetary amounts due and owing to any independent contractors engaged by the Company which
remain unpaid as of the Closing Date have been incurred in the ordinary course of business consistent with the Company’s
past practices.

 

 

 

 

 

    	 	21	 

     

    

 

4.15.3.       The
Company has not effectuated (i) a “plant closing” as defined in the WARN Act, affecting any site of employment
or one or more facilities or operating units within any site of employment or facility of the Company or (ii) a “mass
layoff” (as defined in the WARN Act) affecting any site of employment or facility of the Company; nor has the Company been
affected by any transaction or engaged in layoffs or employment terminations sufficient in number to trigger application of any
state, local or foreign Applicable Laws or regulation similar to the WARN Act. To Company’s Knowledge, the employees employed
by the Company have not suffered an “employment loss” (as defined in the WARN Act) in the previous ninety (90) calendar
days. The Company has complied in all material respects with its obligations under the WARN Act, or any similar local, state or
foreign Applicable Laws and shall be solely liable and responsible for any debt, obligation contribution or other Liability arising
from any failure by the Company to comply fully with the WARN Act or any similar local, state or foreign Applicable Laws.

 

4.15.4.       Schedule 4.15.4
sets forth a true and complete list of each Employee Plan.

 

4.15.5.       With
respect to each Employee Plan, the Company has made available to Purchaser true and complete copies of (i) each Employee Plan (or,
if not written, a written summary of its material terms), including without limitation all plan documents, trust agreements, insurance
contracts or other funding vehicles and all amendments thereto, (ii) all summary plan descriptions, including any summary of material
modifications (iii) the most recent annual report (Form 5500 series) filed with the Internal Revenue Service, (iv) the most recent
actuarial report or other financial statement relating to such Employee Plan, (v) the most recent determination or opinion letter,
if any, issued by the Internal Revenue Service, (vi) the most recent nondiscrimination tests performed under the Code, and (vii)
all filings made with any Governmental Authority, including but not limited to any filings under the Employee Plans Compliance
Resolution System or the Department of Labor Delinquent Filer Program.

 

4.15.6.       Each
Employee Plan complies in all material respects in form and operation, and has been administered in all material respects in accordance
with, its terms and all applicable laws, including ERISA and the Code.

 

4.15.7.       Each
Employee Plan which is intended to qualify under Section 401(a), Section 401(k), Section 401(m) or Section 4975(e)(7) of the Code
has either (i) received a favorable determination letter from the Internal Revenue Service as to its qualified status, or (ii)
may rely upon a favorable prototype opinion letter from the Internal Revenue Service, and each such Employee Plan is so exempt.

 

4.15.8.       To
the Company’s Knowledge, there has been no prohibited transaction (within the meaning of Section 406 of ERISA or Section
4975 of the Code and other than a transaction that is exempt under a statutory or administrative exemption) with respect to any
Employee Plan that could result in liability to the Company or any ERISA Affiliate. No suit, administrative proceeding, action
or other litigation has been brought, or to the Company’s Knowledge is threatened, against or with respect to any such Employee
Plan, including any audit or inquiry by the Internal Revenue Service or United States Department of Labor. Neither the Company
nor any ERISA Affiliate has any Liability under Section 502 of ERISA.

 

4.15.9.       No
Employee Plan is now or at any time has been subject to Part 3, Subtitle B of Title I of ERISA or Title IV of ERISA. Neither the
Company nor any ERISA Affiliate has ever contributed to, or been required to contribute to any “multiemployer plan”
(as defined in Section 3(37) of ERISA) (a “Multiemployer Plan”) and neither the Company nor any ERISA Affiliate
has any liability (contingent or otherwise) relating to the withdrawal or partial withdrawal from a Multiemployer Plan.

 

4.15.10.       Except
as set forth in Schedule 4.15.10, neither the execution and delivery of this Agreement nor the consummation of the
Contemplated Transactions will result in any payment, acceleration or creation of any rights of any person to benefits under any
Employee Plan.

 

4.15.11.       No
amount that could be received (whether in cash, property, the vesting of property or otherwise) as a result of or in connection
with the consummation of the Contemplated Transactions (either alone or in combination with any other event or occurrence) or by
any of the Transaction Documents, by any employee, officer, director or other service provider of the Company who is a “disqualified
individual” (as such term is defined in Treasury Regulation Section 1.280G-1) could be characterized as an “excess
parachute payment” (as defined in Section 280G(b)(1) of the Code).

 

 

 

 

    	 	22	 

     

    

 

4.15.12.       Except
as required by Applicable Law, no Employee Plan provides any of the following retiree or post-employment benefits to any person:
medical, disability or life insurance benefits. No Employee Plan is a voluntary employee benefit association under Section 501(a)(9)
of the Code. Each Employee Plan that constitutes a “non-qualified deferred compensation plan” within the meaning of
Section 409A of the Code, complies in both form and operation with the requirements of Section 409A of the Code so that no amounts
paid pursuant to any such Benefit Plan is subject to tax under Section 409A of the Code. The Company does not have any obligation
to indemnify, hold harmless or gross-up any individual with respect to any penalty tax or interest that may be imposed under Section
409A, Section 280G or Section 4999 of the Code.

 

4.15.13.       The
Company and each ERISA Affiliate has, for purposes of each Employee Plan and for all other purposes, correctly classified all individuals
performing services for the Company as common law employees, leased employees, independent contractors or agents, as applicable.

 

Section 4.16.    
Governmental Authorizations; Compliance with Laws; Permits.
The Company is not, and has never been, in violation of or Default under, nor has the Company received any notice of any violation
of or Default under: (i) any Licenses which are necessary to entitle the Company to own, lease, operate or otherwise use the
properties owned, leased, operated or otherwise used by the Company and to conduct the Business as now conducted; (ii) any
Court Order of any court or administrative agency applicable to it or the Business; or (iii) any Applicable Laws, including
all Health Laws. The Company and the operation of the Business are in compliance with all Applicable Laws, including all Health
Laws.

 

Section 4.17.    
Licenses. Schedule 4.17 sets forth a complete
list of all Licenses used in the operation of the Business. The Company owns, possesses or lawfully uses in the operation of the
Business all Licenses which are necessary to conduct the Business as now or previously conducted, free and clear of all Encumbrances.
The Company is not in Default, nor has it received any notice of, nor is the Company aware of, any claim of Default, with respect
to any such License. Except as otherwise governed by Applicable Laws, all such Licenses are renewable by their terms or in the
ordinary course of business without the need to comply with any special qualification procedures or to pay any amounts other than
routine filing fees and will not be adversely affected by the completion of the Contemplated Transactions. Except as set forth
on Schedule 4.17, no present or former stockholder, director, officer or employee of the Company or any of its Affiliates,
or any other Person owns or has any proprietary, financial or other interest (direct or indirect) in any License used in the operation
of the Business which the Company owns, possesses or uses.

 

Section 4.18.    
Insurance Policies. Schedule 4.18 lists
all policies of fire, liability, workmen’s compensation, life, property and casualty and other insurance owned, maintained
or held by the Company, copies of which have been made available to Purchaser. All such policies are in full force and effect and
the Company has not committed any Default thereunder. No written notice of cancellation or non-renewal has been received by the
Company with respect to any of such policies.

 

Section 4.19.    
Vendors/Agents. Schedule 4.19 includes
a correct and current list, in all material respects, of the names of the twenty (20) largest vendors with which the Company has
purchased goods or services relating to the operation of the Business during the 12 month period prior to the date of this Agreement.
None of such vendors (i) has terminated or indicated to the Company an intention or plan to terminate, any Contract with the
Company, (ii) has decreased materially or threatened to decrease or limit materially its services or supplies to the Company,
or to Company’s Knowledge, intends to modify materially its relationship with the Company, or (iii) has given the Company
any notice that it will not sell raw materials, supplies, merchandise or other goods to the Company at any time after the Closing
Date by reason of the consummation of the Contemplated Transactions or for any other reason. To Company’s Knowledge, all
such vendors have operated in material compliance with all Applicable Laws in providing goods and/or services to the Company and/or
the Business. Schedule 4.19 includes a correct and current list, in all material respects, of the names all agents used
by the Business during the three (3) year period prior to the date of this Agreement (the “Agents”) and the
revenue associated with each such agent for each of those three (3) years. Except as set forth on Schedule 4.19, all sums
due to Agents have been paid, in full, and no amount is otherwise due to any Agent.

 

Section 4.20.    
No Real Property. The Company has never and does
not own, lease or have any interest in or to any Real Property.

 

 

 

 

    	 	23	 

     

    

 

Section 4.21.    
Acquired Accounts Receivable. Except as set forth
on Schedule 4.21, all Acquired Accounts Receivable of the Company as set forth on the Interim Balance Sheet or arising
since the date of the Interim Balance Sheet (i) have arisen in bona fide transactions in the ordinary course of the Business
for goods sold and delivered or services performed, (ii) constitute or will constitute a valid claim in the full amount thereof
against the debtor charged therewith on the books of the Company, (iii) are collectible in full at the recorded amounts thereof,
net of any allowance for doubtful accounts specifically established therefor, (free of any, and subject to no, defenses, setoffs
or counterclaims) in the ordinary course of business (without resort to Litigation or assignment to a collection agency), but in
no event later than 90 days after the Closing Date. No account debtor has any valid setoff (except for warranty claims for which
reserve amounts have been maintained and are set forth in the Financial Statements), deduction or defense with respect thereto,
and no account debtor has asserted such setoff, deduction or defense.

 

Section 4.22.    
No Other Agreement. Other than for sales of assets
in the ordinary course of the Business, none of the Additional Parties, or the Company (or any other person on their behalf) has
entered into any Contract with respect to the sale or other disposition of any of the Purchased Assets or Assumed Liabilities or
all or a significant portion of assets that are incremental or related to the Company.

 

Section 4.23.    
No Brokers. Except as set forth on Schedule
4.23, the Company is not obligated for the payment of any fees or expenses of any investment banker, broker, finder or similar
party.

 

Section 4.24.    
Product and Service Warranties. Set forth on
Schedule 4.24 are the standard forms of product and service warranties and guarantees utilized by the Company in connection
with the Business together with all other material product and service warranties and guarantees used by the Company in connection
with the Business. No Claims for breach of product or service warranties or guarantees to customers of the Business have been received
by the Company which have not, or will not be, fully satisfied prior to the Closing (by the replacement of the allegedly defective
or damaged products (if applicable)) by the Company.

 

Section 4.25.    
Product or Service Liability. Except as set forth
on Schedule 4.25, there is no action, suit, proceeding, inquiry or investigation by or before any court or Governmental
Authority pending or threatened against or involving the Company or the Business relating to any services performed by the Company
and alleged to have been defective or improperly rendered, or any products delivered or sold by the Company which are alleged to
be defective or not in compliance with contractual requirements.

 

Section 4.26.    
Transactions with Affiliates. Except as disclosed
on Schedule 4.26 or the Interim Balance Sheet, no Affiliate of the Company has: (i) borrowed money from or loaned
money to the Company, which remains outstanding or (ii) any contractual arrangements with the Company involving future payments
that are both (A) made in the ordinary course of business of the Company consistent with the Company’s past practices relating
to its day-to-day operations, and (B) have been conducted at arm’s-length.

 

Section 4.27.    
Import/Export Activities.

 

4.27.1.     All of the
Company’s imports have been made in accordance with Applicable Laws, including U.S. import control laws. The Company has
paid all customs duties owing with respect to any and all imported goods or items imported by the Company. All customs entry information
provided by the Company to any Governmental Authority in connection with the import thereof has been true and correct in all material
respects, and no issue has been raised with the Company by any Governmental Authority that is currently pending in connection with
any customs entry, including but not limited to U.S. Customs and Border Protection and the Transportation Security Administration.
There is no unresolved issue or unpaid deficiency, fine or penalty relating to any audit, examination or investigation of the Company’s
customs entries. The Company has exercised reasonable care in conducting all of its customs related activities.

 

4.27.2.     All of the
Company’s exports have been made in accordance with Applicable Laws, including U.S. export control laws. The Company has
complied with all export reporting and licensing requirements with respect to any and all exported goods or items exported by the
Company. All export control reporting and licensing information provided by the Company to any Governmental Authority in connection
with any and all exports has been true and correct in all material respects, and no issue has been raised with the Company by any
Governmental Authority that is currently pending in connection with any export, including but not limited to the U.S. Department
of Homeland Security, the Directorate of Defense Trade Controls of the U.S. Department of State, the Bureau of Industry and Security
of the U.S. Department of Commerce, and the Office of Foreign Assets Control of the U.S. Department of the Treasury. There is no
unresolved issue or unpaid deficiency, fine or penalty relating to any audit, examination or investigation of the Company’s
exports. The Company has exercised reasonable care in conducting all of its export related activities.

 

 

 

 

    	 	24	 

     

    

 

4.27.3.     All import
and export transactions and activities conducted on behalf of any other company, customer, client, or party have been made in accordance
with all Applicable Laws, including specifically all U.S. import and export control laws.

 

Section 4.28.    
Operation of Business. Except as set forth on
Schedule 4.28, (i) the Business has been conducted by the Company only through the Company and not through any
other division or direct or indirect subsidiary or Affiliate of the Company, and (ii) no part of the Business is operated
by the Company through any entity other than the Company.

 

Section 4.29.    
Absence of Undisclosed Liabilities.

 

4.29.1.       The
Company does not have any Liabilities of any kind that would be required to be disclosed on a balance sheet of the Company or in
the notes thereto in accordance with GAAP and were not so disclosed in the Financial Statements, except for Liabilities (i) arising
after the date hereof under Contracts to which the Company is a party, provided such Contracts were entered into in the ordinary
course of business of the Company consistent with the Company’s past practices, (ii) incurred in the ordinary course of business
of the Company since the Interim Balance Sheet Date, (iii) disclosed in the Schedules or (iv) incurred directly as a result of
or arising out of the transactions contemplated by this Agreement.

 

4.29.2.       The
Company is not a party to, nor or has any commitment to become a party to, (i) any joint venture, off-balance sheet partnership
or any similar Contract (including any Contract relating to any transaction or relationship between or among the Company, on the
one hand, and any unconsolidated Affiliate, including any structured finance, special purpose or limited purpose entity or Person,
on the other hand, where the result, purpose or effect of such Contract or arrangement is to avoid disclosure of any material transaction
involving, or material liabilities of, the Company or any of its Subsidiaries in the Financial Statements) or (ii) any “off-balance
sheet arrangements” (as defined in Item 303(a) of Regulation S-K promulgated under the Securities Act).

 

Section 4.30.    
Absence of Certain Changes. Except as contemplated
by this Agreement or as set forth on Schedule 4.30, since the Interim Balance Sheet Date, the Company has conducted
the Business in the ordinary course and there has not been:

 

4.30.1.any amendment
to the Charter Documents of the Company affecting the Business, the Purchased Assets or the Contemplated Transactions;

 

4.30.2.any change
that has had or might be reasonably expected to have a Material Adverse Effect;

 

4.30.3.increase in
the compensation, rate of pay, commission, severance entitlement or bonus eligibility of, or benefits made available under any
Employee Plan to, any Business Employees or Independent Contractors;

 

4.30.4.any adoption,
amendment, termination or modification of any Employee Plan;

 

4.30.5.any sale,
assignment or transfer of the Purchased Assets (or assets that would constitute Purchased Assets but for such sale, assignment
or transfer), or any additions to or transactions involving any assets that are incremental or related to, or used or usable in
connection with, the operation of the Business, other than those made in the ordinary course of the Business;

 

4.30.6.other than
in the ordinary course of the Business, any waiver or release of any claim or right or cancellation of any debt held;

 

 

 

 

 

    	 	25	 

     

    

 

4.30.7.any modification
of the material terms of any Material Contract or any Contract between the Company and any of the Key Accounts;

 

4.30.8.any dividends
or distributions, including distributions in kind, to any Company Stockholder;

 

4.30.9.any payment
or payments involving a transaction or series of related transactions to any Affiliate of the Company other than any such payment
or payments that are both (i) made in the ordinary course of business of the Company consistent with the Company’s past practices
relating to its day-to-day operations at arm’s-length, and (ii) less than $5,000, in the aggregate;

 

4.30.10.any capital
expenditure or series of related capital expenditures in excess of $5,000;

 

4.30.11.any incurrence
of any debts for money borrowed other than incurrence of debts by the Company pursuant to the Company’s then existing lines
of credit in the ordinary course of business of the Company;

 

4.30.12.any making
or revocation of or other change to any material election with respect to Taxes, any change in any method of Tax accounting or
Tax accounting period, any amendment to any Tax Return, any entrance into a closing or other agreement or arrangement with any
Governmental Authority with respect to Taxes, any surrender of any right to claim a refund for Taxes, or any consent to an extension
or waiver of the statute of limitations applicable to any Tax claim or assessment;

 

4.30.13.any agreement
to acquire, any business or Person, whether by merger or consolidation, purchase of assets or Securities or any other manner;

 

4.30.14.any agreement
to indemnify any Person;

 

4.30.15.any agreement
to guarantee the obligations of any Person; or

 

4.30.16.any
action taken or omitted to have been taken that would result in the occurrence of any of the foregoing.

 

Section 4.31.    
Fraudulent Conveyance.

 

4.31.1.Each of the
Additional parties and the Company is able to pay its debts generally as they become due and is solvent and will not be rendered
insolvent as a result of the Contemplated Transactions. None of the Additional Parties or the Company has, either voluntarily or
involuntarily, (i) admitted in writing that it is or may become unable to pay its debts generally as they become due, (ii) filed
or consented to the filing against it of a petition in bankruptcy or a petition to take advantage of an insolvency act, (iii) made
an assignment for the benefit of its creditors, (iv) consented to the appointment of a receiver for itself or for the whole
or any substantial part of its property, (v) had a petition in bankruptcy filed against it, (vi) been adjudicated a bankrupt
or filed a petition or answer seeking reorganization or arrangement under any Applicable Laws, including without limitation federal
bankruptcy laws, or (vii) incurred, or believed or reasonably should have believed it would incur, debts that are or will
be beyond its ability to pay as such debts mature.

 

4.31.2.The Company
is receiving reasonably equivalent and fair value in exchange for the Purchased Assets. No transfer of property is being made and
no obligation is being incurred voluntarily or involuntarily in connection with the Contemplated Transactions in order to effect
the Contemplated Transactions with the actual intent to hinder, delay or defraud either present or future creditors of the Company.
Consummation of the Contemplated Transactions will not constitute a fraudulent transfer or fraudulent conveyance under any Applicable
Laws or under any similar Applicable Laws relating to creditors’ rights generally.

 

Section 4.32.    
Powers of Attorney. There are no outstanding
powers of attorney executed on behalf of the Company or any Additional Party relating to the Company or the Business.

 

 

 

 

    	 	26	 

     

    

 

Section 4.33.    
Representations Regarding Consideration. The
Company:

 

4.33.1.is acquiring
the Purchaser Common Stock being issued to it pursuant to this Agreement solely for its own account and not with a view to resale
or distribution of all or any part thereof, and has no present arrangement, understanding or agreement for transferring or disposing
of all or any part of the Purchaser Common Stock being issued to it pursuant to this Agreement, except as such Purchaser Common
Stock may be distributed by the Company to the Company Stockholders in accordance with Applicable Law;

 

4.33.2.has such knowledge
and experience in financial and business matters that it is capable of evaluating the merits and risks of an investment in the
Purchaser Common Stock being issued to it pursuant to this Agreement and to form an investment decision with respect thereto, and
it and its advisers, if any, have also made such investigation, review, examination and inquiry concerning Purchaser and its business
and affairs as they have deemed appropriate;

 

4.33.3.is an “accredited
investor” within the meaning of Rule 501 of Regulation D under the Securities Act;

 

4.33.4.recognizes
that an investment in Purchaser is speculative and involves certain risks and such party has taken full cognizance of and understands
and can evaluate all of the risks of the investment in the Purchaser Common Stock being issued to it pursuant to this Agreement;

 

4.33.5.has adequate
net worth and means of providing for its current needs and personal contingencies to sustain a complete loss of such party’s
investment in Purchaser;

 

4.33.6.understands
that the shares of Purchaser Common Stock in the Consideration are being offered and sold in reliance on specific exemptions from
the registration requirements of federal and state securities laws and that Purchaser is relying upon the truth and accuracy of
the representations, warranties, agreements, acknowledgments and understandings set forth herein in order to determine the applicability
of such exemptions and the suitability of such party to acquire the shares of Purchaser Common Stock being issued to it pursuant
to this Agreement; and

 

4.33.7.understands
that, neither Purchaser nor any other Person has any obligation or intention to effect the registration of the shares of Purchaser
Common Stock being issued to it pursuant to this Agreement for sale, transfer or disposition by such party under the Securities
Act, or applicable state securities laws and any other applicable Law, or to take any action or provide any information (including,
without limitation, the filing of reports or the publication of information required by Rule 144) which would make available any
exemption from the registration requirements of the Securities Act or applicable state securities laws and any other Applicable
Law.

 

Section 4.34.    
Statements and Other Documents Not Misleading.
Neither this Agreement, including all schedules and exhibits, nor any other document, Financial Statement, or other instrument
heretofore or hereafter furnished by any Additional Party or the Company to Purchaser in connection with the Contemplated Transactions
contains or will contain any untrue statement of any material fact or omits or will omit to state any material fact required to
be stated in order to make such statement, document or other instrument not misleading. There is no fact, to Company’s Knowledge,
which is reasonably likely to have a Material Adverse Effect on the Company, the Business or the Contemplated Transactions that
has not been disclosed to Purchaser on or prior to the date hereof in connection with the Contemplated Transactions.

 

Section 4.35.    
Anti-Terrorism Laws.

 

4.35.1.None of the
Additional Parties, the Company or, to Company’s Knowledge, any of their Affiliates, is in violation of any Applicable Laws
relating to terrorism or money laundering (the “Anti-Terrorism Laws”), including Executive Order No. 13224 on
Terrorist Financing, effective September 24, 2001 (the “Executive Order”), and the Uniting and Strengthening
America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, Public Law 107-56, signed into
law October 26, 2001 (the “USA Patriot Act”).

 

 

 

 

 

    	 	27	 

     

    

 

4.35.2.None of the
Company, the Additional Parties or, to Company’s Knowledge, any of their Affiliates, is any of the following:

 

(a)       a
Person that is listed in the annex to, or is otherwise subject to the provisions of, the Executive Order;

 

(b)       a
Person owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject
to the provisions of, the Executive Order;

 

(c)       a
Person that commits, threatens or conspires to commit or supports “terrorism” as defined in the Executive Order; or

 

(d)       a
Person that is named as a “specially designated national and blocked person” on the most current list published by
the USA Treasury Department Office of Foreign Assets Control (“OFAC”) at its official website or any replacement
website or other replacement official publication of such list.

 

4.35.3.None of the
Additional Parties, the Company or, to Company’s Knowledge, any of their Affiliates, (i) conducts any business or engages
in making or receiving any contribution of funds, goods or services to or for the benefit of any Person described in Section 4.35.2(b)
above, (ii) deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant
to the Executive Order, or (iii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose
of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law.

 

Section 4.36.    
Anti-Bribery.

 

4.36.1.None of the
Additional Parties, the Company, or any of their Affiliates, have:

 

(a)       violated
any Anti-Corruption Laws;

 

(b)       directly
or indirectly made any offer, payment, promise to pay, or authorized payment, or offered a gift, promised to give, or authorized
the giving of anything of value to any Government Official or any other person while knowing or having reason to know that all
or a portion of such money, gift or thing of value will be offered, paid or given, directly or indirectly, to any Government Official,
for the purpose of (i) improperly influencing an act or decision of the Government Official in his or her official capacity, (ii)
inducing the Government Official to do or omit to do any act in violation of the lawful duty of such official, (iii) securing an
improper advantage, or (iv) improperly inducing the Government Official to use his or her influence to affect or influence any
act or decision of a government or instrumentality, in order to assist the Company, its Affiliates or the Business.

 

4.36.2.None of the
employees, directors, officers, agents or principals of the Company or the Business is a Government Official.

 

4.36.3.For purposes
of this Section 4.36:

 

(a)       “Anti-Corruption
Laws” means, both collectively and separately, any anti-corruption, anti-bribery or similar governmental ethics and transparency
laws that have particular jurisdiction or that govern or apply to any Additional Party, the Company, or the Business in any general
manner, including, without limitation, the US Foreign Corrupt Practices Act of 1977 and the UK Bribery Act 2010.

 

(b)       “Government
Official” means any officer, employee or other person acting in an official capacity for any government department, agency
or instrumentality, including state-owned or state-controlled companies, and public international organizations, as well as a political
party or official thereof or candidate for political office.

 

 

 

    	 	28	 

     

    

 

Article
5

REPRESENTATIONS AND WARRANTIES OF PURCHASER

 

Purchaser hereby makes
the following representations and warranties to the Company as of the date hereof and as of the Closing Date.

 

Section 5.1.        
Organization and Standing. Purchaser is a corporation
duly organized, validly existing and in good standing under the laws of the State of Nevada, having all requisite corporate power
and authority to perform its obligations under this Agreement.

 

Section 5.2.        
Authority. Purchaser has the requisite corporate
power and authority to enter into and perform this Agreement and each of the Transaction Documents to which it is a party and to
consummate the Contemplated Transactions. The execution, delivery and performance by Purchaser of this Agreement and each of the
Transaction Documents to which it is a party, and the consummation by it of the Contemplated Transactions have been duly authorized
by all necessary limited-liability company action on the part of Purchaser. This Agreement and each of the Transaction Documents
to which Purchaser is a party have been duly executed and delivered by Purchaser and, assuming due authorization, execution and
delivery by the Company and the Additional Parties constitute legal, valid and binding obligations of Purchaser enforceable against
Purchaser in accordance with their respective terms, except as such enforcement may be limited by the Bankruptcy and Equity Exceptions.

 

Section 5.3.        
Conflict with other Instruments; Absence of Restrictions.
The execution, delivery and performance of this Agreement and each of the Transaction Documents, and the consummation of the Contemplated
Transactions, by Purchaser do not and will not: (a) result in a Default of or under (i) any of the terms of the organizational
documents of Purchaser, or (ii) any law, Permit, Court Order or material Contract applicable to or binding upon Purchaser; or (b)
(1) result in the termination, amendment or modification of, or give any party the right to terminate, amend, modify, abandon,
or refuse to perform any material Contract or Permit to which Purchaser is a party or by which it, or any of its respective properties
or assets, is bound, or (2) result in the acceleration or modification, or give any party the right to accelerate or modify, the
time within which, or the terms under which, any duties or obligations are to be performed, or any rights or benefits are to be
received under any material Contract or Permit to which Purchaser is a party or by which it, or any of its respective properties
or assets, is bound.

 

Section 5.4.        
Government Approvals. No Consent of any Governmental
Entity is required (a) for the execution, delivery and performance by Purchaser of this Agreement or any of the Transaction Documents
to which Purchaser is a party, or (b) in connection with Purchaser’s consummation of the Contemplated Transactions.

 

Section 5.5.        
No Brokers. Purchaser is not obligated for the
payment of any fees or expenses of any investment banker, broker, finder or similar party in connection with the origin, negotiation
or execution of this Agreement or in connection with the Contemplated Transactions.

 

Section 5.6.        
Purchaser SEC Documents. Purchaser has filed
with or furnished to the SEC all forms, reports, statements, certifications and other documents required to be filed by it with
the SEC since January 1, 2020 (collectively, and in each case including all exhibits and schedules thereto and documents incorporated
by reference therein, the “Purchaser SEC Documents”). As of their respective effective dates (in the case of
Purchaser SEC Documents that are registration statements filed pursuant to the requirements of the Securities Act) and as of their
respective SEC filing dates (in the case of all other Purchaser SEC Documents), Purchaser SEC Documents complied in all material
respects with the requirements of the Securities Act, the Securities Exchange Act of 1934, as amended, (the “Exchange
Act”) and the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), as the case may be, and the rules
and regulations of the SEC thereunder applicable to such Purchaser SEC Documents, and none of Purchaser SEC Documents as of such
respective dates (or, if amended prior to the date of this Agreement, the date of the filing of such amendment, with respect to
the disclosures that are amended) contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not
misleading. As of the date of this Agreement, no Subsidiary of Purchaser is subject to the reporting requirements of Section 13(a)
or 15(d) under the Exchange Act. Each of the audited consolidated financial statements and unaudited consolidated financial statements
of Purchaser included in Purchaser SEC Documents (including the related notes and schedules), as of their respective effective
dates (in the case of Purchaser SEC Documents that are registration statements filed pursuant to the requirements of the Securities
Act) and as of their respective SEC filing dates (in the case of all other Purchaser SEC Documents), complied as to form in all
material respects with all applicable accounting requirements and with the published rules and regulations of the SEC with respect
thereto (except, in the case of unaudited statements, as permitted by Quarterly Report Form 10-Q of the SEC), were prepared in
accordance with GAAP and applicable accounting requirements and published rules and regulations of the SEC consistently applied
during the periods involved (except (i) with respect to financial statements included in Purchaser SEC Documents filed as of the
date of this Agreement, as may be indicated in the notes thereto, or (ii) as permitted by the rules and regulations of the SEC,
including Regulation S-X), and fairly present in all material respects the consolidated financial position of Purchaser and its
consolidated Subsidiaries as of the dates thereof and the consolidated statements of operations, changes in stockholders’
equity and cash flows of such companies as of the dates and for the periods shown therein.

 

 

 

 

 

    	 	29	 

     

    

 

Section 5.7.        
Valid Issuance of Purchaser Shares. Upon its
receipt of the Purchaser Common Stock, the Company will acquire good and valid title to such Purchaser Common Stock, free and clear
of all Encumbrances (other than any Encumbrances or other restrictions set forth, or described, in this Agreement). The Purchaser
Common Stock will, when issued in accordance with the provisions of this Agreement, be validly issued, fully paid and nonassessable.

 

Section 5.8.        
No Additional Representations. Except for the
representations and warranties contained in this Article 5, neither Purchaser nor any other Person makes any express or implied
representation or warranty on behalf of Purchaser, and Purchaser hereby disclaims any representations, warranties or other statements
made by it or any of its direct or indirect directors, equity holders, subsidiaries, Affiliates or representatives with respect
to the subject matter hereof.

 

Article
6

ADDITIONAL COVENANTS

 

Section 6.1.        
Further Assurances.

 

6.1.1.       Subject
to the terms and conditions of this Agreement, each of the parties hereto agrees to use its commercially reasonable efforts to
take, or cause to be taken, all action, and to do, or cause to be done, all things necessary, or advisable under Applicable Laws,
to consummate and make effective the Contemplated Transactions, including, but not limited to, the Company’s causing the
satisfaction of the conditions set forth in Section 7.2 and Purchaser’s causing the satisfaction of the conditions set forth
in Section 7.1.

 

6.1.2.       If,
at any time after the Closing, any party reasonably determines that further action is necessary to effectuate the Contemplated
Transactions, the other parties shall take or cause to be taken all such action as may be reasonably requested and execute, deliver
and file, or cause to be executed, delivered and filed, all such documentation as may be reasonably requested.

 

Section 6.2.        
Fulfillment of Agreements. The Company shall
conduct the Business in such a manner that at the Closing Date the representations and warranties contained in Article 4 shall
be true and correct as though such representations and warranties were made on, as of, and with reference to the Closing Date.

 

Section 6.3.        
Standstill. From the date hereof through the
Closing (or, if earlier, the date of termination of this Agreement in accordance with Section 7.3), (a) the Company shall not sell
or otherwise transfer, or grant any rights with respect to, any of its assets (other than sales of assets in the ordinary course
of day-to-day business consistent with past practices and that are specifically permitted by this Agreement) to any other Person.
In addition, from the date hereof through the Closing (or, if earlier, the date of termination of this Agreement in accordance
with Section 7.3), the Company and the Additional Parties shall not, and shall not cause or permit any of their respective officers,
directors, managers, employees, representatives or agents, to, directly or indirectly, solicit, initiate or participate in any
way in discussions or negotiations with, or provide any information or assistance to, any Person or group of Persons (other than
Purchaser and its agents and representatives) concerning any acquisition of an equity interest in, or in a merger, consolidation,
liquidation, dissolution, disposition of assets of the Company or any disposition of any of their respective ownership or other
interests in the Company (other than pursuant to the Contemplated Transactions) (each, an “Acquisition Proposal”),
or assist or participate in, facilitate or encourage any effort or attempt by any other Person to do or seek to do any of the foregoing.
The Company and the Additional Parties shall promptly communicate to Purchaser the terms of any Acquisition Proposal which any
of them may receive.

 

Section 6.4.        
Conduct of Business Pending Closing. From and
after the date hereof through the time immediately preceding the Closing, and unless Purchaser (in its sole discretion) shall otherwise
agree in writing, the Company covenants and agrees that:

 

6.4.1.       Ordinary
Course. The Business will be conducted only in the ordinary course of business, consistent with past practices, including in
respect of customer billing.

 

 

 

 

    	 	30	 

     

    

 

6.4.2.       Preservation
of Business. The Company will use commercially reasonable efforts to:

 

(a)       preserve
its present business operations, organization and goodwill;

 

(b)       preserve
the present relationships with its customers, suppliers, vendors, service providers, insurance carriers, brokers, agents, personnel
and others having business relations with it;

 

(c)       preserve
intact the material assets and properties related to the Business;

 

(d)       confer
with Purchaser prior to implementing operational decisions not contemplated by this Agreement that will involve the expenditure
of an amount equal to or exceeding $5,000; and

 

(e)       keep
in full force and effect, without amendment, and comply with all Permits, certificates, Licenses, approvals and authorizations
required, to Company’s Knowledge, under all Applicable Laws in connection with the Business and the Company, and comply with
all Applicable Laws.

 

6.4.3.       Material
Actions. Without limiting the generality of the foregoing, the Company will not, without the prior written consent of Purchaser:

 

(a)       amend
its Charter Documents in a manner that will affect the Business, the Purchased Assets or the Contemplated Transactions;

 

(b)       change
its authorized or issued Securities or issue any rights or options to acquire Securities;

 

(c)       authorize
for issuance, issue, deliver, sell, redeem, pledge, dispose of or grant (A) any Securities; (B) any Securities convertible into
or exchangeable for, or any options, warrants or rights to acquire, any such Securities or (C) any “phantom” stock,
“phantom” stock rights, stock appreciation rights or stock-based performance units;

 

(d)       enter
into any Contract or commitment related to the Business, the Purchased Assets or the Assumed Liabilities the performance of which
may extend beyond the Closing, except those entered in the ordinary course of business consistent with past practices and which
would not or could not reasonably be expected to have a Material Adverse Effect;

 

(e)       increase
the base salary, commission, bonus or other incentive compensation for any employee, except as required under any Employee Plan
as in effect on the date hereof (and that have been disclosed to Purchaser);

 

(f)       enter
into, adopt, amend or terminate any Material Contract;

 

(g)       enter
into any employment, severance, consulting or similar Contract or arrangement with any Person which is not terminable at will without
penalty or Liability on the part of the Company or modify or terminate any employment, severance, consulting or similar Contract;

 

(h)       incur,
create, assume or suffer to exist any restriction, Encumbrance, tenancy, encroachment, covenant, condition, right-of-way, easement,
Claim, charge or other matter adversely affecting title on any of its assets other than Permitted Encumbrances;

 

(i)       accelerate
the collection of any of the Acquired Accounts Receivable;

 

(j)       delay
the payment of any of its accounts payable or other Liabilities;

 

 

 

 

    	 	31	 

     

    

 

(k)       waive
or surrender any rights related to any pending or threatened Litigation to the extent affecting the Business, the Company, the
Purchased Assets or the Assumed Liabilities;

 

(l)       make,
change or revoke any Tax election or enter into any Contract or arrangement with respect to Taxes, change any annual tax accounting
period, adopt or change any method of Tax accounting, amend any Tax Returns, file claims for Tax refunds, enter into any closing
agreement as described in Section 7121 of the Code or analogous provision of other Tax law, settle any Tax claim, audit or assessment,
surrender any right to claim a Tax refund, offset of other reduction in Tax liability or take any other action that would have
the effect of increasing the Tax liability or reducing any Tax asset of the Company;

 

(m)       incur
any Indebtedness for Borrowed Funds;

 

(n)       loan,
advance funds or make an investment in or capital contribution to any Person;

 

(o)       take
any action that would make any representation or warranty of the Company set forth in Article 4 inaccurate;

 

(p)       take
any action or commit any omission that could reasonably result in (A) a material delay in the Contemplated Transactions or (B)
a Material Adverse Effect;

 

(q)       enter
into any Contract or commitment giving any Person an option, right of first refusal or other similar right with respect to the
assets of the Company;

 

(r)       enter
into any Related Party Agreement;

 

(s)       waive
the benefits of, or agree to modify in any manner, any confidentiality, standstill or similar Contract;

 

(t)       take
any action or omit to take any action that would result in the occurrence of any event described in Section 4.31;

 

(u)       take
any action or omit to take any action which will result in a violation of any Applicable Law;

 

(v)       fail
to maintain and keep in full force and effect all insurance on assets and property or for the benefit of the Company, all liability
and other casualty insurance and all bonds on personnel presently carried, fail to present all claims under such insurance policies
in a proper and timely manner or breach any obligation under such insurance policies;

 

(w)       guaranty
any obligation of or agree to indemnify any Person;

 

(x)       except
as required to comply with Applicable Law, amend, modify or terminate any Employee Plan without the express written consent of
Purchaser or as otherwise contemplated by this Agreement;

 

(y)       incur
any Liability outside of the ordinary course of business consistent with past practices; or

 

(z)       authorize,
recommend, propose or announce an intention to do any of the foregoing, or enter into any Contract to do any of the foregoing.

 

 

 

 

    	 	32	 

     

    

 

Section 6.5.        
Employees.

 

6.5.1.       In
Purchaser’s sole discretion, Purchaser may extend, or cause its Affiliates to extend, employment or other service offers
to one or more Business Employees in addition to the Additional Parties, with such terms and conditions to be determined by Purchaser
in its sole discretion. The Company shall reasonably cooperate with Purchaser in connection with the foregoing, and shall terminate
the employment or other service of each Business Employee (including each Additional Party) who has received such an offer, with
such termination effective no later than the date immediately preceding the Closing Date. The Business Employees who accept Purchaser’s
(or its Affiliate’s) offer of employment and commence employment with Purchaser or its Affiliate (including the Additional
Parties) shall be referred to herein as “Transferred Employees”.

 

6.5.2.       The
Company shall retain sponsorship of, and shall retain and indemnify and hold harmless Purchaser and its Affiliates against, all
Liabilities related to employment, termination of employment, compensation or employee benefits of any nature (including, but not
limited to any Liabilities or obligations under the Employee Plans), whether arising before, on or after the Closing, that are
with respect to Business Employees and Transferred Employees (provided that with respect to Transferred Employees such Liabilities
would consist only of such Liabilities incurred on or prior to the Closing Date), or any other former or current employees or contractors
of the Company, or the beneficiaries of any such individuals (the “Excluded Employee Liabilities”). Purchaser
and its Affiliates shall not assume sponsorship of, contribute to or maintain, or have any Liability with respect to, the Employee
Plans. For the avoidance of doubt, any and all Liabilities (including statutory or contractual severance benefits and change in
control payments or transaction bonuses) arising as a result of the actual or constructive termination of a Business Employee’s
employment with the Company as a result of the transactions contemplated by this Agreement, whether or not such individual becomes
a Transferred Employee, shall be considered Excluded Employee Liabilities. All vacation days and other paid time off accrued but
not taken by Transferred Employees on or prior to the Closing Date shall also be considered Excluded Employee Liabilities and such
Liabilities shall be paid solely by the Company.

 

6.5.3.       Nothing
contained in this Section 6.5, whether express or implied, may be construed to (i) create any Third Party beneficiary or other
rights in any person other than the parties to this Agreement, (ii) constitute an establishment, amendment, modification or termination
of, or an undertaking to establish, amend, modify or terminate, any Employee Plan, or other benefit or compensation plan, (iii)
prohibit or limit the ability of the Company, Purchaser or any of their respective Affiliates to establish, amend, modify or terminate
any Employee Plan, or other benefit or compensation plan, or (iv) create any obligation on the part of Purchaser or any of its
Affiliates, as applicable, to continue to employ or engage for the performance of services any person (including any Transferred
Employee), or to limit the ability of Purchaser or any of its Affiliates to terminate the employment or service of any person at
any time for any or no reason.

 

Section 6.6.        
Access to Information.

 

6.6.1.       Prior
to Closing. Prior to the Closing, the Company shall provide Purchaser’s accountants, counsel, and other representatives
access to all of the Company’s employees, books, contracts, commitments, records, properties (including, if requested, access
to accounting software of the Business) and such other information as are related to the Business, the Company, the Purchased Assets
or the Assumed Liabilities. Such access shall be upon reasonable advance notice and during business hours. During such hours, the
Company shall furnish to Purchaser all such information concerning the Business, the Company and the Company’s assets.

 

6.6.2.       Post-Closing.
Following the Closing, Purchaser shall provide the Company’s accountants, counsel, and other representatives access, for
any proper purpose, to all of Purchaser’s books, contracts, commitments, records, properties (including, if requested, access
to accounting software of the Business) and such other information to the extent related to the Purchased Assets or the Assumed
Liabilities prior to the Closing Date. Such access shall be upon reasonable advance notice and during business hours. During such
hours, Purchaser shall furnish to the Company all such information concerning the Purchased Assets and the Assumed Liabilities.
The Company and the Additional Parties shall cooperate with Purchaser in the preparation of any document or the provision of information
related to or respecting the Purchased Assets, the Company, this Agreement or the transactions contemplated by this Agreement that
is required to be included in any document filed with or furnished to the SEC (whether such filed or furnished document is required
to have been filed or furnished in connection with this Agreement and the transactions contemplated hereby or not).

 

 

 

 

    	 	33	 

     

    

 

Section 6.7.        
Public Announcements. Except as required by law,
none of the Additional Parties, the Company or Purchaser shall issue or make any press release or other public statements with
respect to this Agreement or the Contemplated Transactions to employees, customers, distributors, suppliers, vendors or other Persons
except and unless such release, statement or announcement has been jointly approved by the Company and Purchaser (which approval
shall not be unreasonably, withheld or delayed). The Company and Purchaser will consult with each other concerning the means by
which the employees, customers, suppliers and vendors of the Company and other Persons having dealings with the Company will be
informed of the Contemplated Transactions. Without limiting the foregoing, the Company and the Additional Parties acknowledge and
agree that a representative of Purchaser will be allowed to be present at the time disclosure of this transaction is made to the
Business Employees.

 

Section 6.8.        
Supplemental Information. From time to time prior
to the Closing, the Company will promptly deliver to Purchaser in writing any information which, if existing, occurring or known
at the date of this Agreement, would have been required to be set forth or described in any Schedule or which is necessary to correct
any information in any Schedule which has been rendered inaccurate thereby. No supplement or amendment shall have any effect for
the purpose of determining (i) satisfaction of the conditions to Closing set forth in Section 7.2 hereof, (ii) the compliance
by any Person with the covenants set forth herein, or (iii) whether the Company or the Additional Parties shall have breached
any representation or warranty contained herein.

 

Section 6.9.        
Restrictive Covenants.

 

6.9.1.       Confidentiality.
The Company and the Additional Parties recognize and acknowledge that the Confidential Information (as defined below) is a valuable,
special and unique asset of the Company. As a result, from and after the Closing, the Company and the Additional Parties will not,
without the prior written consent of Purchaser, for any reason divulge to any third party or use for its own benefit, or for any
purpose other than the exclusive benefit of Purchaser and Purchaser’s Affiliates, any Confidential Information. Notwithstanding
the foregoing, if the Company or any Additional Party (or any of their Affiliates) is compelled to disclose Confidential Information
by Court Order, to the extent permitted by Applicable Laws, the Company or applicable Additional Party shall promptly so notify
Purchaser so that Purchaser may seek a protective order or other assurance that confidential treatment of such Confidential Information
shall be afforded, and the Company or the applicable Additional Party shall reasonably cooperate with Purchaser and Purchaser’s
Affiliates in connection therewith. If the Company or the applicable Additional Party (or any of their Affiliates) is so obligated
by Court Order to disclose Confidential Information, it or they, as applicable will disclose only the minimum amount of such Confidential
Information as is necessary for such Person to comply with such Court Order. For purposes of this Section 6.9.1, “Confidential
Information” shall mean nonpublic information concerning the terms of this Agreement and the other Transaction Documents,
financial data, strategic business plans, product development (or other proprietary product data), customer lists and requirements,
marketing plans and other nonpublic, proprietary and confidential information relating to the Business, the Purchased Assets, the
Assumed Liabilities or the Company.

 

6.9.2.       Acknowledgements.
The Company and the Additional Parties acknowledge that the restrictive covenants set forth in this Section 6.9 and in the Company
Restrictive Covenant Agreement (the “Restrictive Covenants”) are reasonable and necessary to protect the legitimate
interests of Purchaser and Purchaser’s Affiliates, that the duration and scope of the Restrictive Covenants are reasonable
given the global geographic scope of the Business, and that Purchaser would not enter into this Agreement but for the agreement
of such parties to be bound by the Restrictive Covenants. The Company and the Additional Parties also acknowledge that any Claim
that the Company or any Additional Party may have against Purchaser shall not constitute a defense to the enforcement by Purchaser
of the Restrictive Covenants. The Restrictive Covenants are independent of any other provision in this Agreement and of any other
promise made to the Company or any Additional Party.

 

6.9.3.       Accounting.
If the Company, any Additional Party or any of their Affiliates breach any of the Restrictive Covenants, Purchaser or its Affiliates,
as applicable, will have the right and remedy to require such breaching party to account for and pay over to Purchaser or his Affiliates,
as applicable, all compensation, profits, monies, accruals, increments or other benefits derived or received by such breaching
party as the result of such breach. This right and remedy will be in addition to, and not in lieu of, any other rights and remedies
available to Purchaser and its Affiliates under law or in equity or as otherwise set forth in this Agreement.

 

 

 

 

    	 	34	 

     

    

 

6.9.4.       Extension
of Restricted Period. If the Company or any Additional Party or any of their Affiliates breaches Section 6.9 in any respect,
the restrictions contained in that section as against such breaching party will be extended for a period equal to the period that
such breaching party was in breach.

 

Section 6.10.    
Judicial Modification of Covenants. If any covenant
contained in this Agreement or any part thereof is hereafter construed by a court having jurisdiction to be invalid or unenforceable,
the same shall not affect the remainder of such covenant or any other covenants, which shall be given full effect, without regard
to the invalid portions, and any court having jurisdiction shall have the power to modify such covenant to the least extent necessary
to render it enforceable and, in its modified form, said covenant shall then be enforceable and, in the event any provision is
deemed invalid or unenforceable, each party will request such modification by the applicable court. Neither the Company nor any
Additional Party shall assert that such restrictions should be eliminated in their entirety by such court.

 

Section 6.11.    
Tax Matters. Notwithstanding Section 1.2.3, if
any jurisdiction requires Purchaser to file a Tax Return with respect to any Purchased Asset or the Business for a Straddle Period,
the parties agree that the amount of Taxes attributable to the portion of the Straddle Period up to and including the Closing Date
(the “Interim Period”) shall be determined by (i) in the case of Taxes not based on income, receipts or expenses,
multiplying the Taxes for the entire Straddle Period by a fraction, the numerator of which is the number of calendar days in the
Interim Period and the denominator of which is the number of calendar days in the entire Straddle Period, and (ii) in the case
of Taxes based on income, receipts or expenses, such Taxes shall be allocated to the Interim Period based on a closing of the books
method as of the close of business on the Closing Date.

 

Section 6.12.    
Transfer Taxes. The Company shall file all Tax
Returns with respect to Transfer Taxes with respect to the Contemplated Transactions and shall, as promptly as reasonably practicable
after Closing, pay all such Transfer Taxes arising out of or in connection with the Contemplated Transactions.

 

Section 6.13.    
Cooperation on Tax Matters. The Parties shall,
and shall each cause its Affiliates to, cooperate in (i) providing any information reasonably necessary to allow Purchaser or the
Company to comply with any information reporting contained in the Code or other Applicable Laws with respect to the Purchase Assets
and/or the Assumed Liabilities; (ii) providing certificates or forms, and timely executing any Tax Return, as reasonably requested,
that may be necessary or appropriate to establish an exemption for (or reduction in) any Transfer Tax; and (iii) providing records
and information that are reasonably relevant to any audit, litigation or other Tax proceeding with respect to the Purchased Assets
and/or the Assumed Liabilities. Such cooperation shall include the retention and (upon the other Party’s request) the provision
of records and information reasonably relevant to any such Tax Returns, Tax liability, or audit or other proceeding. Each Party
will retain all Tax Returns and related records and materials of Company for the Tax periods first ending after the Closing Date
and for all prior Tax periods until the expiration of the applicable statute of limitations (and, to the extent the other Party
reasonably requests, any extensions thereof) for the Tax periods to which the Tax Returns and other records and materials relate,
and abide by any applicable record retention agreements entered into with any Governmental Authority. Thereafter, the Party holding
such Tax Returns or related records or materials may dispose of them provided that such Party shall give the other Party the notice
in accordance with Section 9.2 prior to doing so, and if the other Party so requests allow the other Party to take possession or
make copies of such Tax Returns or related records or materials. Each Party shall make its employees reasonably available on a
mutually convenient basis (at the cost of the party requesting access to such employees) to provide explanation of any documents
or information so provided.

 

Section 6.14.    
Bulk Sales Laws. The Parties hereby waive compliance
with the provisions of any bulk sales, bulk transfer or similar laws of any jurisdiction that may otherwise be applicable with
respect to the sale of any or all of the Purchased Assets to Purchaser; provided that such waiver will not relieve any Party of
any obligation such Party may have to indemnify for any obligations and liabilities related to any Taxes of the Company for any
taxable period and Taxes related to the Business or the Acquired Assets for any taxable period (or portion thereof) ending on or
before the Closing Date (including Taxes attributable to an Interim Period under Section 6.11), including any such Taxes that become
an obligation or liability of Purchaser as a transferee or successor or pursuant to any Applicable Law.

 

 

 

    	 	35	 

     

    

 

Section 6.15.    
Customer and Supplier Inquiries; Accounts Receivable; Name; Dissolution.

 

6.15.1.       Within
10 Business Days following the Closing, (i) none of the Company nor any of its respective Affiliates will use or operate under
the name “Prevacus, Inc.” or any variation or modification thereof, (ii) the Company will take all actions necessary
to cause the name of “Prevacus, Inc.” to be changed to a name that is not similar to or in any manner subject to confusion
with its present name, including without limitation filing with the appropriate agency of the State of Delaware a certificate of
amendment effecting such name change to exclude “Prevacus,” and (iii) the Company will suspend its use of, and will
facilitate Purchaser’s full operation of, all domain names associated with the Business, including but not limited to prevacus.com.

 

6.15.2.       Following
the Closing and for a period of one year thereafter: (i) the Company shall use commercially reasonable efforts to refer to Purchaser
all customer, supplier, employee regulatory or other inquiries or correspondence concerning or relating to the Business and the
Purchased Assets after the Closing Date; and (ii) Purchaser shall use commercially reasonable efforts to refer to the Company all
inquiries and correspondence concerning or relating to the Company or the Company’s business or operations other than the
Business after the Closing Date.

 

6.15.3.       The
Company shall (and shall cause its Affiliates to) promptly remit to Purchaser all payments and invoices received after the Closing
Date to the extent related to the Purchased Assets or the Assumed Liabilities, and Purchaser shall (and shall cause its Affiliates
to) promptly remit to the Company all payments and invoices received after the Closing Date to the extent related to the Excluded
Assets or the Excluded Liabilities. From and after the Closing, Purchaser shall have the right and authority to collect for its
own accounts all items that are included in the Purchased Assets and to endorse with the names of the Company any checks or drafts
received with respect to any such items. From and after the Closing, the Company shall use commercially reasonable efforts to assist
with Purchaser’s reasonable requests related to the collection of the Acquired Accounts Receivable.

 

6.15.4.       After
the Closing Date and for a period of 2 years thereafter, the Company shall, and shall cause its Affiliates, to refer all inquiries
regarding the Business to Purchaser.

 

6.15.5.       The
Company agrees that it shall not take any action which shall constitute the dissolution or liquidation of the Company until the
later of (a) the date that is two years after the Closing Date and (b) the time of the final resolution of the last remaining claim
outstanding under Article 8.

 

Section 6.16.    
Company Stockholder Approval. The Company shall
obtain, in accordance with the relevant provisions of Applicable Law, the Company Stockholder Approval.

 

Section 6.17.    
Restricted Securities. The Company acknowledges
that the shares of Purchaser Common Stock being issued hereunder are subject to significant restrictions on transfer as imposed
by state and federal securities laws.

 

Section 6.18.    
Future Purchaser Financings. In the event the
Purchaser conducts a financing or offering within the twelve months after the Closing Date in which the net proceeds to the Purchaser
are in excess of $5,000,000, the Purchaser shall apply at least $1,500,000 of such net proceeds toward funding a Phase I Clinical
Trial for PRV-02 sponsored by Purchaser or an Affiliate thereof.

 

 

 

 

 

    	 	36	 

     

    

 

Section 6.19.    
Product Books and Record. The Company shall transfer
to Purchaser on the Closing Date (or as soon as reasonably practicable after the Closing Date) the Product Books and Records and
the Regulatory Information that are (a) accessible by the Company or an Affiliate, and (b) reasonably identifiable and reasonably
separable from other books and records of the Company. To the extent that the Company is unable to transfer any such Product Books
and Records and Regulatory Information on the Closing Date, the Company shall use commercially reasonable efforts to deliver such
Product Books and Records and Regulatory Information to Purchaser (i) with respect to any such Product Books and Records and Regulatory
Information that are in hard copy format, within 30 days following the Closing Date and (ii) with respect to any such Product Books
and Records and/or Regulatory Information that are in an electronic format, within 30 days following the date on which Purchaser
has established systems that are compatible with the relevant electronic format to facilitate such delivery; provided, however,
that if Purchaser fails to establish such systems within 12 months of the Closing, the Company’s obligation to transfer such
Product Books and Records to Purchaser in electronic format shall expire. The Company may transfer copies or originals of the Product
Books and Records and Regulatory Information at its election, unless Purchaser reasonably requests an original copy of any such
Product Books and Records and Regulatory Information.

 

Section 6.20.    
Regulatory Matters.

 

6.20.1.       Transfer
of Governmental Authorizations. The Company shall use commercially reasonable efforts to assign to Purchaser all of the Company’s
right, title, obligations and interest existing in and to the Transferred Governmental Authorizations on the Closing Date, and
Purchaser shall assume such right, title, obligations and interest from the Company upon the Company’s assignment of the
Transferred Governmental Authorizations. On the Closing Date, each of the Company and Purchaser shall execute and deliver to the
FDA the Company FDA Transfer Letters and the Purchaser FDA Transfer Letters, as the case may be, and to other appropriate Governmental
Authorities in the United States such documents and instruments of conveyance as necessary and sufficient to effectuate the transfer
of each Transferred Governmental Authorization to Purchaser under Applicable Law on the Closing Date or as soon as possible if
the Transferred Governmental Authorizations are assigned after the Closing.

 

6.20.2.       Governmental
Authority Contacts. Purchaser and the Company shall promptly give written notice to the other upon becoming aware of any action
by, or notification or other information which it receives (directly or indirectly) from, any Governmental Authority in the United
States (together with copies of correspondence related thereto), which (A) raises any material concerns regarding the safety or
efficacy of the products of the Company, (B) which indicates or suggests potential material liability for either party to third
parties arising in connection with the such products, or (C) which indicates a reasonable potential for a need to initiate a recall,
market withdrawal or similar action; in each case with respect to the products sold by the Company on or prior to the Closing Date
or products sold by Purchaser using any of the names and logos of the Company and all of its Affiliates.

 

6.20.3.       Product
Complaints. From and after the Closing, Purchaser shall be solely responsible for responding to any complaint regarding the
products of the Company that is received by either Purchaser or the Company after the Closing Date from any source and for investigating
and analyzing such complaint and making required reports to FDA, regardless of whether the products involved were sold by the Company
or Purchaser.

 

Section 6.21.    
Incentive Plan. Purchaser shall prepare, authorize
and implement an equity incentive plan pursuant to which any equity securities to be issued to Dr. VanLandingham and Mr. Lewandowski
shall be made (the “Incentive Plan”) and file a “Registration Statement on Form S-8” relating to
such Incentive Plan (the “Form S-8”) with the SEC within one (1) year of the date of closing.

 

Section 6.22.    
Restrictive Covenant Agreement. Dr. VanLandingham and Mr. Lewandowski agree to and shall reduce to writing a Restrictive
Covenant Agreement by and between each of them individually and the Purchaser restricting the Company and each of them individually
from working on brain-related drugs and/or devices for the pendency of their agreements with the Purchaser. The Company shall agree
to a Restrictive Covenant Agreement under similar terms.

 

 

 

 

    	 	37	 

     

    

 

Article
7

CONDITIONS TO THE CLOSING

 

Section 7.1.        
Conditions to Obligations of the Additional Parties and
the Company. The obligations of the Additional Parties and the Company to consummate the Contemplated Transactions will
be subject to the fulfillment (or waiver in writing by the Company), at or prior to the Closing, of each of the following conditions:

 

7.1.1.       The
representations and warranties of Purchaser set forth in Article 5 (i) which are qualified by materiality will be true and
correct in all respects and (ii) which are not qualified by materiality will be true and correct in all material respects,
in each case on and as of the Closing as if made on the Closing Date.

 

7.1.2.       All
the covenants contained in this Agreement to be performed or complied with by Purchaser on or before the Closing will have been
performed or complied with in all material respects.

 

7.1.3.       No
Governmental Authority will have enacted, issued, promulgated, enforced or entered any statute, rule, regulation, injunction, judgment,
decree or other order (whether temporary, preliminary or permanent) which is in effect and has the effect of making the Contemplated
Transactions illegal or otherwise restraining or prohibiting the consummation of such transactions.

 

7.1.4.       No
suit, Claim, cause of action, arbitration, investigation or other proceeding contesting, challenging or seeking to alter or enjoin
or adversely affect the Contemplated Transactions, will be pending or threatened.

 

7.1.5.       Purchaser
shall have delivered the items to be delivered by Closing under Section 3.4.

 

Section 7.2.        
Conditions to Obligations of Purchaser. The obligations
of Purchaser to consummate the Contemplated Transactions will be subject to the fulfillment (or waiver in writing by Purchaser),
at or prior to the Closing, of each of the following conditions:

 

7.2.1.       The
representations and warranties of the Additional Parties and the Company set forth in Article 4 (i) which are qualified by
materiality will be true and correct in all respects and (ii) which are not qualified by materiality will be true and correct
in all material respects, in each case on and as of the Closing as if made on the Closing Date.

 

7.2.2.       All
the covenants contained in this Agreement to be performed or complied with by the Additional Parties and/or the Company on or before
the Closing will have been performed or complied with.

 

7.2.3.       No
Governmental Authority will have enacted, issued, promulgated, enforced or entered any statute, rule, regulation, injunction, judgment,
decree or other order (whether temporary, preliminary or permanent) which is in effect and has the effect of making the Contemplated
Transactions illegal or otherwise restraining or prohibiting the Contemplated Transactions or that threatens to compel Purchaser
to divest itself of the Purchased Assets or the Assumed Liabilities, or restrict or limit Purchaser’s use of, any of the
Company’s properties or assets.

 

7.2.4.       No
suit, Claim, cause of action, arbitration, investigation or other proceeding contesting, challenging or seeking to alter or enjoin
or adversely affect the Contemplated Transactions, will be pending or threatened.

 

7.2.5.       The
Additional Parties and/or the Company (as applicable) shall have obtained the written consent, waiver, authorization or approval
(in form and substance acceptable to Purchaser) of all landlords, customers, vendors, suppliers, Governmental Authorities or other
Persons necessary to consummate the Contemplated Transactions, including, but not limited, to the Required Consents. The Additional
Parties and/or the Company (as applicable) shall have delivered the foregoing consents to Purchaser.

 

 

 

 

    	 	38	 

     

    

 

7.2.6.       The
Company Stockholder Approval shall have been obtained.

 

7.2.7.       No
event, occurrence, fact, condition, change, development or effect shall have occurred that, individually or in the aggregate, has
constituted or resulted in, or could reasonably be expected to constitute or result in any Material Adverse Effect.

 

7.2.8.       The
Company shall have provided Purchaser evidence satisfactory to Purchaser that all Indebtedness shall have been paid and any liens
on the Purchased Assets shall have been released (or any lienholder shall have authorized Purchaser to release such liens following
the Closing), including, but not limited to, the Tax Liens.

 

7.2.9.       The
Company shall have provided Purchaser evidence satisfactory to Purchaser that all Indebtedness shall have been paid regarding the
Amex Lien.

 

7.2.10.       The
Form S-8 shall have been declared effective by the SEC.

 

7.2.11.       The
Company and each Additional Party shall have delivered the items to be delivered by Closing under Section 3.2 and Section 3.3,
respectively.

 

Section 7.3.        
Termination.

 

7.3.1.       This
Agreement may be terminated (whether before or after Company Stockholder Approval has been obtained) (a) at any time by mutual
written agreement of the parties, or (b) in whole and not in part by Purchaser or the Company (on behalf of the Additional
Parties) by written notice to the other party if the conditions set forth in Article 7 hereof shall not have been complied with
or performed or if the Closing has not taken place on or prior to February 28, 2021 (or such later date as the parties may hereafter
mutually agree to in writing), provided the terminating party is not otherwise in Default under this Agreement in any material
respect and the terminating party shall not have materially breached any of its representations, warranties, covenants or agreements
contained herein.

 

7.3.2.       Except
as otherwise set forth in this Section 7.3.2, in the event of a termination of this Agreement by any party as provided in Section
7.3.1, this Agreement shall forthwith become void and there shall be no liability or obligation on the part of Purchaser, the Company,
the Additional Parties or their respective Affiliates, officers or directors; provided, however, that (i) the
provisions of Section 7.3.1, Section 9.6 and Article 8 and the confidentiality obligations of the parties under the Share Exchange
Agreement shall remain in full force and effect and survive any termination of this Agreement and (ii) no party hereto shall
be relieved or released from any liabilities or damages (whether at law or in equity) arising out of its breach of any representation,
warranty, covenant or agreement set forth in this Agreement.

 

7.3.3       If
this Agreement is terminated by either Party or fails to Close by the Closing Date for any reason, or expires, the Company shall
return One Million (1,000,000) common stock shares the Company received from the Master Agreement signed in 2019. The shares shall
be returned within seven days of termination or expiration, to Empire Transfer Agent in Nevada with instructions to cancel the
shares or return the shares to Purchaser treasury.

 

 

 

 

 

    	 	39	 

     

    

 

Article
8

INDEMNIFICATION

 

Section 8.1.        
Survival of Representations and Warranties. The
representations and warranties of the parties hereto contained in this Agreement shall survive the consummation of the Contemplated
Transactions (and any examination or investigation by or on behalf of any party hereto) until the date that is two years following
the Closing Date (the “General Survival Date”), provided, however, that the representations and warranties
set forth in (i) Section 4.1 (Organization; Good Standing), Section 4.3 (Power and Authority), Section 4.6 (Title
to and Adequacy of Tangible Assets), Section 4.10 (Intellectual Property), Section 4.12 (Regulatory Matters),
Section 4.16 (Governmental Authorizations; Compliance with Laws; Permits), Section 4.23 (No Brokers), Section 4.36
(Anti-Bribery), Section 5.1 (Organization and Standing), Section 5.2 (Authority) and Section 5.5 (No Brokers)
shall survive indefinitely, and (ii) Section 4.8 (Tax Matters), Section 4.13 (Environmental Matters)
and Section 4.15 (Labor and Employment Matters) shall survive until the date that is 30 days following the date that the
applicable statute of limitations (including any extension thereof) expires (each such date, including the General Survival Date,
being a “Survival Date”); and provided, further, that if any notice of a Claim by a Purchaser Indemnified
Party, a Company Indemnified Party (as defined in Section 8.3), or any Third Party shall have been given prior to the applicable
Survival Date, the representations and warranties that are the subject of such notice shall survive until such time as such Claim
is finally resolved.

 

Section 8.2.        
Indemnification by the Company and the Additional Parties.
The Company and each Additional Party, jointly and severally, agrees to defend, indemnify and hold harmless Purchaser and each
of Purchaser’s officers, directors, employees, members, shareholders, representatives, attorneys, agents, subsidiaries and
Affiliates (each, a “Purchaser Indemnified Party”) from and against any Claims or Damages arising out of, resulting
from, or in connection with: (i) any misrepresentation or breach of any representation or warranty made by any Additional
Party and/or the Company in this Agreement; (ii) the failure of any Additional Party or the Company to perform or observe
in all respects any covenant, agreement or provision to be performed or observed by it pursuant to this Agreement; (iii) any
Liability of or Claim against Purchaser relating to the operation of the Business prior to the Closing Date whether or not incurred
prior to the Closing, which is not an Assumed Liability under Section 1.3; (iv) any Indebtedness of the Company, (v) any Transaction
Fees, (vi) any Liability of or Claim against Purchaser in any way related to any Employee Plan which Liability or Claim arose or
is any way related to any period of time prior to Closing, (vii) any Excluded Liability, Excluded Employee Liability or Liability
arising from any Excluded Asset, (viii) any Tax imposed on or relating to (A) the Company with respect to any taxable period or
portion thereof ending on or before the Closing Date, (B) the Company as a transferee or successor, or by contract, to the extent
that the Taxes or the events or transactions giving rise to the Taxes are with respect to any taxable period or portion thereof
ending on or before the Closing Date, and (C) another Person for which the Company is liable pursuant to Applicable Law as a result
of the Company’s relationship with such other Person in a taxable period or portion thereof ending on or before the Closing
Date, (ix) any Encumbrances with respect to Acquired Assets as set forth in Section 4.8.3, (x) any Liabilities which arise out
of or relate to the matters listed on Schedule 4.9, (xi) any Liabilities of, Claims by, or Claims against (A) PreSolMD,
LLC, (B) any Subsidiary, or (C) or any other Person in which the Company or any of the Additional Parties has an interest, and
(xii) any Liabilities arising in connection with (A) the due authorization and approval of the Contemplated Transactions by the
Company, (B) the governance of the Company, (C) any distributions of Excluded Assets or proceeds from the Contemplated Transactions
to the Company Stockholders, or (D) any other Claims of Company Stockholders.

 

Section 8.3.        
Indemnification by Purchaser. Purchaser agrees
to defend, indemnify and hold harmless the Company and each of the Company’s Affiliates, heirs, successors, assigns, attorneys,
agents and representatives (each, a “Company Indemnified Party”), from and against any Claims or Damages arising
out of, resulting from, or in connection with: (i) any misrepresentation or breach of any representation or warranty made
by Purchaser in this Agreement; and (ii) the failure of Purchaser to perform or observe any covenant, agreement or provision
to be performed or observed by it pursuant to this Agreement.

 

Section 8.4.        
Third-Party Claims. In the event that a Company
Indemnified Party or Purchaser Indemnified Party becomes aware of a Third-Party claim which such Indemnified Party believes may
result in Damages for which such Indemnified Party would be entitled to indemnification pursuant to this Article 8 (a “Third-Party
Claim”), the procedures to be followed with respect to the defense or settlement of such Third-Party Claim shall be as
follows:

 

 

 

 

 

    	 	40	 

     

    

 

8.4.1.       Such
Indemnified Party shall promptly notify the Company (who shall receive such notice, to the extent applicable, on behalf of all
Additional Parties) or Purchaser, as the case may be (the “Indemnifying Party Representative”), of such Third
Party Claim. No delay in notifying such Indemnifying Party Representative of such Third-Party Claim in accordance with the terms
of this Agreement shall affect an Indemnified Party’s rights, unless (and then only to the extent that) such Indemnifying
Party Representative or Purchaser or any Additional Party, as the case may be, are actually prejudiced thereby. The Indemnifying
Party Representative, at the sole expense of the party from whom indemnification is sought (the “Indemnifying Party”),
may assume the defense thereof with counsel reasonably acceptable to the Indemnified Party by written notice to the Indemnified
Party provided within 20 days of the Indemnifying Party’s receipt of the notice of claim. The Indemnified Party may participate
in the defense of such claim that is defended by such Indemnifying Party Representative with co-counsel of its choice; provided,
however, that the fees and expenses of the Indemnified Party’s counsel shall be paid by such Indemnified Party unless
(i) such Indemnifying Party Representative has agreed in writing to pay such fees and expenses or (ii) a claim shall have been
brought or asserted against the Indemnified Party as well as the Indemnifying Party, and the Indemnified Party shall have reasonably
determined that there are one or more factual or legal defenses available to it that are in conflict with those that are available
to the Indemnifying Party, in which case such co-counsel shall be at the expense of the Indemnifying Party. Assuming the defense
of such claim shall constitute an admission by the Indemnifying Party that such claim is a proper or valid claim for indemnification,
but shall not constitute an admission by the Indemnifying Party, as to the amount of the Damages asserted in the Claim.

 

8.4.2.       The
Indemnifying Party Representative shall have full right to enter into any compromise or settlement that is dispositive of the matter
involved; provided, however, that (i) except for the settlement of a Third Party Claim (A) that involves no obligation
of any Indemnified Party other than the payment of money for which indemnification in full is provided hereunder or (B) that is
related to Taxes, the Indemnifying Party Representative shall not settle or compromise any Third Party Claim without the prior
written consent of the Indemnified Party; and (ii) the Indemnifying Party Representative may not consent to entry of any judgment
or enter into any settlement in respect of a Third Party Claim that does not include an unconditional release of the Indemnified
Party from all liability in respect of such Third Party Claim; provided further, that, if in the reasonable judgment of
the Indemnified Party it would be materially harmed or otherwise prejudiced by not entering into a proposed settlement or compromise
and the Indemnifying Party Representative refuses to enter into such settlement or compromise, the Indemnified Party may enter
into such settlement or compromise, but such settlement or compromise shall not be conclusive as to the existence or amount of
the liability of Indemnifying Party or any Third Party.

 

8.4.3.       If
the Indemnifying Party Representative does not so assume control of such defense, the Indemnified Party shall control such defense
and the Indemnified Party shall have full right to enter into any compromise or settlement on its behalf that is dispositive of
the matter involved.

 

8.4.4.       The
party controlling such defense shall keep the other party advised of the status of such proceeding and the defense thereof and
shall consider in good faith recommendations made by the other party with respect thereto.

 

8.4.5.       Notwithstanding
anything to the contrary contained herein, no provision of this Article 8 shall be construed to limit, re-characterize or otherwise
modify those Liabilities that are Excluded Liabilities.

 

Section 8.5.        
Recovery From Escrow Account.

 

8.5.1.       The
Escrow Account shall be available to compensate each of the Purchaser Indemnified Parties for any Damages suffered or incurred
by each such Purchaser Indemnified Party for which such Purchaser Indemnified Parties are entitled to indemnification by any party
pursuant to Article 8. Upon the determination that such Purchaser Indemnified Party is entitled to indemnification for Damages
hereunder, then, such number of shares of Purchaser Common Stock (rounded up or down to the nearest whole share) determined pursuant
to Section 8.6 (the “Indemnity Cancelled Purchaser Stock”) shall be returned to Purchaser, deemed to be cancelled
and all rights the Company may have to such Purchaser Common Stock shall be extinguished. Purchaser and the Company shall promptly
inform the Escrow Agent of the number of shares of Indemnity Cancelled Purchaser Stock and shall take such action as is necessary
to have the Escrow Agent promptly return to Purchaser certificates representing such number of shares of Indemnity Cancelled Purchaser
Stock.

 

8.5.2.       All
claims for recovery for any Damages from the Escrow Account shall be made pursuant to and in accordance with, and governed by the
terms of, the Escrow Agreement and Section 8.6.2.

 

 

 

 

    	 	41	 

     

    

 

8.5.3.       Purchaser
may (but is not obligated to) satisfy any portion of indemnification obligations of the Company by setting off any such Claims
against any unpaid Milestone Payments due to the Company, as applicable.

 

Section 8.6.        
Distribution of Escrow Fund.

 

8.6.1.       Subject
to the requirements of this Agreement, the Escrow Account shall remain in existence until the Escrow Termination Date (the “Escrow
Period”). Upon the expiration of the Escrow Period, the Escrow Purchaser Shares remaining in the Escrow Fund shall promptly
be delivered to the Company as provided in the Escrow Agreement; provided, however, that at the conclusion of the
Escrow Period, any portion of the Escrow Fund that is the subject of an unresolved or unsatisfied claim for Damages (including
potential future Damages pursuant to pending Claims or Third-Party Claims) that has been made by Purchaser in accordance with the
Escrow Agreement prior to the Escrow Termination Date shall remain in the Escrow Account until such claims have been finally and
fully resolved or satisfied in accordance with the terms of the Escrow Agreement and this Agreement. Purchaser and the Company
shall cause the Escrow Agent to deliver the remaining portion of the Escrow Account not required to satisfy such claims to the
Company immediately. Deliveries from the Escrow Account to the Company pursuant to this Section 8.6 and the Escrow Agreement shall
be made as provided in the Escrow Agreement.

 

8.6.2.       Except
with regard to claims for indemnification pursuant to Section 8.2(viii), all calculations intended to determine the number of Purchaser
Common Stock applicable to a particular claim for indemnification under this Article 8 shall be made using the Release Date Share
Value as of the date any Escrow Purchaser Shares are to be released to the Company or returned to Purchaser and deemed cancelled
and all calculations shall be rounded up or down to the nearest whole share. Calculations intended to determine the number of shares
of Purchaser Common Stock applicable to a claim for indemnification under Section 8.2(viii) shall be made using the Closing Date
Share Value.

 

Section 8.7.        
Adjustments to Consideration8.7.1.. All indemnification
payments under this Article 8 shall be treated as adjustments to the Consideration for Tax purposes, except as otherwise provided
by Applicable Law.

 

Article
9

GENERAL PROVISIONS

 

Section 9.1.        
Assignment. This Agreement shall be binding upon
and inure to the benefit of and be enforceable by the respective heirs, legal representatives, successors and permitted assigns
of the parties hereto. No party hereto shall assign this Agreement or any right, benefit or obligation hereunder without the prior
written consent of each other party and any purported assignment without such consent will be void, provided, however
that (A) Purchaser shall be entitled to assign, in its sole discretion, any or all of its rights, interests and obligations hereunder
(i) to any Affiliate of Purchaser, or (ii) in connection with a sale of all or substantially all of the assets or capital stock
of Purchaser, and (B) following Closing, the Company shall be entitled to assign, in its sole discretion, any or all of its rights,
interests and obligations hereunder to Purchase or to any Affiliate of Purchaser.

 

 

 

 

 

    	 	42	 

     

    

 

Section 9.2.        
Notices. All notices, requests, demands, waivers,
consents, approvals, or other communications which are required or permitted hereunder shall be in writing and shall be delivered
personally, sent by reputable overnight courier service (such as Federal Express), sent by facsimile (with a copy mailed or sent
by courier service not later than the next Business Day), or sent by registered or certified mail, return receipt requested, postage
prepaid, to the addresses set forth below:

 

If to Purchaser:

 

Odyssey Group International, Inc.

2372 Morse Avenue

Irvine, CA 92614

Attention: Michael Redmond, Chief
Executive Officer

Email: michael@odysseygi.com

 

With a copy to:

 

Brinen
& Associates, LLC

90
Broad Street, Tenth Floor

New
York, New York 10004

Attn:Joshua
D. Brinen, Esq.

Telephone
(212) 330-8151

Facsimile
(212) 227-0201

Email:jbrinen@brinenlaw.com

 

If to the Company:

 

Prevacus, Inc.

1400 Village
Square Boulevard, Unit 3

Tallahassee,
FL 32312

Attention: Jacob VanLandingham

 

 

If to Dr. VanLandingham:

 

Jacob VanLandingham, Ph.D.

Prevacus, Inc.

1400 Village
Square Boulevard, Unit 3

Tallahassee,
FL 32312

850-544-2962

 

If to Mr. Lewandowski:

 

Michael Lewandowski

10191 Lake Grove Dr.

Odessa, FL 33556

727-692-6196

 

 

 

 

    	 	43	 

     

    

 

 

or to such other address or facsimile number
as the party entitled to receive such notice may, from time to time, specify in writing to the other party. Following Closing,
notices to the Company shall be sent to Purchaser at the address above (with copies to those listed to be copied with Purchaser).
Any such notice shall be deemed given when actually received by the Person to whom notice is being given personally, when receipt
is confirmed by telephone or answer-back of any notice given by facsimile, on the second day after dispatch by overnight courier
service promising next day delivery (or on the day after the scheduled delivery date if next day delivery is not scheduled) or
on the fifth day after mailing if sent postage prepaid by first class mail. In the event that any action or performance shall be
due hereunder on a Saturday, Sunday or any legal holiday observed in New York, New York, the time for such action or performance
shall be extended until the end of the next Business Day.

 

Section 9.3.        
Interpretation. Unless the context of this Agreement
clearly requires otherwise, (a) references to the plural include the singular, the singular the plural, the part the whole,
(b) references to any gender include all genders, (c) “or” has the inclusive meaning frequently identified
with the phrase “and/or,” (d) “including” has the inclusive meaning frequently identified with the
phrase “but not limited to,” and I references to “hereunder” or “herein” relate to this
Agreement. The section and other headings contained in this Agreement are for reference purposes only and shall not control or
affect the construction of this Agreement or the interpretation thereof in any respect. Section, subsection, schedule and exhibit
references are to this Agreement unless otherwise specified. Each accounting term used herein that is not specifically defined
herein shall have the meaning given to it under GAAP. Any matter noted or referenced on any Schedule to this Agreement shall be
deemed to be disclosed under each and every part, category or heading of that Schedule and all other Schedules, and shall be deemed
to qualify the representations and warranties of the Company in this Agreement, if (i) a cross reference to such other Schedule
to this Agreement is made, or (ii) it is reasonably apparent on its face and without any investigation that the disclosed matter,
document or item would relate to other representations or warranties or the matters covered thereby. References to Purchaser Common
Stock, Escrow Purchaser Shares, Closing Date Share Value and Release Date Share Value shall be automatically adjusted, if there
occurs a stock split, stock dividend, recapitalization, reclassification, split up, combination, exchange of shares, readjustment
or similar transaction with respect to the outstanding Purchaser Common Stock prior to the Closing Date (or a record date for any
such transaction occurs prior to the Closing Date).

 

Section 9.4.        
Severability. If any provision contained in this
Agreement or any part of any such provision is for any reason held to be invalid, illegal or unenforceable in any respect, such
invalidity, illegality or unenforceability shall not affect the remainder of such provision or any other provision, which shall
be given full effect, without regard to invalid provisions or the invalid portions thereof, as the case may be, and the parties
intend that any court having jurisdiction shall modify any such provision to the least extent necessary to render it enforceable
and, in its modified form, said provision shall then be enforceable.

 

Section 9.5.        
No Third-Party Beneficiaries. Except as contemplated
by Article 8 of this Agreement, this Agreement is for the sole benefit of the parties hereto, their successors and any permitted
assigns, and nothing herein, express or implied, is intended to or will confer upon any other Person any legal or equitable right,
benefit or remedy of any nature whatsoever under or by reason of this Agreement.

 

Section 9.6.        
Expenses. The parties hereto shall pay their
own expenses incidental to the preparation of this Agreement, the carrying out of the provisions of this Agreement and the Contemplated
Transactions, whether or not the Contemplated Transactions are consummated.

 

Section 9.7.        
Amendment; Waiver. This Agreement may not be
amended or modified except by an instrument in writing duly executed by each of the parties hereto. Any term or provision of this
Agreement may be waived at any time (whether before or after Company Stockholder Approval has been obtained) by the party entitled
to the benefit thereof by a written instrument duly executed by such party. Any waiver so granted will not be construed as a waiver
of any subsequent breach or waiver of the same term or condition, or a waiver of any other term or condition of this Agreement.

 

 

 

 

    	 	44	 

     

    

 

Section 9.8.        
Governing Law.

 

Section 9.8.1This
Agreement and any claims arising out of relating to this Agreement, whether in contract or tort, statutory or common law, shall
be governed exclusively by, and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts
of laws.

 

Section 9.8.2Forum
Selection and Consent to Jurisdiction. ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT,
SHALL BE BROUGHT AND MAINTAINED EXCLUSIVELY IN THE COURTS OF THE STATE OF NEVADA OR IN THE UNITED STATES DISTRICT COURT FOR THE
DISTRICT OF NEVADA; PROVIDED THAT ANY SUIT SEEKING ENFORCEMENT AGAINST ANY COLLATERAL OR OTHER PROPERTY MAY BE BROUGHT, AT THE
LENDER’S OPTION, IN THE COURTS OF ANY JURISDICTION WHERE SUCH COLLATERAL OR OTHER PROPERTY MAY BE FOUND. THE PARTIES AND
THE ADDITIONAL PARTIES HEREBY EXPRESSLY AND IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH THEY
MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH LITIGATION BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM
THAT ANY SUCH LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

Section 9.8.3Waiver
of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, THE PARTIES OR THE ADDITIONAL PARTIES HERETO
HEREBY WAIVE, AND COVENANT THAT THEY WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY
IN ANY ACTION ARISING IN WHOLE OR IN PART UNDER OR IN CONNECTION WITH THIS AGREEMENT, ANY ANCILLARY DOCUMENT, THE PURCHASE AND
SALE OR THE NEGOTIATION, TERMS OR PERFORMANCE HEREOF OR THEREOF, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING
IN CONTRACT, TORT OR OTHERWISE. THE PARTIES HERETO AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS PARAGRAPH WITH ANY COURT AS
WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES HERETO. THE PARTIES HERETO FURTHER AGREE
TO IRREVOCABLY WAIVE THEIR RIGHT TO A TRIAL BY JURY IN ANY PROCEEDING AND ANY SUCH PROCEEDING WILL INSTEAD BE TRIED IN A COURT
OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY.

 

Section 9.8.4Service of Process: Each party and the Additional
Parties hereto hereby consents to service of process in any action between any of the Parties or the Additional Parties hereto
arising in whole or in part under or in connection with this Agreement, any document related to, or the negotiation, terms or
performance hereof or thereof, (a) in any manner permitted by Nevada law or (b) by overnight delivery by a nationally recognized
courier service at the respective address specified in this Agreement, and waives and agrees not to assert (by way of motion,
as a defense or otherwise) in any such Action any claim that service of process made in accordance with clause (a) or (b) does
not constitute good and valid service of process.

 

Section 9.9.        
Counterparts. This Agreement may be executed
in two or more counterparts and by facsimile or PDF (or other electronic transmission), each of which shall be binding as of the
date first written above, and all of which shall constitute one and the same instrument. Each such copy shall be deemed an original,
and it shall not be necessary in making proof of this Agreement to produce or account for more than one such counterpart.

 

Section 9.10.    
Construction of Agreement. This Agreement has
been negotiated by Purchaser, on the one hand, and the Additional Parties and the Company, on the other hand, all of which have
legal counsel, and the parties hereto waive the application of any law, regulation, holding or rule of construction providing that
ambiguities in an agreement, certificate or document will be construed against the party drafting such agreement, certificate or
document.

 

Section 9.11.    
Entire Agreement. This Agreement, the Exhibits
and the Schedules hereto constitute the entire agreement of the parties hereto with respect to the subject matter hereof and supersede
all prior agreements and undertakings with respect to the subject matter hereof, both written and oral.

 

 

 

 

    	 	45	 

     

    

 

Section 9.12.    
Calculation of Time. Except as specified herein,
all periods of time shall include all days that are not Business Days including Saturday, Sundays and days on which banks are required
or authorized by law to be closed in Los Angeles, California; provided that, if the last day to perform any act or give notice
falls on a day which is not a Business Day, then such act or notice shall be timely performed if given on the next succeeding Business
Day.

 

Section 9.13.    
Expenses, Costs, Attorneys’ Fees. Should
any litigation be commenced concerning, in connection with or relating to this Agreement, the sale and purchase of the Business,
the Contemplated Transactions or the rights and duties of any party with respect to any of them, except as otherwise expressly
contemplated herein, each party shall bear its own expenses, costs and attorneys’ fees incurred in connection with such litigation.

 

Section 9.14.    
Specific Performance. Each of the parties hereto
hereby acknowledges and agrees that the other parties may be damaged irreparably in the event that any of the material provisions
of this Agreement are not substantially performed in accordance with their specific terms or are otherwise breached. Accordingly,
each of the parties hereto hereby agrees that the other parties shall be entitled to an injunction or injunctions to prevent breaches
of the material provisions of this Agreement and to enforce specifically this Agreement and the terms and provisions hereof in
any action instituted in addition to any other remedy to which they may be entitled pursuant hereto.

 

[remainder of page intentionally blank;
signature pages to follow]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	46	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Asset Purchase Agreement on the date first above written.

 

 

 

	 	 	PURCHASER:
	 	 	 
	 	 	Odyssey Group International,
Inc.
	 	 	 
	 	By:	_______________________________
	 	 	Name:
	 	 	Title:
	 	 	 
	 	 	COMPANY:
	 	 	 
	 	 	PREVACUS, INC.
	 	 	 
	 	By:	_______________________________
	 	 	Name:
	 	 	Title
	 	 	 
	 	 	 
	 	 	ADDITIONAL PARTIES:
	 	 	 
	 	 	_______________________________
	 	 	Michael Lewandowski
	 	 	 
	 	 	 
	 	 	_______________________________
	 	 	Jacob VanLandingham, Ph.D.
	 	 	 
	 	 	 

 

 

 

[Signature Page to Asset Purchase
Agreement]

 

    	 	47	 

     

    

 

Exhibits

 

Exhibit ADefined Terms

 

Exhibit BRevived US Patents

 

Exhibit CRevived Foreign Patents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	48	 

     

    

 

Exhibit
A

 

Defined
Terms

 

The following terms shall
have the meanings as ascribed to them or referenced below (such terms shall be equally applicable to both the singular and plural
forms of the terms defined):

 

“Acquired
Accounts Receivable” shall have the meaning set forth in Section 1.1.1.

 

“Acquisition
Proposal” shall have the meaning set forth in Section 6.3.

 

“Affiliate”
means, with respect to a particular party, any Person controlling, controlled by or under common control with that party, as well
as any officers, directors and majority-owned entities of that party and of its other Affiliates. For the purposes of the foregoing,
ownership, directly or indirectly, of greater than 25% or more of the voting stock or other equity interest shall be deemed to
constitute control.

 

“Allocation
Statement” shall have the meaning set forth in Section 2.8.

 

“Amex Lien”
shall have the meaning set forth in Section 1.4.11.

 

“Anti-Corruption
Laws” shall have the meaning set forth in Section 4.36.3.

 

“Anti-Terrorism
Laws” shall have the meaning set forth in Section 4.35.1.

 

“Applicable
Law(s)” means all foreign, federal, state, local, municipal or other statutes, laws, codes, ordinances, regulations,
rules and other provisions having the force or effect of law, and all judicial and administrative orders, writs, injunctions, awards,
judgments, decrees and determinations, applicable to a specified Person or to such Person’s assets, properties or business,
including all Health Laws.

 

“Assigned
Contracts” shall have the meaning set forth in Section 1.1.3.

 

“Assignment
and Assumption Agreement” shall have the meaning set forth in Section 3.2.2

 

“Assumed
Liabilities” shall have the meaning set forth in Section 1.1.3.

 

“Bankruptcy
and Equity Exceptions” shall have the meaning set forth in Section 4.3.1.

 

“Business”
shall have the meaning set forth in the Background.

 

“Business
Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law to
be closed in New York, New York.

 

“Business
Employees” shall have the meaning set forth in Section 4.15.1.

 

“Cash”
means cash in the bank less any outstanding checks to the extent that the amounts to be paid by such checks have reduced accounts
payable, plus (i) deposits in transit to the extent there has been a reduction of receivables on account thereof, (ii) any
held checks to the extent that the amounts to be paid by such checks have been included in accounts payable and (iii) petty
cash.

 

“Cash Equivalents”
means marketable direct obligations or securities issued by, or guaranteed by, the United States government (or any agency thereof),
any state, commonwealth or territory of the United States (or any agency, political subdivision or taxing authority thereof) or
by any foreign government, certificates of deposit, time deposits, eurodollar time deposits or overnight bank deposits, commercial
paper, securities backed by standby letters of credit issued by any commercial bank, money market or similar funds, in each case,
with maturities of one year or less from the date of acquisition.

 

 

 

 

    	 	A-1	 

     

    

 

“CERCLA”
shall have the meaning set forth in the below definition for “Environmental Law”.

 

“Change of
Control” means the occurrence of any of the following, in one transaction or a series of related transactions: (i) the
sale, transfer, assignment or other disposition (including by merger or consolidation) of more than 50% of the voting power represented
by the then outstanding equity securities of Purchaser, (ii) the sale or other disposition of all or substantially all the
assets of Purchaser, or (iii) the liquidation or dissolution of Purchaser.

 

“Charter Documents”
means an entity’s certificate or articles of incorporation or formation, bylaws, certificate defining the rights and preferences
of securities, articles of organization, general or limited partnership agreement, operating agreement, certificate of limited
partnership, joint venture agreement or similar document(s) governing the entity along with any and all amendments, exhibits, schedules
and appendices to any of the foregoing.

 

“Claim”
means any and all manner of actions, cause and causes of action, suits, debts, sums of money, accounts, reckonings, bonds, controversies,
Damages, judgments, executions, losses, expenses, claims, and demands.

 

“Closing”
shall have the meaning set forth in Article 3.

 

“Closing Date”
shall have the meaning set forth in Article 3.

 

“Closing Date
Share Value” means the average of the closing price of the Parent Common Stock reported by the OTCQB market for the ten
trading days immediately prior to the Closing Date.

 

“Closing Share
Consideration” shall have the meaning set forth in Section 2.1.1.

 

“COBRA”
means the Consolidated Omnibus Budget Reconciliation Act of 1985.

 

“Code”
means the Internal Revenue Code of 1986, as amended, and the rules and regulations thereunder. Any reference to the Code shall
automatically include a reference to any subsequent or successor internal revenue code or law.

 

“Company’s
Knowledge” or “Knowledge of the Company” or any reference as to whether the Company “knows”
or has “knowledge” of a given fact, circumstance or condition means the actual knowledge of any of Michael Lewandowski,
Jacob VanLandingham, Ph.D., and any other director or officer of the Company and the knowledge such Persons would have had after
reasonable inquiry.

 

“Company FDA
Transfer Letters” shall mean the letters from the Company to the FDA, duly executed by the Company (and any Affiliate
of the Company, as applicable), notifying the FDA of the transfer of the rights to the Transferred Governmental Authorizations
to Purchaser.

 

“Company Restrictive
Covenant Agreement” shall have the meaning set forth in Section 3.2.12.

 

“Company Stockholders”
means, collectively, the holders of the Company’s capital stock.

 

“Company Stockholder
Approval” shall have the meaning set forth in Section 4.3.3.

 

 

 

 

 

    	 	A-2	 

     

    

 

“Computer
Software” means all computer software (including source and object code), owned or licensed, whether for general business
usage (e.g., accounting, word processing, graphics, spreadsheet analysis, etc.) or specific, unique-to-the-business usage
(e.g., order processing, manufacturing, process control, design, shipping, etc.), all computer operating security or programming
software, owned or licensed, and all documentation relating to any of the foregoing, excluding COTS Software.

 

“Confidential
Information” shall have the meaning set forth in Section 6.9.1.

 

“Consideration”
means the Closing Share Consideration, plus the Milestone Consideration, if any, plus the Escrow Purchaser Shares, as adjusted
after Closing in accordance with this Agreement.

 

“Contemplated
Transactions” means the sale and purchase of the Purchased Assets and the Assumed Liabilities hereunder and the transactions
ancillary thereto.

 

“Contemplated
Transactions” shall have the meaning set forth in Section 1.5.2.

 

“Contract”
means any written or oral contract, agreement, understanding, License, lease, plan, instrument or other document, commitment, obligation,
arrangement, undertaking, practice or authorization that is or may be binding on any Person or its property under Applicable Laws.

 

“Control”
means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a
Person, whether through the ownership of voting securities or general partnership or managing member interests, by contract or
otherwise. Without limiting the generality of the foregoing, a Person shall be deemed to Control any other Person in which it owns,
directly or indirectly, a majority of the ownership interests.

 

“Copyrights”
means rights arising from or in respect to copyrights and copyrightable works (whether registered or unregistered), applications
and renewals for registration thereof, mask works and registrations and applications for registration or renewals thereof, including
copies and tangible embodiments (in whatever form or medium) thereof whether protected, created or arising under the laws of the
United States or any other jurisdiction.

 

“COTS Software”
means software that is readily obtainable by the Company under “shrink wrap,” “click wrap” other “click
through” or standard form licensing agreement without material cost or expense.

 

“Court Order”
means any judgment, writ, decree, injunction, order, award or ruling of any Governmental Authority or other authority that is binding
on any Person or its property under any Applicable Laws.

 

“Customer
Contracts” means all Contracts which provide for the sale or supply of products and/or the performance of services by
the Company relating to the Business; provided, however, that the term Customer Contracts shall also include all
purchase orders (or series of purchase orders with the same customer) pursuant to which (i) the Company has any outstanding obligations,
and (ii) the Company has received or will receive consideration.

 

“Damages”
means any and all losses, Liabilities, obligations, costs, expenses, damages or judgments of any kind or nature whatsoever (including
but not limited to reasonable attorneys’, accountants’, and experts’ fees, disbursements, and other costs and
expenses actually incurred in pursuing or defending Claims).

 

“DEA”
shall mean the United States Drug Enforcement Agency.

 

 

 

 

 

 

    	 	A-3	 

     

    

 

“Default”
means (i) a breach, default or violation, (ii) the occurrence of an event that with or without the passage of time or
the giving of notice, or both, would constitute a breach, default or violation or (iii) with respect to any Contract, the
occurrence of an event that with or without the passage of time or the giving of notice, or both, would give rise to a right of
termination, renegotiation or acceleration.

 

“Delivery
Device” means the device the Company is developing to deliver PRV-001 and PRV-002.

 

“Employee
Plan” means (i) any “employee benefit plan” (as such term is defined in Section 3(3) of ERISA) and (ii) any
other pension, retirement, supplemental retirement, deferred compensation, excess benefit, profit sharing, bonus, incentive, stock
purchase, stock ownership, stock option, stock appreciation right, profits interest, employment, severance, salary continuation,
termination, change of control, health, life, disability, group insurance, vacation, holiday and fringe benefit plan, program,
contract, or arrangement maintained, contributed to, or required to be contributed to, by the Company or any ERISA Affiliate for
the benefit of any current or former employee, director, officer or independent contractor of the Company or under which the Company
or any ERISA Affiliate has or could incur Liability (contingent or otherwise).

 

“Encumbrance”
means any pledge, lien (including but not limited to liens for Taxes), collateral assignment, security interest, mortgage, title
retention, conditional sale or other security arrangement, or any charge, adverse claim of title, ownership or right to use, or
any other encumbrance of any kind whatsoever, including but not limited to any restriction on (i) the voting of any security,
(ii) the transfer of any security or other asset, (iii) the receipt of any income derived from any asset, (iv) the
use of any asset, and (v) the possession, exercise or transfer of any other attribute of ownership of any asset.

 

“Environmental
Claims” means any and all administrative or judicial actions, suits, orders, claims, liens, notices, investigations,
violations or proceedings related to any applicable Environmental Law or any Environmental Permit brought, issued or asserted by
a Governmental Authority or Third Party for compliance, Damages (including natural resource damages), penalties, removal, response,
remedial or other action pursuant to any applicable Environmental Law or for personal injury or property damage resulting from
the release of a Hazardous Material at, to or from any facility or property of the Company or any facility or property at which
the Company disposed or arranged for the disposal or treatment (with a transporter or otherwise) of Hazardous Materials, including
but not limited to the employees of the Company seeking damages for exposure to Hazardous Materials.

 

“Environmental
Law” means any federal, state or local statute, law, rule, regulation, ordinance, code, or common law in effect and in
each case as amended as of the date hereof and the Closing Date, relating to (i) the protection of the environment or natural
resources, (ii) human health and safety, including but not limited to the Occupational Safety and Health Act of 1970, as amended,
29 U.S.C. § 651 et seq., or (iii) the handling, use, recycle, generation, treatment, storage, transportation or disposal
of Hazardous Materials, including but not limited to the Comprehensive Environmental Response, Compensation and Liability Act of
1980, as amended, 42 U.S.C. § 9601 et seq. (“CERCLA”); the Resource Conservation and Recovery Act, as amended,
42 U.S.C. § 6901 et seq.; the Federal Water Pollution Control Act, as amended, 33 U.S.C. § 1251 et seq.; the Toxic Substances
Control Act, 15 U.S.C. § 2601 et seq.; the Clean Air Act, 42 U.S.C. § 7401 et seq.; and the Safe Drinking Water Act,
42 U.S.C. § 3808 et seq.

 

“Environmental
Permit” means any permit, License, approval, authorization or consent required by any Governmental Authority under any
applicable Environmental Law and includes any and all orders, consent orders or binding agreements issued or entered into by a
governmental authority under any applicable Environmental Law.

 

“ERISA”
means the Employee Retirement Income Security Act of 1974, as amended.

 

 

 

 

 

    	 	A-4	 

     

    

 

“ERISA Affiliate”
means any corporation or trade or business (whether or not incorporated) which is treated with the Company as a single employer
within the meaning of Section 414 of the Code.

 

“Escrow Account”
shall have the meaning set forth in Section 2.3.

 

“Escrow Agent”
means Empire Stock Transfer Inc., a Nevada corporation.

 

“Escrow Agreement”
shall have the meaning set forth in Section 2.3.

 

“Escrow Purchaser
Shares” means 700,000 shares of Purchaser Common Stock.

 

“Escrow Termination
Date” means the date that is 1 year following the Closing Date.

 

“Exchange
Act” shall have the meaning set forth in Section 5.6.

 

“Excluded
Assets” shall have the meaning set forth in Section 1.2.

 

“Excluded
Employee Liabilities” shall have the meaning set forth in Section 6.5.2.

 

“Excluded
Contracts” shall have the meaning set forth in Section 1.2.2.

 

“Excluded
Liabilities” shall have the meaning set forth in Section 1.4.

 

“Executive
Order” shall have the meaning set forth in Section 4.35.1.

 

“Financial
Statements” means, collectively, the Year-End Financial Statements and the Interim Financial Statements.

 

“FDA”
means the United States Food and Drug Administration, or a successor agency in the United States with responsibilities comparable
to those of the United States Food and Drug Administration.

 

“Form S-8”
shall have the meaning set forth in Section 6.21.

 

“GAAP”
means generally accepted accounting principles in the United States, applied on a consistent basis with that applied in, and utilizing
the same accounting methods, policies, practices and procedures, with consistent classifications, judgments and estimation methodology
used in, the preparation of the audited Financial Statements.

 

“General Survival
Date” shall have the meaning set forth in Section 8.1.

 

“Governmental
Authority” any foreign, federal, state, local or other court or governmental agency, body or commission, or any other
regulatory or governmental authority.

 

“Government
Official” shall have the meaning set forth in Section 4.36.3.

 

“Hazardous
Material” means any hazardous, toxic or radioactive substance, material or waste which is regulated as of the Closing
Date by any state or local governmental authority or the United States of America, including but not limited to any material or
substance that is: (A) defined as a “hazardous substance”, “regulated substance” or “solid waste”
under applicable state law, (B) petroleum, petroleum products or waste oil, (C) asbestos, (D) designated as a “hazardous
substance” pursuant to section 311 of the Federal Water Pollution Control Act, as amended, 33 U.S.C. § 1251 et seq.
(33 U.S.C. § 1321), (E) defined as a “hazardous waste” pursuant to section 1004 of the Resource Conservation and
Recovery Act, as amended, 42 U.S.C. § 6901 et seq. (42 U.S.C. § 6903), (F) defined as a “hazardous substance”
pursuant to section 101 of the CERCLA, (G) defined as a “regulated substance” pursuant to section 9001 of the Resource
Conservation and Recovery Act, as amended, 42 U.S.C. § 6901 et seq. (42 U.S.C. § 6991) or (H) otherwise regulated
under the Toxic Substances Control Act, as amended, 15 U.S.C. § 2601 et seq., the Clean Air Act, as amended, 42 U.S.C.
§ 7401 et seq., the Hazardous Materials Transportation Act, as amended, 49 U.S.C. § 1801 et seq., or the
Federal Insecticide, Fungicide and Rodenticide Act, as amended, 7 U.S.C. § 136 et seq., the Emergency Planning and
Community Right-to-Know Act, as amended, 42 U.S.C. § 11001 et seq., the Safe Drinking Water Act, as amended, 42 U.S.C.
§ 300(f) et seq., and the Occupational Safety and Health Act, as amended, 29 U.S.C. § 651 et seq.

 

 

 

    	 	A-5	 

     

    

 

“Health Laws”
shall mean any Law relating to healthcare, including, as amended from time to time, any such Law pertaining to: (i) the research,
development, testing, production, manufacture, transfer, distribution, approval, labeling, marketing, pricing, third party reimbursement
or sale of drugs, biological products and medical devices, including the United States Food, Drug, and Cosmetic Act and the United
States Public Health Service Act; (ii) any federal health care program (as such term is defined in 42 U.S.C. § 1320a-7b(f)),
including those pertaining to providers of goods or services that are paid for by any federal health care program (as such term
is defined in 42 U.S.C. § 1320a-7b(f)), including the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)), the civil
False Claims Act (31 U.S.C. § 3729 et seq.), the administrative False Claims Law (42 U.S.C. § 1320a-7b(a)), Sections
1320a-7 and 1320a-7a of Title 42 of the United States Code, Medicare (Title XVIII of the Social Security Act) and Medicaid (Title
XIX of the Social Security Act); (iii) transparency reports and reporting of certain financial relationships with health care providers,
including the Physician Payment Sunshine Act (42 U.S.C. § 1320a-7h); (iv) any federal health care offenses (as such term is
defined in 18 U.S.C. § 24(a)), and violations of, or conspiracies to violate 18 U.S.C. §§ 287, 371, 664, 666,
669, 1001, 1027, 1035, 1341, 1347, 1343, 1518 and 1954; (v) the privacy and security of patient-identifying health care information,
including the Health Insurance Portability and Accountability Act (42 U.S.C. § 1320d et seq.), as amended by the Health Information
Technology for Economic and Clinical Health Act; (vi) the Comprehensive Drug Abuse Prevention and Control Act of 1970 and any amendments
thereto; (vii) The Controlled Substances Act and any amendments thereto; and (viii) all related rules and regulations of each of
(i) through (vii), and equivalent applicable Laws of other Governmental Authorities.

 

“Incentive
Plan” shall have the meaning set forth in Section 6.21.

 

“IND”
means an Investigational New Drug Application as defined in the FDC Act or United States Public Health Services Act, as each may
be amended from time to time, or any rules, regulations and requirements promulgated thereunder (including all additions, supplements,
extensions, and modifications thereto) or any similar foreign application.

 

“Indebtedness”
means, in relation to the Company the aggregate amount of its borrowings and other financial indebtedness in the nature of borrowings
as of the Closing Date including but not limited to: (i) all obligations for borrowed money, (ii) all obligations evidenced by
bonds, debentures, notes or similar instruments or debt Securities and warrants or other rights to acquire any such instruments
or Securities, (iii) all obligations under conditional sale or other title retention agreements relating to property or assets
of the Company, (iv) all indebtedness secured by any mortgage, lien, pledge, or other Encumbrance on property owned or acquired,
whether or not the obligations secured thereby have been assumed, (v) all lease obligations which are required to be capitalized
in accordance with GAAP, (vi) all obligations issued or assumed as the deferred or contingent purchase price of property or services
(excluding ordinary course trade obligations to creditors for raw materials, inventory and supplies), (vii) all obligations under
interest rates, currency, swap or other hedging transactions (valued at the termination value thereof, assuming termination on
the Closing Date), (viii) all drawn letters of credit issued for the account of the Company, (ix) all obligations secured by (or
for which the holder of such indebtedness has an existing right, contingent or otherwise, to be secured by) any Encumbrance on
property owned or acquired, (x) all obligations arising from cash/book overdrafts or in connection with any guarantee by the Company
or any Additional Party, (xi) payables associated with capital investments, (xii) all trade payables aged greater than ninety (90)
calendar days; and (xiii) all accrued and unpaid interest, fees, expenses, breakage costs, premiums and other amounts payable or
obligations on any of the foregoing items.

 

“Indemnified
Parties” shall mean, as applicable, the Purchaser Indemnified Parties and the Company Indemnified Parties.

 

“Indemnifying
Party” shall have the meaning set forth in Section 8.4.1.

 

“Indemnifying
Party Representative” shall have the meaning set forth in Section 8.4.1.

 

“Indemnity
Cancelled Purchaser Stock” shall have the meaning set forth in Section 8.4.1.

 

“Independent
Contractors” shall have the meaning set forth in Section 4.15.1.

 

 

 

 

    	 	A-6	 

     

    

 

“Intellectual
Property” means collectively, all U.S. and foreign Copyrights, Patents, Trademarks, Intellectual Property Licenses, Software,
computer systems and related proprietary documentation, Trade Secrets and all other proprietary information and similar intangible
rights.

 

“Intellectual
Property Assets” means all Intellectual Property that is owned by the Company and used in or necessary for
the conduct of the Business as currently conducted.

 

“Intellectual
Property Assignments” shall have the meaning set forth in Section 3.2.3

 

“Intellectual
Property Licenses” means any Contracts by which the Company (i) receives any right to use or receive
benefit from a third party’s Intellectual Property; (ii) grants a third party the right to use the Company’s Intellectual
Property; or (iii) receives any royalty or other consideration in exchange for the grant of any right in the Company’s
Intellectual Property.

 

“Interim Balance
Sheet Date” means [June 30, 2020].

 

“Interim Balance
Sheet” means the unaudited balance sheet of the Company as of the Interim Balance Sheet Date.

 

“Interim Financial
Statements” means, collectively, the Interim Balance Sheet and the unaudited statements of operations and statement of
cash flows of the Company for the six-month period ended on the Interim Balance Sheet Date.

 

“Interim Period”
shall have the meaning set forth in Section 6.11.

 

“Inventory” shall
have the meaning set forth in Section 1.1.2.

 

“IRS”
means the Internal Revenue Service.

 

“Key Accounts”
shall have the meaning set forth in Section 4.19.

 

“Lewandowski
Agreement” shall have the meaning set forth in Section 3.3.2.

 

“Lewandowski
Restricted Stock Agreement” shall have the meaning set forth in Section 3.3.2.

 

“Liability”
means any liability, Indebtedness, obligation, expense, claim, loss, damage, deficiency, guaranty or endorsement of or by any Person,
whether accrued or unaccrued, absolute or contingent, direct or indirect, matured or unmatured, determined or determinable, known
or unknown, due or to become due, liquidated or unliquidated, including but not limited to those arising under any law, action
or governmental order and those arising under any Contract, agreement, arrangement, commitment or undertaking.

 

“Licenses”
means any Permits, licenses, franchises, registrations, certificates, variances, exemptions, consents, approvals, clearances and
other authorizations granted by any Governmental Authority.

 

“Litigation”
means any action, suit, arbitration, mediation, administrative or other proceeding, criminal prosecution, claim or governmental
investigation or inquiry.

 

 

 

 

    	 	A-7	 

     

    

 

“Master Agreement
for a Joint Venture” shall have the meaning set forth in the Background.

 

“Material
Adverse Effect” means any change or effect that is, or is reasonably likely to be, materially adverse to the Business,
the Company, or the operations, properties, assets, prospects, liabilities, financial conditions, results of operations, or cash
flow, of the Company, or the Company’s ability to consummate the Contemplated Transactions.

 

“Material
Contract(s)” shall have the meaning set forth in Section 4.11.1.

 

“Multiemployer
Plan” shall have the meaning set forth in Section 4.15.9.

 

“NDA”
means a New Drug Application or a Biologics License Application, as applicable, as defined in the FDC Act or United States Public
Health Services Act, as each may be amended from time to time, or any rules, regulations and requirements promulgated thereunder
(including all additions, supplements, extensions, and modifications thereto) or any similar foreign application.

 

“Non-Dilutive
Financing” means any financing or offering of securities by Purchaser that (i) does not involve the issuance, grant,
sale or conveyance of equity securities of Purchaser or securities or other instruments convertible, exchangeable or exercisable
into equity securities of the Purchaser and (ii) the proceeds of which shall be used exclusively for the development of PRV-001
or PRV-002.

 

“OFAC”
shall have the meaning set forth in Section 4.35.2.

 

“Patents”
means rights arising from or in respect to all national, regional and international patents and patent applications, including
provisionals, divisions, continuations, continuations-in-part, additions, re-issues, renewals, extensions, substitutions, re-examinations
or restorations, registrations and revalidations, and supplementary protection certificates and equivalents to any of the foregoing
as well as any patent disclosures and inventions, draft patent applications and foreign versions of the foregoing whether protected,
created or arising under the laws of the United States or any other jurisdiction.

 

“Permit”
means, with respect to any Person, any License, permit (including, any Environmental Permit), authorization, approval, clearance,
certificates of authority, registration, franchise, right, Order, qualification, variance (including zoning variances), easement,
rights-of-way or similar consent or certificate granted or issued to such Person.

 

“Permitted
Encumbrances” means (i) liens for Taxes, assessments or similar charges to the extent not yet due and payable; and
(ii) liens of mechanics, materialmen, warehousemen, carriers, or other like liens securing obligations incurred in the ordinary
course of the Business.

 

“Person”
means any natural person, partnership, corporation, limited-liability company, proprietorship, association, joint venture, trust,
unincorporated organization or other legal entity.

 

“Phase I Clinical
Trial” means a clinical trial of any pharmaceutical product, the principal purpose of which is a preliminary determination
of safety, tolerability, pharmacological activity or pharmacokinetics in healthy individuals or patients or similar clinical study
prescribed by a Governmental Authority, including all tests and studies that are required by the FDA from time to time, pursuant
to law or otherwise, including the trials referred to in 21 C.F.R. §312.21(a), as amended.

 

“Phase Ib
Clinical Trial” means a Phase I clinical trial of any pharmaceutical product, the principal purpose of which is to determine
the optimal safe dose through dose escalation.

 

 

 

 

    	 	A-8	 

     

    

 

“Phase II
Clinical Trial” means a clinical trial of any pharmaceutical product, the principal purpose of which is a determination
of safety and efficacy in the target patient population, which is prospectively designed to generate sufficient data that may permit
commencement of pivotal clinical trials, or a similar clinical study prescribed by a Governmental Authority, from time to time,
pursuant to Applicable Law or otherwise, including all tests and studies that are required by the FDA from time to time, pursuant
to law or otherwise, including the trials referred to in 21 C.F.R. §312.21(b), as amended.

 

“Phase III
Clinical Trial” means a human clinical trial of a product in an indicated patient population that is designed to establish
that such product is safe and efficacious for its intended use and to provide adequate data and information for inclusion in product
labeling, which trial is intended to support marketing approval of such product, including all tests and studies that are required
by the FDA from time to time, pursuant to law or otherwise, including the trials referred to in 21 C.F.R. §312.21(c), as amended.

 

“Privacy Laws”
shall have the meaning set forth in Section 4.10.4.

 

“Privacy Policies”
shall have the meaning set forth in Section 4.10.4.

 

“Property”
shall have the meaning set forth in Section 4.6.

 

“Proprietary
Information” means at any date, any information of a Person, that is not already generally available to the public (unless
such information has entered the public domain and become available to the public through fault on the part of the Party to be
charged hereunder), which constitute trade secrets, personally identifiable financial information, or personal health information
under governing law, including: (i) financial information, including information set forth in internal records, files and ledgers,
or incorporated in profit and loss statements, fiscal reports and business plans; (ii) all financial data, pricing terms, information
memoranda and due diligence reports relating thereto; (iii) technology and ecommerce strategies, business plans and implementations,
inventions, algorithms, computer hardware, software and applications (including but not limited to any Computer Software); (iv)
all internal memoranda and other office records, including electronic and data processing files and records; (v) regulatory data
packages including pediatric data package exclusivity extensions or the like; and (vi) any other information constituting a trade
secret under the governing trade secrets law.

 

“PRV-001”
means the enantiomer or mirror image of the neurosteroid Progesterone.

 

“PRV-001 Program”
means the Company’s study of PRV-001 [seeking to improve function and lifespan in pediatric disorders where de-myelination
and cell death is widespread in the cortex and cerebellum regions of the brain].

 

“PRV-002”
means the enantiomer or mirror image of the neurosteroid 19-Norprogesterone.

 

“PRV-002 Program”
means the Company’s study of PRV-002 [for use in the neurology market].

 

“Purchaser
Common Stock” means Purchaser’s common stock, par value $0.001 per share.

 

“Purchaser
FDA Transfer Letters” shall mean the letters from Purchaser to the FDA, duly executed by Purchaser, notifying the FDA
of the transfer of the rights to the Transferred Governmental Authorizations to Purchaser.

 

“Purchaser
Indemnified Party” shall have the meaning set forth in Section 8.2.

 

“Purchaser
SEC Documents” shall have the meaning set forth in Section 5.6.

 

“Purchased
Assets” shall have the meaning set forth in Section 1.1.

 

 

 

 

    	 	A-9	 

     

    

 

“Real Property”
means all real property owned, leased or occupied by the Company or any of its Subsidiaries, together with all buildings, improvements
and fixtures located thereon.

 

“Registered
Intellectual Property” means Patents, patent rights, registrations for and applications to register, Trademarks, domain
names, and Copyrights.

 

“Regulatory
Information” shall mean (a) all correspondence and submissions between the Company and any Governmental Authority, including
the FDA and the DEA, with respect to the Transferred Governmental Authorizations, including any reports, filings, or notices submitted
to any Governmental Authority to support, maintain or obtain such Transferred Governmental Authorizations; and (b) records and
data from all clinical and pre-clinical studies and trials and any other tests or research conducted or being conducted by or on
behalf of the Company and are (i) described or referenced in the Governmental Authorizations, (ii) the subject of a post-marketing
requirement as imposed by the FDA or the subject of a post-marketing commitment to the FDA, or (iii) listed on Schedule A;
in each case of (a) and (b) to the extent not already in the possession or control of Purchaser. For the avoidance of doubt, Regulatory
Information shall include a complete copy of applicable NDAs, INDs, 510(k) or pre-market approval applications.

 

“Related Party
Agreements” means Contracts of the Company with (i) any Additional Party, present or former director, officer, stockholder,
equity holder, employee of the Company or Affiliate of any of the foregoing, and (ii) any financial advisors or consultants that
requires the payment or incurrence of Liabilities of more than $5,000 annually, or under which there are remaining obligations
of either party after the Closing Date, including but not limited to indemnification agreements and any financial advisory, oversight
or similar agreement.

 

“Release”
shall have the meaning set forth in Section 3.3.1.

 

“Release Date
Share Value” means the average of the closing price of the Purchaser Common Stock reported by the OTCQB market for the
ten trading days immediately prior to fifth trading day prior to a particular date on which Escrow Purchaser Shares are to be released
to the Company or returned to Purchaser and deemed cancelled pursuant to this Agreement.

 

“Relevant
Group” shall mean any affiliated, combined, consolidated, unitary or similar group of which the Company is or was a member.

 

“Required
Consent(s)” shall have the meaning set forth in Section 4.4.

 

“Restrictive
Covenants” shall have the meaning set forth in Section 6.9.2.

 

“Revised Statements”
shall have the meaning set forth in Section 2.8.

 

“Sarbanes-Oxley
Act” shall have the meaning set forth in Section 5.6.

 

“Schedule” means
the Disclosure Schedules delivered by the Company and Purchaser concurrently with the execution and delivery of this Agreement.

 

“SEC”
means the Securities and Exchange Commission.

 

“Securities”
means, with respect to a Person that is an entity, any shares of capital stock, options, warrants, notes, bonds or other equity
or debt securities of such Person which have ever been offered or sold by such Person.

 

 

 

 

    	 	A-10	 

     

    

 

“Securities
Act” means the Securities Act of 1933, as amended (including the rules and regulations promulgated thereunder).

 

“Share Exchange
Agreement” shall have the meaning set forth in the Background.

 

“Software”
means any and all computer software and code, including but not limited to assemblers, applets, compilers, objects, source code,
object code, data (including but not limited to image and sound data), design tools and user interfaces, in any form or format,
however fixed. Software includes source code listings, programmer’s notes, documentation and any and all other material related
to the Software.

 

“Subsidiary”
means a corporation or other entity of which 50% or more of the voting power or value of the equity securities is owned, directly
or indirectly, by the Company.

 

“Survival
Date” shall have the meaning set forth in Section 8.1.

 

“Tangible
Personal Property” shall have the meaning set forth in Section 1.1.5.

 

“Tax”
or “Taxes” means (i) all foreign, federal, state, local, municipal and other taxes, duties, charges, fees,
contributions, levies or other assessments, including but not limited to income, alternative, add-on minimum income, gross receipts,
gains, estimated, franchise, excise, personal property, real estate, property transfer, sales, use, employment, social security,
unemployment , insurance, disability, workers compensation license, lease, payroll, service, ad valorem, documentary, severance,
stamp, withholding, occupation, recording, value added or transfer taxes, customs taxes and any other taxes (whether payable directly,
by withholding or otherwise), together with any interest, fines, penalties, additions to tax, and additional amounts with respect
thereto; (ii) any liability for the Taxes of another Person; or (iii) any liability to any other Person for or in respect
of any of the foregoing items.

 

“Tax Liens”
shall have the meaning set forth in Section 1.4.11.

 

“Tax Return”
means any return, report, form, information return, declaration, statement, schedule or other similar document (including but not
limited to any related or supporting information and estimated or amended returns, reports, forms, information returns, declarations,
statements or schedules) and, in each case, any amendment thereof, relating to Taxes.

 

“Termination
Agreement” shall have the meaning set forth in Section 3.2.21.

 

“Third Party”
means any Person other than Purchaser, the Company, the Additional Parties, or an Affiliate of any of the foregoing.

 

“Third-Party
Claim” shall have the meaning set forth in Section 8.4.

 

“Trademarks”
means rights arising from or in respect to trademarks, service marks, trade names, logos, internet domain names and corporate names
(whether registered or unregistered, including any applications for registration of the foregoing), trade dress rights and general
intangibles of a like nature, industrial or product designs together with all of the goodwill associated therewith, and foreign
versions of the foregoing whether protected, created or arising under the laws of the United States or any other jurisdiction.

 

“Trade Secrets”
means rights arising from or in respect to trade secrets and other confidential information including, without limitation, ideas,
formulas, compositions, inventions (whether patentable or unpatentable and whether or not reduced to practice), know-how, concepts,
manufacturing and production processes and techniques, research and development information, drawings, specifications, designs,
plans, proposals, technical data, financial and marketing plans and customer and supplier lists and information whether defined,
protected, created or arising under the laws of the United States or any other jurisdiction, which are subject to reasonable efforts
under the circumstances to maintain their secrecy and which derive independent economic value, actual or potential, from not being
generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from their
disclosure or use.

 

 

 

 

    	 	A-11	 

     

    

 

“Transferred
Employee” shall have the meaning set forth in Section 6.5.1.

 

“Transferred
Governmental Authorizations” shall have the meaning set forth in Section 1.1.6.

 

“Transaction
Documents” means this Agreement, the Escrow Agreement, the Bill of Sale, the Assignment and Assumption Agreement, the
Intellectual Property Assignments, the Power of Attorney, the Company Restrictive Covenant Agreement, the Release, the VanLandingham
Employment Agreement, the VanLandingham Incentive Agreement, the VanLandingham Finder Agreement, the Lewandowski Agreement and
all other Contracts, instruments and certificates created in connection with the Contemplated Transactions; provided, however,
that, for the avoidance of doubt, the “Transaction Documents” shall not include the Charter Documents of the Company,
the books and records of the Company or any other document, instrument or certificate to the extent such other document, instrument
or certificate (or any portion thereof or attachment thereto) was not created by the parties hereto in connection with the Contemplated
Transactions.

 

“Transaction
Fees” shall mean all amounts due to lawyers, accountants and other professional service providers and all other expenses
incurred by or on behalf of the Company in connection with the negotiation of this Agreement and the consummation of the Contemplated
Transaction, including, without limitation, any amounts which the Company or any Additional Party may be obligated to pay to any
broker, finder or investment banker in connection with, and conditioned upon, the consummation of the Contemplated Transactions
or a transaction similar to the Contemplated Transaction.

 

“Transfer
Taxes” means sales, use, transfer, real property transfer, recording, documentary, stamp, registration, stock transfer
and other similar Taxes and fees (including any penalties and interest).

 

“USA Patriot
Act” shall have the meaning set forth in Section 4.35.1.

 

“VanLandingham
Employment Agreement” shall have the meaning set forth in Section 3.3.1.

 

“VanLandingham
Finder Agreement” shall have the meaning set forth in Section 3.3.1.

 

“VanLandingham
Incentive Agreement” shall have the meaning set forth in Section 3.3.1.

 

“WARN Act”
means the Worker Adjustment and Retraining Notification Act.

 

“Year-End
Financial Statements” means the Company’s balance sheets as of December 31, 2017, December 31, 2018 and December
31, 2019, and the related audited statements of operations, changes in stockholders’ equity and cash flow for each of the
years then ended.

 

 

 

 

 

 

    	 	A-12	 

     

    

 

EXHIBIT B

 

REVIVED US PATENTS

 

[attached]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

EXHIBIT
C

 

Revived
Foreign Patents 

 

[attached]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 1.1.3

 

Contracts, including Intellectual
Property Licenses and Contracts related to, PRV-002 and the Delivery Device

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 1.1.4

 

Intellectual Property
Assets for PRV-002 and the Delivery Device including chemical structure and device schematics.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 1.1.6

 

Licenses and Permits, including Environmental
Permits Transferred

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 1.2.5

 

Excluded Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 1.3

 

Excluded Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.1

 

Company’s Jurisdiction

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.2

 

Subsidiaries of the Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.4

 

Required Consents of the Company and the
Additional Parties

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.6.

 

Permitted Encumbrances

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.8.3

 

Tax Encumbrances

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.8.5

 

Tax Returns

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.9

 

Litigation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.10.1

 

Intellectual Property of the Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.10.6

 

List of all Contracts (including licenses
and sublicenses) pertaining to any Company Intellectual Property

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.10.11

 

Company Government Funding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.13

 

Environmental Matters

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.14

 

Inventory

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.15.1

 

Employees of the Business

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.15.2

 

Independent Contractors of the Business

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.15.4

 

Employee Plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.15.10

 

Acceleration Rights Triggered by this Agreement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.17

 

Licenses used in the operation of the Business

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

 

Schedule 4.18

 

Insurance Policies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.19

 

Twenty Largest Vendors – Last 12 Months

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.21

 

All Acquired Accounts Receivable of the
Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.23

 

Brokers

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.24

 

Product or Service Warranties

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.25

 

Product or Service Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule 4.26

 

Transaction with Affiliates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 

                                                                                 

                                                                                 

                                                                                 
	 

     

    

 

 

Schedule 4.30

 

Material Changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	 	 

     

    

 

Schedule A

 

Regulatory Information

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]